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Abstract
Background
In recent years there are a number of reports showing a deterioration in male
reproductive health, i.e. diminished semen quality and increases in the incidence of
testicular cancer and the congenital malformations cryptorchidism and hypospadias.
It is hypothesised that these changes have been caused by increasing in utero
exposure to environmental oestrogens and/or anti-androgens.
Objectives
(i) Describe the geographical distributions of three indicators of male
reproductive health in Scotland (i.e. testicular cancer, cryptorchidism and
hypospadias).
(ii) Describe the conjoint geographical distribution of the three indicators
specified in (i).
(iii) Identify explanatory factors that might account for the geographical
distribution of male reproductive health in Scotland.
Methods
An epidemiology study modelling the geographical distributions using routinely
collected data of the three indicators. The primary assessment of the geographical
distribution of the indicators was by means of the relative risks at postcode sector
level. If geographically varying risk factors (environmental or not) are associated
with these conditions then would expect to see clustering of relative risks. Bayesian
methods were used to estimate the relative risks so as to account for their variability
due to areas with small number of cases. These Bayesian models were developed
further by including potential covariates to assess if these area specific factors
explain the spatial variation of the three indicators. In addition, Bayesian modelling
of individual data pertaining to the cryptorchidism cases was also carried out to
explore whether the spatial variation in risk might also be explained by the nature of
the cases within each postcode sector rather than area specific covariates. Finally, a
Bayesian model which combined all three indicators was developed to examine the
spatial relationships between the three disease/conditions.
ii
There are similarities in the spatial pattern of the cryptorchidism and hypospadias
relative risks, with both conditions having clusters of high relative risks in the East
and South-West of Scotland. The spatial variation of the testicular cancer relative
risks is not similar to the other two conditions nor is it conclusive that it has a distinct
spatial pattern. The relative risks of the postcode sectors for all the indicators are
associated with radon measurements and the rural/urban indicator. The spatial
analysis of individual information concerning the cryptorchidism cases indicate that
the spatial variation of the relative risks might also be explained by individual
information; namely maternal age and co-morbidity with hypospadias.
Conclusions
There does appear to be geographically varying risk factors associated with these
three conditions. Furthermore, as the spatial variation of cryptorchidism and
hypospadias is similar it is likely that they have some common aetiology. As the
same risk factors were found to be associated with testicular cancer and the
congenital malformations, then this carcinoma appears to share some aetiology with
cryptorchidism and hypospadias. Therefore there are geographically varying risk
factors whose exposure occurs in utero, that are associated with all three conditions,
providing some evidence to support the proposed hypothesis. Flowever, the common
aetiology of these conditions could not only to be environmental but also due to
genetic and life-style factors, that could pertain to the individual cases rather than the
specific area. Therefore, further studies are required to investigate the associations
between all the disease/conditions of male reproductive heath and the various
potential risk factors.
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Spatial Epidemiology of Indicators of Male Reproductive Health in Scotland
Chapter 1 : Introduction
Over recent decades, there have been growing concerns regarding men's
reproductive health. These concerns stem from several reports in various countries
showing that over time semen quality has declined, testicular cancer incidence has
increased and the incidence of the congenital malformations cryptorchidism and
hypospadias have risen.
It has been postulated that this reported decline in male reproductive health is a result
of increasing exposure in utero to particular environmental chemicals, and that the
various conditions associated with male reproductive health are varying degrees of
one underlying entity - Testicular dysgenesis syndrome (TDS).
However, these statements as regards male reproductive health remain controversial.
Firstly, the evidence that shows temporal or geographical differences is not robust for
some of these conditions. Furthermore, other potential risk factors not related to the
proposed in utero environmental exposure may also be involved in any proposed
temporal and geographical differences in these conditions. Finally that evidence
showing associations between these conditions is limited.
Chapter 2 outlines these debates regarding male reproductive health. Firstly, the
evidence used to argue that there has been a decline in male reproductive health and
that these changes are due to a common environmental aetiology is reviewed for each
disease/condition. Secondly, the proposed TDS hypothesis is discussed in terms of
the known aetiology and biology of the conditions.
The review of the evidence used to show a decline in male reproductive health
highlights that there are concerns about the robustness of this research for certain
conditions. Therefore doubts remain that there are either temporal or geographical
differences for some of these conditions. If the differences in conditions over space
and time could be due to differences in data quality then the basis for the proposed
changes in in utero environmental exposure is undermined. Furthermore, the
examination of the current literature shows the complex nature of the known
aetiology of all of these conditions. Subsequently, the testicular dysgenesis syndrome
hypothesis might not be the only possible explanation for the proposed decline in
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these conditions and that other non in utero environmental risk factors might be
involved.
Therefore, there would appear to be a number of unresolved issues from previous
male reproductive health research, which this research project aims to address. The
aims of the research project are to:
(i) Describe the geographical distributions of three indicators of male
reproductive health in Scotland (i.e. testicular cancer, cryptorchidism and
hypospadias).
(ii) Describe the conjoint geographical distribution of the three indicators
specified in (i).
(iii) Identify explanatory factors that might account for the geographical
distribution of male reproductive health in Scotland.
The use of consistently collected high-quality data in this analysis would overcome
concerns of some of the previous research on these conditions. Furthermore, a
combined analysis of these conditions, would take into account all aspects of the
proposed syndrome TDS, rather than focusing on one condition and so explore
possible relationships. Finally, the exploration of potential risk factors would take
into account that more than one risk factor could be involved and that they could be
involved in all the conditions aetiology or specific ones.
Chapter 3 outlines the methods used to achieve these aims, i.e. the data used and the
analysis carried out. As the study is a spatial epidemiological analysis, this is a key
theme of this chapter. The concepts of spatial epidemiology are introduced and the
particular spatial analysis methods used are outlined. As the spatial analysis is based
on Bayesian Methods, these too are introduced.
The next four chapters provide the results of the spatial analysis, the first three of
which are disease-specific.
The cryptorchidism analysis (Chapter 4) shows that there is distinct pattern to the
relative risks per postcode sector estimated from the Bayesian Hierarchical models.
There are clusters of higher relative risks in the East and South-West and clusters of
lower relative risks in the North and a corridor reaching from the central Borders to
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the West Coast of Scotland. This spatial pattern of the cryptorchidism relative risks
appeared to be explained by a rural/urban indicator (population density) and two
-2
radon measurements - mean radon level Bq/m within each postcode area and the
"2
proportion of measurements within a postcode area that exceeds 200 Bq/m . The
spatial variation of cryptorchidism could also be explained by information
concerning the cases themselves; namely maternal age and co-morbidity with
hypospadias.
The spatial pattern of the hypospadias relative risks (Chapter 5) was very similar to
those for cryptorchidism, suggesting at common aetiology. The spatial variation of
hypospadias was also explained by the rural/urban indicator and one of the radon
measurements namely, the proportion of measurements within a postcode area that
exceeds 200 Bq/m , but not the mean radon level. Again, suggesting some common
aetiology.
The spatial pattern of the testicular cancer relative risk (Chapter 6) was not similar to
the cryptorchidism or hypospadias cases. Furthermore, it is inconclusive that there
was a distinct spatial pattern to the variation in relative risks. However there was
some evidence that higher relative risks were clustered in the far North and South,
with lower relative risks in a region from the Central Belt to the South West.
Although the spatial variation of the testicular cancer relative risk was different from
the cryptorchidism and hypospadias, it too was explained by the rural/urban
"2
indicator, and the mean radon level Bq/m within each postcode area.
The final results chapter provides a combined analysis of the three disease/conditions
(Chapter 7). This analysis confirms the similarities between the spatial patterns of
cryptorchidism and hypospadias, and the dissimilarities between these two
congenital malformations and testicular cancer.
The final chapter brings together the results raised from the analysis in context of the
study aims and current male reproductive health research. From this analysis there
appears to be geographically varying risk factors, whose exposure occurs in utero,
that are associated with these three conditions. Furthermore, the analysis provides
evidence of common aetiology particularly between cryptorchidism and hypospadias.
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The exploration of possible aetiology shows that various risk factors are associated
with these conditions and reflect that both environmental, genetic and life-style
factors may explain the geographical differences. Further studies are required to
explore the aetiologies of these conditions in order to answer this important health
question, and a number of directions are suggested in the conclusion of the
discussion chapter.
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Chapter 2 : Male Reproductive Health
2.1 Introduction
In recent years there has been accumulating evidence of a deterioration in male
reproductive health, in terms of semen quality, testicular cancer and the congenital
malformations cryptorchidism and hypospadias. It is hypothesised that these changes
in male reproductive health are a result of increasing in utero exposure to
environmental oestrogens and anti-androgens. However this hypothesis and some of
the evidence that led to the concerns regarding male reproductive health are
controversial.
This chapter reviews previous male reproductive health research and highlights
remaining questions and uncertainties. The research presented here aims to examine
the arguments and research put forward to suggest that male reproductive health is in
decline, and the hypothesis postulated to explain these changes. Firstly, the evidence
that has been used to show a decline in the indicators of male reproductive health,
namely testicular cancer, cryptorchidism, hypospadias and semen quality is
considered in terms of the known aetiology and morphology of each condition.
Furthermore, the argument that these conditions have some common aetiology is also
examined within the same context. Finally, the hypothesis known as Testicular
Dysgenesis Syndrome (TDS), which is postulated to explain the adverse trends in
male reproductive health, is then reviewed taking into consideration the previously
outlined background of the various conditions.
Therefore this chapter describes the concerns in relation to male reproductive health
and highlights the outstanding issues raised from the previous research. While not all
these issues are addressed by this research project it is necessary to discuss them. As
the research project carried out stems from the concerns in relation to male
reproductive health and the proposed environmental aetiology, the previous research
needs to be examined to place the project in context.
Chapter 2: Male Reproductive Health 5
Spatial Epidemiology of Indicators of Male Reproductive Health in Scotland
2.2 Evidence for a decline in male reproductive health
As will be shown in this section, the evidence of a temporal decline is not conclusive
for all conditions related to male reproductive health. This is largely due to the
quality of data previously used to show a decline in certain conditions and investigate
their aetiology. Therefore, the proposed decline in male reproductive health could be
based on limited evidence for particular conditions, and so any research into these
conditions should aim to overcome the limitations of previous research.
Furthermore, while there is some evidence of common aetiology for these conditions,
other risk factors that are not relevant to the proposed in utero environmental
exposure hypothesis also have important associations with the various conditions.
Consequently, these other risk factors might in part explain variations in the
conditions - either temporal or geographical, and so they should be considered when
any research of these indicators is carried out.
Each of the conditions related to the decline in male reproductive health are
discussed separately. The reports of a temporal decline in each condition are
discussed in relation to the known aetiology of each. The morphology of each of the
conditions is outlined first so as to provide the necessary background required to
review and so understand their aetiology and epidemiology.
Although this research project is a geographical based one, as can be seen this is not
the emphasis of the literature reviewed here. The temporal changes in the various
conditions are examined in detail as these reports instigated the concerns in relation
to male reproductive health. Also, the changes over time in the conditions were used
as evidence to argue an environmental cause to the decline in male reproductive
health. Furthermore, little geographical analysis has been carried out on these
conditions, even though there is a proposed environmental aetiology. However,
where geographical analysis has been done on certain conditions, it is discussed.
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2.2.1 Testicular Cancer
While testicular cancer represents only 1% of cancers in men overall, it is the most
common malignancy in men aged 15 to 35 (Bringhurst and Amato, 2002).
Furthermore, there is considerable evidence that the incidence of testicular cancer
has risen over the last 60 years in Western Europe, Japan and the USA (Irvine,
2001). This section will review the current literature concerning testicular cancer in
relation to these two statements. Firstly, the morphology, natural history, treatment
and prognosis will be outlined to provide an overview of the disease. Secondly a
review of the known epidemiology and aetiology of testicular cancer will highlight
the disease's place in the current concerns regarding male reproductive health.
2.2.1.1 Morphology of testicular cancer
As outlined in a review of its oncology, testicular cancer is a general term for several
distinct but related neoplasms (Bringhurst and Amato, 2002). The neoplasms are
distinct in their incidence (age and rates) and prognosis as well as their pathology,
although there are overlaps between them. According to the oncology review, an
epidemiology review of the disease (Buetow, 1995) and a summary of its pathology
(Robbins et al., 1999), there are several methods of morphology classification used
across the world. Furthermore there are a large number of morphological types of
testicular cancer within each of the classifications used. This has resulted in
confusion and difficulties in comparing across classifications of neoplasms.
However, these reviews suggest that the main differentiation between the neoplasms
is whether they are germ-cell or non germ-cell. As noted in the oncological review,
the majority (93%) of primary testicular cancer cases are germ-cell neoplasms
(Bringhurst and Amato, 2002). As the non germ-cell neoplasms are of low
prevalence, the sub-categories of these neoplasms are not detailed here.
Within the germ-cell neoplasms classification there are two groups of malignancies,
the seminomas group and the nonseminomatous tumour group (NSGCT). These are
different from a clinical standpoint both in terms of treatment and prognosis and also
prevalence. While within each group of tumours there are further sub-classifications
with differing pathology, the main differences are between the two germ-cell groups.
For instance, while the tumours within the categories in the NSGCTs group are
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diverse, they frequently present together. In general, the NSGCTs present in specific
age groups while seminomas present at a broad age range and are generally slower to
spread and less aggressive than the NSGCTs.
In the germ-cell neoplasm group there is also a non-malignant germ cells known as
carcinoma-in-situ (CIS). These cells are known as precursors to testicular cancer, for
example, a study found that 7 years from incidence of CIS, 70% of cases have
progressed to malignancy and none had regressed (Skakkebaek, Berthelsen, and
Muller, 1982). Furthermore, between 75% and 99% of testicular cancer tumours are
found with CIS adjacent to them (Gondos, Berthelsen, and Skakkebaek, 1983). As
will be seen in the overview of the disease's epidemiology, the aetiology of these
non-malignant cells could give an insight into the aetiology of testicular cancer.
The different classifications for testicular cancer have different methods of diagnosis
and treatment. While the diagnosis and treatments methods, are dependent on the
morphology category of testicular cancer, generally for all cases the prognosis of the
disease is good. A study of trends in testicular cancer cases in England and Wales
between 1971 and 1999 found that the age-standardised mortality rate decreased by
71%; from 1.0 per 100,000 to 0.3 per 100,000 (Power et al., 2001). The increase in
survival rate has led to the misperception that the increase in incidence of testicular
cancer is as a result of better diagnosis and treatment. However, as noted by Sharpe,
while treatment has improved the diagnosis of testicular cancer has been consistently
accurate (Sharpe, 2002). Therefore the increase in incidence outlined next is due to
reasons other than better diagnosis.
2.2.1.2 Epidemiology and aetiology of testicular cancer
Many studies have found increases in the incidence of testicular cancer in developed
countries. The study of trends in testicular cancer cases in England and Wales
between 1971 and 1999, mentioned previously in relation to survival, also found an
88% increase in the age standardised incidence rates; from 2.9 per 100,000 in 1971
to 5.4 per 100,000 in 1997 (Power et al., 2001). Adami et al. compared the incidence
of testicular cancer in nine Northern European countries from as far back as 1943
through to 1989 (Adami et al., 1994). They observed increases in the age-
standardised incidence rates in all the countries; between 2.3 to 3.4 per cent annually
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in the Nordic countries and by about 5 per cent in Poland and Germany. Another
comparison in Europe, this time of six countries, again found increases in testicular
cancer incidence; ranging from 2.3% increase annually in Sweden to 5.2% annually
in East Germany (Bergstrom et al., 1996). According to data from the Surveillance,
Epidemiology and End Results Programme (SEER), in the US, the incidence of
testicular cancer has increased by 51% from 3.61 per 100,000 in 1973 to 5.44 per
100,000 in 1995, (McKiernan et al., 1999).
While there is very strong evidence of an increase in incidence of testicular cancer
across the developed world, there are a few exceptions to this trend. For example, the
incidence in the African-American population has not risen over time and has
remained at a low rate (Van Den Eeden and Weiss, 1989). Also, a high annual
incidence of 10 per 100,000 has remained stable between 1974 and 1987 in the
Canton Vaude, Switzerland (Levi, Te, and La Vecchia, 1990). Furthermore, studies
that have shown an increase in incidence have also reported a stabilising of rates in
the most recent years. For example, further analysis of the SEER data showed that
the rates of incidence of testicular cancer levelled off in the early 1990's (Pharris-
Ciurej, Cook, and Weiss, 1999). And while an analysis of the incidence trends of
Denmark showed an increase of 2.6% per year from 1943 to 1996, it also suggested
that the incidence rates stabilised for birth cohorts after 1963.
The testicular cancer registry data used in these studies have on the whole been
consistently recorded and any changes in registration or diagnosis can explain little
of the overall rise in incidence (Buetow, 1995). For example, the comparisons of
European countries examined differences in ascertainment and found that even when
these were accounted for, there still appeared to be changes in time and between
countries (Adami et al. 1994; Bergstrom et al. 1996).
Therefore the evidence does indicate that there has been an increase in incidence of
testicular cancer over time, and that geographical differences occur. These and other
studies have been used to suggest that this is a result of increasing geographically
varying environmental factors namely in utero exposure to environmental oestrogens
and anti-androgens, in combination with a genetic predisposition. Furthermore,
previous studies have been used to argue that environmental rather than genetic
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factors are the most important. However separating out genetic and/or environmental
factors' roles in the risk of testicular cancer is very difficult and might not be
appropriate, as it could be an interaction between the two. Also, as will be seen it is
far from clear that these are the only potential mechanisms to explain the increase in
testicular cancer incidence.
Bergstrom et al.'s comparison of six European countries found that birth cohort was
a stronger effect on testicular cancer risk than year of incidence. For example, men
born in 1965 had a risk of developing testicular cancer that was 3.9 (Sweden) to 11.4
times (East Germany) higher than for men born in 1905. Other studies have also
found that later year of birth is associated with increased testicular cancer risk
(Toppari et al., 1996;Zheng et al., 1996). It is argued that the association between the
increase in risk and when the man was born suggests that whatever is causing these
changes only occurred in relatively recent years. Therefore it would suggest
environmental factors rather than an accumulation of genetic defects are at play.
However, the association between birth cohort and increasing risk are more likely to
be a genetic/environmental interaction. In fact, 80% of germ cell tumours have found
to have a chromosomal abnormality of the isochromosome i(12p).
There are studies that provide evidence that there is 'genetic pre-disposition' to
testicular cancer. It has also been found that fathers of testis cancer sufferers have an
increased risk (1.96; 95% CI: 1.01-3.43) of the disease, and that brothers of a
subcohort of these men with testicular cancer have an even higher risk (RR = 12.3;
95% CI: 3.37-31.5) (Westergaard et al., 1996). Furthermore, twins of brothers who
have had testicular cancer have a 12 to 37 fold increased risk of testicular cancer
(Swerdlow et al., 1997). These studies support the possibility that genetic factors
may be involved in the development of testicular cancer. However, they could also
support the possibility of similar environmental conditions, particularly in siblings
(Irvine, 1999).
The comparisons of country specific rates have been used to show a geographical
variation of the incidence of testicular cancer. However, only one study appears to
have looked at the spatial variation of testicular cancer at a small area level
(Toledano et al., 2001). This analysis looked at electoral ward variation in incidence
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in two regions of Great Britain (North West Thames and Yorkshire) to represent a
diverse mix of urban, suburban and rural populations. No local spatial variation in
the incidence of testicular cancer was found. This could be because no spatially
varying factor is associated with testicular cancer, but also because of the long
latency periods between incidence and the possible exposure in utero, and the effects
of migration. With a long latency period, the chance of an individual moving is
increased, and this might be within, out or into the particular region studied.
Therefore the spatial variation of the incidence of testicular cancer will reflect this
migration rather the geographical variation of the underlying potential exposure. This
is particular relevant to the regions studied as both include metropolitan areas so
increasing the likelihood of migration. Furthermore, the age range of highest
incidence of testicular cancer is the 20's and 30's which is when the highest rates of
migration occur.
Other studies have found associations between testicular cancer and other indicators
of male reproductive health which might indicate that they have a common aetiology.
The strongest risk factor for testicular cancer found so far is cryptorchidism. One
study in Denmark estimated that men with a history of cryptorchidism had a 3.6 fold
(95% CI 1.8-6.9) increased risk of developing testicular cancer (Moller, Prener, and
Skakkebaek, 1996) while another study also in Denmark found a 5.2 fold risk (95%
CI 2.1-13.0) (Prener, Engholm, and Jensen, 1996). Perner and colleagues also found
an association with other congenital malformations such as inguinal hernia,
hypospadias and hydrocoele and the risk of testicular cancer. Other studies have
found strong associations between testicular cancer risk and cryptorchidism in other
settings (Forman et al., 1994;Weir et al., 2000).
While cryptorchidism has the strongest association with testicular cancer risk
(Buetow, 1995), there are other possible reasons for this rather than just common
aetiology. The continual higher local temperature could result in damage to the
testes, and an undescended testis might be more likely to be abnormal than a partly
or fully descended one. Both of these scenarios have the potential of resulting in
neoplasms in the future, although there is conflicting evidence on which holds true.
Furthermore, it is unclear if the potential damage to the testes is reversed by the
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correction of cryptorchidism, irrespective of age (Buetow, 1995). Therefore, the
association between testicular cancer and cryptorchidism could well be due to a
common aetiology but other mechanisms could also explain the relationship.
It has been suggested that the geographical variation of testicular cancer might be
linked to similar differences in semen quality so they too might have the same
aetiology (Irvine, 1999). For example, testicular cancer is four times more common
in Denmark than Finland, while studies have shown that sperm counts are rather low
in Denmark (Jensen et al., 1996) and semen quality appears to be better in Finland
(Vierula et al., 1996). While the testicular cancer data are consistently collected
across both time and registries, this cannot be said of the semen quality data. As will
be discussed in the review of the semen quality literature, there are considerable
inconsistencies between studies of semen quality, i.e. study participants, sample
collection and analysis, meaning that comparisons between them are flawed.
Although the aetiology of testicular cancer is still largely unknown, some other risk
factors have been identified. For instance, recent socio-economic changes have
meant a higher intake of fat and a more sedentary lifestyle, both of which have been
associated with testicular cancer, particularly during childhood (Buetow, 1995).
Childhood trauma/injury and illness such a mumps and meningitis have also been
found to increase the risk of testicular cancer, although recall bias can not be ruled
out in relation to trauma/injury. Therefore, if in utero exposure to environmental
chemicals does result in an increase risk in testicular cancer, there are other potential
risk factors that might also contribute, and research identifying which risk factors are
the most important has been limited.
Finally, as mentioned earlier CIS cells are known as precursors to testicular cancer
and the aetiology of such cells might shed light on possible risk factors for the
malignancy. It has been found that they originate during foetal life and that
subnormal androgen exposure and/or increased oestrogen exposure are risk factors
(Slowikowska-Hilczer, Walczak-Jedrzejowska, and Kula, 2001), so giving some
credence to the in utero environmental exposure hypothesis. However, the reasons
for and the biological mechanism for the development of these germ cells is still
unclear.
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2.2.1.3 Summary ofprevious research of testicular cancer
There is evidence that the incidence of testicular cancer has increased over the last 60
years, however it is unclear why this has happened. There is evidence of an
environmental/genetic interaction and that changes in socio-economic factors have
resulted in some of the increase. It has been argued that the associations between
testicular cancer and other conditions of male reproductive health are due to common
aetiology, however this is not conclusive. Furthermore, while the aetiology of CIS
cells, the precursors to testicular cancer, indicate an origin in foetal life and an
association with hormones, there development and aetiology is largely unclear.
Therefore, while there has been an increase in incidence in testicular cancer over
time, it can not be shown that this is largely due to increasing in utero exposure to
environmental chemicals.
2.2.2 Hypospadias
The estimates of birth prevalence of hypospadias ranges from 0.2 to 2% (Kallen et
ah, 1986). As with testicular cancer there have been reports of an increase in the
prevalence of the congenital malformation of the male genital tract hypospadias over
time (Paulozzi, Erickson, and Jackson, 1997), however the evidence for this is not as
conclusive as with the sarcoma. This section will provide an overview of previous
research that show both an increase and decline in the prevalence of this condition
and reflect on these differing results. However, firstly a description of hypospadias
will provide an overview of the condition.
2.2.2.1 Morphology of hypospadias
Hypospadias is an abnormality of the location of the urethral opening on the shaft of
the penis. It is believed to be as a result of a congenial defect of the urethral
development that occurs embryologically. As it is a congenital malformation it is
usually detected at birth and treatment is surgical repair. Previously, surgery was
carried out from age 3 years onwards, as the procedure would be technically easier
with a larger penis. However, from the 1980's, most surgery has been carried out
when the child is 6-18 months so as to limit possible emotional and psychological
trauma (Duckett, 1998).
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The most used classification of hypospadias is based on the location of the abnormal
urethral opening as outlined by Duckett (1998). There are 3 classifications which are
of increasing severity i.e. location from normality - anterior (glandular and
subcoronal), middle (distal penile, midshaft and proximal penile) and posterior
(penoscrotal, scrotal and perineal). The most common of these is anterior (50% of
cases), followed by posterior (30%) and middle (20%), so the least severe of
hypospadias cases are also the most common.
2.2.2.2 Epidemiology and aetiology of hypospadias
The first reports showing increases over time in hypospadias prevalence came from
birth defect monitoring programmes in different countries including several
European countries, such as Norway (Bjerkedal and Bakketeig, 1975), Sweden
(Kallen and Winberg, 1982), Denmark (Kallen et al., 1986), England and Wales
(Matlai and Beral, 1985) and also the United States (ICBDMS, 1991).
However the registering of hypospadias and other malformations has not been
standard across registries and time, making comparisons across countries and time
unreliable (Toppari, Kaleva, and Virtanen, 2001). In particular, the increasing
sensitivity of surveillance systems might explain the apparent increase in cases,
especially the least severe cases. As already mentioned the least severe cases are also
the most common and so would make a greater impact on the prevalence rates.
But it is still not clear that the changing sensitivity of the surveillance systems would
fully account for the entire temporal trend. In a retrospective review of two neonatal
intensive care units (NICU) in Connecticut a 10-fold (0.4% to 4%) higher incidence
of hypospadias admissions was found from 1987 to 2000. As these admissions to
intensive care would have been more likely to be severe cases, it is argued that it is
unlikely that increased sensitivity of reporting would have accounted for the changes
over time. However, it is not clear if the threshold for 'severe' cases has also shifted
and as the change in incidence in the NICU population is based on the percentage of
admissions, shifts in admission policies for both hypospadias cases and other
conditions might affect the admission rates.
Further analysis of the ICBDMS data mentioned previously highlighted the different
experiences of hypospadias globally (Paulozzi, 1999). Those registries which saw
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increases included Atlanta (from 17 cases per 10,000 births in 1968 to 31 cases per
10,000 births), Norway and Demark (doubling of mild hypospadias cases in 1970s
and 1980s) as well as other European countries and Japan. At the same time other
systems did not experience these increases - California showed no upward trends,
incidence actually fell in the 1980s in northern Netherlands and remained constant in
China, Hungary, Mexico and South America. Furthermore, many of those systems
that did show an increase in incidence appeared to plateau after 1985.
The author of this analysis did note that differences in registrations meant that it was
unclear if increases in incidence had taken place. However, another study was able to
show that geographical differences between rates of hypospadias could not wholly be
explained by ascertainment differences. Seven malformation international
surveillance systems were analysed and, on taking account of differences in
ascertainment, still found geographical variations in the prevalence of hypospadias
(Kallen et al., 1986). This reported geographical variation in hypospadias has been
used to argue that environmental and/or genetic factors are associated with this
condition. However as it is not clear that the different surveillance systems are
comparable then any conclusions based on any apparent differences are dubious.
The reported risk factors for hypospadias show that, as with testicular cancer, various
potential mechanisms could result in this condition. In the previously mentioned
descriptive epidemiological study of data concerning hypospadias from seven
surveillance systems across the world, the study group found a correlation between
hypospadias and increasing maternal age, parity, lower birth weight, shorter
gestational age, seasonality and male-male twin births (both monozygotic and
dizygotic) (Kallen et al., 1986). Therefore while the in utero environment is
associated with hypospadias, it is not clear that this milieu is only a result of
environmental chemicals or also due to other socio-economic and life-style factors.
As already mentioned in relation to testicular cancer, hypospadias has been reported
to be a risk factor for the development of this cancer (Prener et al., 1996); also men
with cryptorchidism and/or hypospadias were overrepresented among patients with
testicular cancer (Giwercman, Muller, and Skakkebaek, 1988). Furthermore, Kallen
et al. (1986) found a correlation between the prevalence of isolated hypospadias at
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birth and decreasing fertility in a population, it has also been reported that impaired
semen quality was found in fathers of boys with hypospadias (Fritz and Czeizel,
1996). However as already discussed in relation to testicular cancer it is not possible
to ascertain if these associations are due to a common environmental aetiology
and/or due to other risk factors.
2.2.2.3 Summary ofprevious research of hypospadias
Therefore, there is evidence that hypospadias might have increased in particular
countries and that there are geographical differences in the rates. The possible risk
factors for this condition point to the intrauterine environment and there is some
evidence of a relationship between hypospadias and other conditions of male
reproductive health.
However, any results from these reports are inconclusive due to data quality issues
raised by the use of registry-based data. As recommended by Toppari et al. (2001),
further epidemiological studies should be based on cohort data with standardised
diagnostic criteria, and this has begun to be implemented. Also, if registry data are
used that they are consistent in classification over time and a thorough assessment of
data collection systems, from which the data are derived, should be carried out before
their use.
2.2.3 Cryptorchidism
Cryptorchidism is the most common congenital malformation presented with a birth
prevalence estimated as ranging from 1 and 3%. As with hypospadias and testicular
cancer there are reports showing increases in the incidence of this congenital
malformation of the male genital tract (Ansell et al., 1992). However, as with
hypospadias the evidence is inconclusive.
2.2.3.1 Morphology of cryptorchidism
Cryptorchidism literally means hidden or obscure testis and refers to an undescended
or maldescended testis (Kolon, 2002). The most useful clinical classification of
cryptorchidism is whether the testes are apparent upon physical examination. If not
apparent the testes may be intra-abdominal or absent, while if palpable they may be
undescended, ectopic or retractile. Treatment is dependent on the classification of
cryptorchidism i.e. the presence and location of testes. In some cases manipulation of
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the scrotum may resolve the problem and spontaneous descent of the testes can occur
up to the age of 1 year. When one of these scenarios is not possible or does not occur
then either hormonal treatment or surgery would be carried out, depending on the
severity of the condition. Previously, these treatments were carried out at older ages
than the now usual age of approximately 1 year (Docimo, 1995). This reduction in
the age of treatment is in response to the evidence that spontaneous descent rarely
occurs after 1 year and that earlier treatment results in improved fertility.
Unlike the other congenital malformation hypospadias, cryptorchidism is not always
identified at birth. Furthermore, as we have already seen spontaneous descent of the
testes can occur up until the boy is 1 year. These elements of its morphology have an
impact on the results of previous research of cryptorchidism epidemiology.
2.2.3.2 Epidemiology and aetiology of cryptorchidism
The body of evidence showing an increase in prevalence of cryptorchidism is not as
strong as that for hypospadias. One of the first published studies of cryptorchidism
has been used as a reference point for future work as case ascertainment was
assessed as accurate as they were based on well-defined classifications (Scorer,
1964). He found that the percentage of boys born in a London hospital with
cryptorchidism was 21% for those boys born weighing less than 2,500g, while 2.7%
of boys born weighing 2,500g and more were identified with cryptorchidism. These
children were followed for one year and at 3 months the relevant percentages had
reduced to 1.7% and 0.9% respectively.
Following on from this research, that identified that low birth weight is associated
with cryptorchidism, a larger UK study that used the same criteria showed that the
cryptorchidism rate at birth had increased by 35.1% and at 3 months by 92.7% over
the 30 years from the 1950s (Ansell et al., 1992).
However, other studies of international data do not mirror these results. Paulozzi's
(1999) analysis of the ICBDMS data for hypospadias, as discussed previously, also
included analysis of the equivalent cryptorchidism data. This analysis showed even
greater differences between countries in the temporal trends of cryptorchidism
compared to hypospadias. In South America and Denmark increases over time were
shown, and while increases were found in the U.S in the 1970s and 1980s the rates
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have fallen there since 1985. Furthermore, no changes in incidence were found in the
20 years from 1976 in either Norway or France.
The cryptorchidism data, like the hypospadias data, has limitations as it also based on
registry data (Toppari et al., 2001), so any comparisons across both time and
geography are constrained in what conclusions can be made. This can be underlined
by results from Paulozzi (1999) on cryptorchidism rates in England. While rates
initially rose, they fell from 1990 onwards, probably due to the tightening of
inclusion criteria at the same time.
Another issue that will have affected the recorded rates of cryptorchidism over time
and between surveillance systems is the morphology and natural history of
cryptorchidism. As cryptorchidism is not always identified at birth and testes can
spontaneously descend, case ascertainment depends on individual clinician's
practice. For example, mild cryptorchidism might be identified at birth or not, and if
identified the clinician may not record as they might wait to see if it persists. It would
appear that these potential ascertainment differences are less relevant to identifying a
hypospadias case, as it is more clearly identified at birth and largely treated with
surgery (Duckett, 1998). Therefore although problems have been identified with the
ascertainment of hypospadias cases, the problems appear to be more acute with the
cryptorchidism data.
Although even less research has been published on the aetiology of cryptorchidism it,
like hypospadias, appears to be associated with the in utero environment. But, as like
hypospadias, it is not clear what is causing the changes in utero - chemicals, socio¬
economic or life-style factors. Two studies have suggested that possible risk factors
for cryptorchidism include maternal obesity, low birth weight, preterm delivery, the
presence of other congenital malformations, ethnic group and a family history of the
condition (Berkowitz et al., 1995;Berkowitz and Lapinski, 1996). Furthermore, a
strong association between cryptorchidism and low social class has been suggested
(Moller and Skakkebaek, 1996).
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2.2.3.3 Summary of previous research of cryptorchidism
There are strong reservations concerning the results showing increases in
cryptorchidism rates, and these appear to be more well-founded than concerns over
hypospadias data. Therefore it is more pertinent that the recommendations of Toppari
et al. (2001), concerning the collection of hypospadias and cryptorchidism data in
further epidemiological studies should be adhered to. Until these more consistent
data are presented we can not be sure that any temporal increase in cryptorchidism
has occurred. Furthermore, as there are differences in the registry data, any
geographical differences that might be found would be suspect. Therefore,
consistently collected cryptorchidism data would mean it is possible to investigate
more reliably differences over geography and time.
Finally, while the little research carried out on the possible risk factors for
cryptorchidism point to the intrauterine environment, it is not clear if this is a result
of environmental chemicals, socio-economic or lifestyle factors.
2.2.4 Decline in Semen Quality
Much of the controversy that surrounds the postulated decline in male reproductive
health stems from the reporting of a secular decrease in semen quality. While the
reporting of a temporal decline in semen quality in itself would cause controversy,
the research carried out raised questions and debate. This research project does not
include analysis of semen quality data; however this discussion of previous research
highlights the outstanding issues in relation to male reproductive health generally.
The debates stem from the first meta-analysis of worldwide semen quality in normal
men (Carlsen et al., 1992). Exclusions from the meta-analysis were data on infertile
couples, men selected on the basis of their fertility and data generated using non
classical approaches to semen analysis. Data included have been published in 61
English language papers between 1938 and 1990, and there were semen results for
14,947 men. The meta-analysis found that sperm concentration had declined from
113 x 106/ml in 1940 to 66 x 106/ml in 1990. It was also reported that the average
age of the men studied did not change with time and that age appeared to have no
influence on the observed secular trend. The authors hypothesised that racial.
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geographical and other factors could explain these changes over time; although they
did concede that there were methodological limitations to the analysis.
The publication of this analysis ignited the debate about the possible decline in
semen quality. However, a debate was ignited about the report itself. In particular
about the data used and the analysis carried out. Several papers were published
following this report that provided reanalysis and reinterpretations of these data
which highlighted several criticisms. These included the inappropriate use of linear
regression and issues inherent to meta-analysis i.e. differences in subject selection/
recruitment, time periods and laboratory methodology between studies, as well as the
potential for controlling for confounding variables (e.g. age of men and abstinence
time) being limited (Brake and Krause, 1992;Bromwich et al., 1994;Farrow,
1994;01sen et al., 1995).
Following these papers, part of the data from the Carlsen 1992 paper were re-
analysed which took account of the criticisms (Swan, Elkin, and Fenster, 1997). The
analysis used 54 of the 61 studies used in the original paper and carried out logistic
regression that attempted to control for abstinence, age, proven fertility, different
semen sample collection methods and location. The aim of this analysis was to
examine geographical differences in semen quality and any associations between
region and year - differing results were found depending on region. While a
significant decline in semen density in the United States and Europe, albeit not to the
same extent as in the Carlsen 1992 paper, there was no such pattern in non-Western
countries. A further expansion of the meta-analysis was carried out by the same
research group three years later (Swan, Elkin, and Fenster, 2000), which included a
further 47 studies. They found the same average decline in sperm count as reported
by Swan et al., (1997).
Several other studies were carried out following the Carlsen 1992 meta-analysis but
they too have failed to come to a consensus. (Auger et al., 1995) analysed semen
data from 1,750 men in Paris of proven fertility resulting from consistent methods of
recruitment and laboratory techniques. As well as showing a decrease over time in all
the classical parameters of semen quality they were also able to look at the effect of
age and year of birth while taking account of other factors that may affect sperm
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concentration, such as abstinence. They still found a reduction of 2.6% in sperm
concentration with each year of birth and less dramatic reductions in other
parameters of semen quality. In Scotland of 577 unselected candidate semen donors
born between 1951 and 1973, the median sperm concentration decreased from 98 x
106/ml from donors born before 1959 to 78 x 106/ml from donors born after 1970
(Irvine et al., 1996).
Recently, a study of Danish military conscripts aged 18-20 showed a high proportion
of sub-optimal semen quality (Andersen et al., 2000). Of those of the 708 men who
had no history of reproductive disease and abstinence was at least 48 hours, 18% had
sperm concentrations below 20 million per ml and 40% were below 40 million per
ml. The median sperm concentration of those men with abstinence more than 48
hours was 45 million per ml. Another Danish study, showed similar results for the
same age group and was able to compare this to older men, so showing an age cohort
effect (Bonde et al., 1998). From the 1,196 men who donated semen sampled over
time for occupational health research, those men in the 18-20 year old cohort (i.e.
born 1976-79) had a median sperm concentration of 41 million per ml. Furthermore,
those men born in the years 1937-49 had a median sperm concentration of 63 million
per ml compared to those men born in 1970-74 who had a median sperm
concentration of 52 million per ml.
However, other studies did not find a decrease over time in semen quality. In an
analysis of volunteer sperm donors in Toulouse between 1977 and 1992 there
appeared to be no change over time in mean sperm concentrations when the age of
the donors was accounted for (Bujan et al., 1996). Another analysis of volunteer
semen donors, this time in Australia between 1980 and 1995, found no effect on
median sperm concentration; total sperm number; or ejaculate volume; from year of
observation or year of birth (Handelsman, 1997).
While other studies have shown a decline in semen quality in Denmark, another
study investigating unselected semen donor candidates between 1977 and 1995
found the opposite (Gyllenborg et al., 1999). Although sperm motility declined over
this time, there appeared to be no change in other semen quality measurements
including semen volume and percentage motile. Furthermore, the mean sperm
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concentration actually rose from 53 million per ml in 1977 to 72 million per ml in
1995.
Two recent studies from the Far East have shown higher mean sperm concentrations
than Western studies and no secular trends or association with age (Itoh et al.,
2001 ;Seo et al., 2000). Itoh et al. (2001) found no decline in semen quality between
two groups of healthy volunteers in 1975-80 and 1998 in Sapporo, Japan; and no
association between age in either group was found. The mean sperm concentration
for the 1975-80 group was 70.9 million per ml compared to 79.6 million per ml for
the 1998 group. In Korea between 1989 and 1998 the 22,249 men who presented
with infertility showed no temporal trends in semen concentration and no association
with age or year of birth.
Therefore, the research carried out on temporal trends in semen quality is
inconclusive. The doubts that remain are largely due to the studies that have been
carried out. For example, a number of the studies mentioned above have used
particular groups of the population - semen donors, volunteers, men with proven
fertility, men presenting with infertility, vasectomy patients and military conscripts.
Would these men represent the general male population and would in fact have there
own inherent biases? As discussed by Handelsman (1997), the use of data from self-
selected subjects could introduce considerable biases to the results which would
mean they would not always be generalisable to the general population. Some of
these studies did attempt to overcome these potential biases. Anderson et al.'s (2000)
study of Danish military conscripts was able to show that their volunteers were
representative based on place, year of birth and educational status.
Problems also arise with these studies of semen quality when data from different
locations using different techniques and methods results are compared. While Fisch
et al. (1996) found a small but significant increase in the sperm concentration over
time in 3 locations in the USA between 1970 and 1974, they also found differences
between the locations. The highest concentrations was found in New York (mean =
131.5x 106/ml), then Minnesota (100.8 x 106/ml) with the lowest being in California
(72.7 x 106/ml). While it could be suggested that the geographical variation in semen
concentrations could have been due to geographically varying environmental factors
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and/or genetic pre-disposition, it is unclear because, as noted by the authors, there
were differences in the laboratory techniques and data analysis, between the 3
locations. There same difference in date could explain the reported difference across
time and country/location seen in the other studies described.
Finally, many of these studies are retrospective meaning that controlling for
important confounder can be limited. For example, Gyllenborg et al.'s (1999)
analysis of unselected semen donor candidates between 1977 and 1995 was based on
anonymised records so it was not possible to control for age, a possible confounder.
Therefore the reported stability in the temporal trends found could be due to the
different ages of the donors between the time periods.
As recommended by (Irvine, 2001), future research both on the temporal trends and
possible aetiology of semen quality should be prospective and be carried out on
randomly selected men. Furthermore, that the analysis and collection of the semen
samples should be consistent. In fact, a population study of semen quality has just
been completed in Scotland which aimed to overcome these issues. The Scottish
Male Reproductive Health Study hopes to report on its findings within the next year
(2005).
While most studies of semen quality have concentrated on assessing temporal trends,
some have looked at the possible aetiology. As already mentioned, Fisch et al.
(1996) found differences in semen concentration between the 3 US locations but it
could not be concluded that these differences were genuine or not due to differences
in data collection and analysis. However, another study comparing semen quality
across Europe did find geographical variation (Jorgensen et al., 2001). Although the
data was from men whose partners were pregnant, so a particular sub-group, any
inter-laboratory differences were assessed and the subsequent analysis was
standardised. On standardising to a 30 year old, with abstinence of 96 hours, sperm
concentrations were estimated for both winter and summer as, seasonal variations
had been found, these estimates are shown in Table 1.
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Table 1 Sperm concentrations (million per ml) by European City and Season for 30
year old man who has abstained for 96 hours - data reproduced from
Jorgensen et al., (2001)
European City






While all have lower concentrations in the summer compared to the winter, there are
consistent differences between the four cities, which led the authors to conclude that
these results may indicate different environmental exposures or lifestyle changes in
the four populations. Furthermore, as we have also seen two studies from Far East
did not show temporal trends in semen quality but reported higher mean sperm
concentrations than comparable Western studies (Itoh et al., 2000; Seo et al., 2000).
So there is some evidence of regional differences in semen quality. It has been
hypothesised that these regional differences might be due to ethnic, environmental or
lifestyle factors and so could be used to investigate the aetiology and temporal
changes of semen quality (Irvine et. al., 1996).
2.3 Testicular dysgenesis syndrome (TDS)
As shown previously, there is some evidence, of varying vigour, that testicular
cancer, hypospadias, cryptorchidism and semen quality have shown adverse temporal
trends. This combined body of evidence has led some researchers to hypothesise that
one common aetiology could be causing these reported deteriorations in different
condition/diseases of male reproductive health. Known as the 'oestrogen hypothesis',
Richard Sharpe and Niels Skakkebask proposed that increased in utero exposure to
oestrogens and/or anti-androgens might be related to the increase in male
reproductive anomalies (Sharpe and Skakkebaek, 1993). Since then, this hypothesis
has been further elaborated upon; it is postulated that these adverse trends may in
fact reflect an increasing number of men suffering from varying degrees of one
underlying entity - Testicular dysgenesis syndrome (TDS) (Skakkebaek, Rajpert-De
Meyts, and Main, 2001).
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2.3.1 Development of TDS hypothesis
The first researchers who hypothesised that the in utero environment of the foetus
might be associated with resulting anomalies in male reproductive health, did so in
relation to testicular cancer (Henderson et al., 1979;Depue, Pike, and Henderson,
1983) and cryptorchidism (Depue, 1984). Following the increase in papers showing a
decline in semen quality, and an increase in testicular cancer and the congenital
malformations cryptorchidism and hypospadias, this hypothesis was expanded upon
in relation to all these anomalies (Sharpe and Skakkebaek, 1993).
Sharpe and Skakkebaek proposed that increased in utero exposure to oestrogens
might be related to the increase in all the male reproductive anomalies through two
primary oestrogenic mechanisms;
(i) suppression of gonadotrophin hormones;
(ii) impairment of Leydig cells development.
Gonadotrophins are protein hormones involved in reproductive activity that stimulate
the gonads and primarily act on the Sertoli and leydig cells. The Sertoli cells manage
and control the development of spermatogenesis i.e. production of sperm. The leydig
cells produce testosterone, the principal testicular androgen, which has a key role
both in the early development of the male reproductive system and the reproductive
and sexual function of the adult male (Johnson and Everitt, 2000).
Many chemicals that humans ingest have been found to have oestrogenic properties
including, industrial chemicals such as; particular herbicides, fungicides,
insecticides, nematocides, organophosphates, heavy metals, PCBs and phthalates
(ECETOC (European Centre for Ecotoxicology and Toxicology of Chemicals),
1996).
Since this hypothesis, further work has been carried out both in human and animal
studies and so further potential mechanisms producing damage to the male
reproductive health system have been proposed (Skakkebaek, Rajpert-De Meyts, and
Main, 2001). It is hypothesised that while it is possible that these environmental
pollutants have oestrogenic properties as detailed previously they are more likely to
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have anti-androgen properties that inhibit the normal reproductive tract development
in the male.
These potential anti-androgenic mechanisms include;
(i) suppression of androgen production
(ii) suppression of androgen receptor expression
(iii) suppression of secretion of insulin-like factor-3 (InsL3) by foetal Leydig
cells.
As already discussed androgens play a key role in the development and function of
the whole male reproductive system so the suppression if its production and its
receptors would impair the system and conditions in different ways. InSL3 acts on
the gubernaculums of the testis which plays a key role in guiding the testis during its
transabdominal descent. Therefore the suppression of this factor could induce
cryptorchidism.
Both natural and synthetic substances have been found to have anti-androgen
properties. Particular substances that occur naturally in plants known as
phytoestrogens have been found to have both oestrogenic and anti-androgenic
properties (Colborn, Vom Saal, and Soto, 1993). Medications such as
diethylstilbestrol, ethinyl estradiol and tamoxifen; and industrial chemicals such as
DDT, p-nonylphenol and bisphenol A have been found to have anti-androgenic
properties (Greim, 2004).
In the same paper Skakkebaek and colleagues further expanded on the 'oestrogen
hypothesis'. They proposed that the reports showing a decline in semen quality,
increases in testicular cancer, cryptorchidism and hypospadias are symptoms of one
underlying entity, the testicular dysgenesis syndrome (TDS), which may be
increasingly common due to increases in environmental factors. Within the paper
they illustrated this hypothesis with two diagrams. Firstly, Figure 1 shows the
diagram from the paper explaining the genetic and environmental pathways to the
various manifestations of TDS.
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Figure 1 Schematic representation of pathogenetic links between the components
and clinical manifestations of testicular dysgenesis syndrome - reproduced
from Skakkebaek et al., 2001.
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As can be seen, the impact of both genetic susceptibility and exposure to
environmental factors results in TDS. In turn this syndrome affects different aspects
of the male reproductive system, which in turn results in the manifestation of
different conditions. For example, the disruption of Sertoli cells resulting from the
anti-androgen effect of the oestrogens impairs the differentiation of germ cells. These
impaired germ cells could result in two outcomes. As they are involved in
spermatogenesis then semen quality could be impaired, also these damaged germ
cells could develop into the non-malignant germ cells known as carcinoma-in-situ
(CIS). As previously described, CIS cells have been found to be precursors to
testicular cancer (Slowikowska-Hilczer, Walczak-Jedrzejowska, and Kula, 2001).
While explaining the potential pathways from TDS to the particular conditions
related to male reproductive health, the authors proposed that differing severity of
TDS results in the manifestation of different symptoms/conditions. Figure 2
illustrates the proposed relationship between the relative frequencies of the various
symptoms of TDS. The authors propose that while the overall incidence of TDS
decreases with its severity, the relative incidence of testicular cancer increases while
the relative incidence of the other conditions decrease.
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Figure 2 Illustration of the relationship between the relative frequencies of various
symptoms of the testicular dysgenesis syndrome (TDS) - reproduced from
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While the principal aim of the Skakkebaek and colleagues (2001) paper was to
outline the proposed hypothesis, from an epidemiological framework it also appears
to attempt to prove causality, i.e. that in utero exposure to oestrogens and/or anti-
androgens results in various symptoms of TDS. The criteria for inferring causality as
outlined by Bradford Hill (Hill, 1965) are:
(i) Strength of the association - The stronger an association, the less it could
merely reflect the influence of some other aetiological factor(s). This criterion
includes consideration of the statistical precision (minimal influence of
chance) and methodological rigor of the existing studies with respect to bias
(selection, information, and confounding).
(ii) Consistency - replication of the findings by different investigators, at
different times, in different places, with different methods and the ability to
convincingly explain different results.
(iii) Specificity of the association - there is an inherent relationship between
specificity and strength in the sense that the more accurately defined the
disease and exposure, the stronger the observed relationship should be.
(iv) Temporality - the ability to establish that the putative cause in fact preceded
in time the presumed effect.
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(v) Biological gradient - incremental change in disease rates in conjunction with
corresponding changes in exposure. The verification of a dose-response
relationship consistent with the hypothesized conceptual model.
(vi) Plausibility - we are much readier to accept the case for a relationship that is
consistent with our general knowledge and beliefs. Obviously this tendency
has pitfalls, but commonsense often serves us.
(vii) Coherence - how well do all the observations fit with the hypothesised model
to form a coherent picture?
(viii) Experiment - the demonstration that under controlled conditions changing the
exposure causes a change in the outcome is of great value, some would say
indispensable, for inferring causality.
(ix) Analogy - we are readier to accept arguments that resemble others we accept.
The authors have provided various examples of changes in male reproductive health
(criteria (ii)), a hypothesis to explain the biological pathways from environmental
and genetic factors to TDS and the various conditions of male reproductive health
(vi) and how the observed changes fit the hypothesis (vii). They also attempt to show
that varying exposure results in varying degrees of the syndrome and conditions (v)
and that from animal studies change in dose of chemicals results in varying
conditions (viii).
Although these criteria have been touched upon in the Skakkebask et al. (2001)
paper, an examination of the criteria in relation to current male reproductive health
research provides an insight into the remaining questions surrounding it.
While there a numerous reports showing a decline in male reproductive health in
terms of a decline in semen quality and increases in the rates of testicular cancer,
cryptorchidism, and hypospadias (ii), very little work has been done on assessing the
methodological rigor of this existing evidence (i). In fact, a number of concerns
about the available reports have been highlighted and have been discussed in the
examination of the known aetiology of the conditions. Therefore, the evidence used
to show a decline in male reproductive health is inconclusive and so inferences made
between the changes in conditions and possible risk factors must also be open to
doubt (vii). Furthermore, as will be seen in the next section the many potential
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pathways of exposure for these conditions mean that the strength and specificity of
the association is ambiguous.
2.3.2 Human Exposure to Endocrine disruptors
The TDS hypothesis postulates that exposure to environmental oestrogens and/or
anti-androgens in utero have resulted in a decline in the male reproductive health.
While the previous section outlined how these chemicals, known as endocrine
disrupters, are conjectured to result in changes in the male reproductive health
system; this section will outline how humans are believed to be exposed to these
environmental chemicals.
Endocrine disrupter research is a large and complex field and so only a small part of
this research is discussed here. This section concentrates on the possible routes of
exposure to the foetus, as it is postulated that the exposure to environmental
chemicals in utero results in TDS.
There are various substances that are suspected of being endocrine disruptors
although little direct clinical data to verify these concerns (Hester and Harrison,
1999). They are both naturally occurring and anthropogenic chemicals, with the most
important in terms of human health and their main sources of human exposure shown
in Table 2.
This table shows that even when only identifying the key known or suspected
endocrine disruptors, there are various possible sources of exposure. However there
are key sources of human exposure, the most important being food. While the
majority of endocrine disruptors in food are naturally occurring phytoestrogens
(plant compounds) there are other sources of these chemicals in what we eat (Safe,
1995). For example, natural hormones such as oestrogens, progesterones and
testosterones are found in eggs and meat and diary products, but these can be further
enhanced due to the use of hormones by vets and as growth enhancers (Hartmann,
Lacorn, and Steinhart, 1998). Furthermore, packaged food can contain these
compounds due to leeching from particular containers (e.g. phthalates and bisphenol
A). Pesticides that have not been used for a number of years can still be found in
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food produced in areas where they were last used (UK Ministry of Agriculture
Fisheries and Food and Health and Safety Executive, 1997).
Table 2 Key known or suspected endocrine disruptors
Compound Source of Human Exposure
Natural and synthetic Natural hormones, augmented by hormonal drugs such as those used as
hormones oral contraceptives, are excreted by humans and animals and occur in
sewage
Phytoestrogens Natural constituents ofmany foodstuffs including herbs, grains and
seeds, vegetables, beans and fruits
Mycotoxins Produced by fungi that can contaminate crops
Organochlorine pesticides Common persistent environmental pollutants include DDT, lindane and
beta-HCH
Polychlorinated biphenyls Widespread environmental chemicals
(PCBs)
Alkylpheno! Used in detergents, paints, herbicides, pesticides and plastics.
polyethoxylates (APEs) Breakdown products, such as nonylphenol and octylphenol, are found in
sewage and industrial effluents
Dioxins Products of combustion ofmany materials
Phthalates Widely used in consumer products such as cosmetics, toiletries,
perfumes and medical products. Used widely in plastic packaging and
can leech into the food in small quantities
Bisphenol A Component of polycarbonate plastics and epoxy resins used to line food
cans which again can leech into contents
Drinking Water is also believed to be a potential source of human exposure to
endocrine disruptors, and this is a result of various mechanisms. Firstly,
pharmaceutical drugs and their metabolites find their way into the environment
chiefly via excretion into sewage (Arcand-Hoy, Nimrod, and Benson, 1998).
Furthermore, groundwater can be contaminated by chemicals carried by rainwater,
from leaching of waste sites or waste water carrying industrial or agricultural waste.
Some but not all of these contaminants can be removed by water treatment. While
surface water, rivers and lakes and the sea are very vulnerable to contamination by
waste and airborne pollutants, the air itself can be a source of endocrine disruptors
(Hester and Harrison, 1999). Products of combustion, such as dioxins and polycyclic
aromatic hydrocarbons, are possible endocrine disruptors (Clemons et al., 1998).
Finally, another potential source of exposure by humans to endocrine disruptors is
occupation. Inorganic chemicals such as lead, manganese and mercury, and organic
ones such as dibromochloropropane (DBCP), ethylene glycol and carbon disulfide
are believed to produce adverse effects on male reproductive health (Tas, Lauwerys,
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and Lison, 1996). However it is not clear if these effects are due to endocrine
disruption or primarily the chemical itself, and not other confounding factors related
to lifestyle (smoking, alcohol, and diet) or socioeconomic status.
So even for only some of the common environmental chemicals the potential routes
of exposure to the mother and to the foetus are various (Figure 3) (Sharpe and Irvine,
2004).
Figure 3 Routes of human exposure to some common environmental chemicals*
- reproduced from Sharpe and Irvine (2004)1
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Reproduced with permission from the BMJ publishing group
This illustration, in Sharpe's and Irvine's clinical review of the evidence to link
environmental chemicals and human reproductive health, highlights the complex
issue of attempting to identify the mechanisms by:
(i) which humans are exposed to these environmental chemicals,
(ii) how these chemicals are transferred to a foetus, and
(iii) how this exposure manifests as particular conditions.
For example the mother could have been exposed to some of these chemicals
through-out her lifetime which could bioaccumulate (i.e. build up in the body) in
tissue or she could be exposed to particular chemicals while pregnant. These
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chemicals could accumulate in the amniotic fluid or be transferred to the baby
postnatally via breast feeding. The myriad potential pathways for exposure of the
mother and transfer to the foetus/baby have meant it has been very difficult to show
exactly how exposure to these chemicals has resulted in various degrees of the
testicular dysgenesis syndrome.
Furthermore, measuring the foetal exposure to environmental chemicals and then
relating this to various disorders is not only logistically problematic it is compounded
by when the conditions manifest themselves. This is particularly pertinent to those
conditions which occur decades later than the proposed exposure i.e. testicular cancer
and poor semen quality, but is also relevant to a lesser extent to those conditions that
manifest themselves at birth i.e. cryptorchidism and hypospadias. Table 3 shows that
even for those conditions that manifest at birth the potential risk factors are numerous
and include non-environmental ones.
Table 3 Potential risk factors for the conditions of testicular dysgenic syndrome









Conception Parental Genetics V V ✓ S
Maternal bioaccumulation of V V S V
potential environmental chemicals
Maternal bioaccumulation due to
other non- environmental risk factors V S V s
(e.g. lifestyle)
In utero
Maternal biological response to s S V V
pregnancy
Maternal exposure to potential
y ✓ s senvironmental chemicals while
pregnant
Maternal life-style factors while V s
pregnant (e.g. smoking, diet)
Childhood Breast feeding s s
Illness in childhood (e.g. mumps) V V
Childhood exposure to potential V s
environmental chemicals
Adulthood
Adult lifestyle factors (e.g. smoking, s s
heat exposure)
Exposure to potential environmental s
chemicals (e.g. occupational)
Furthermore, these pathways overlap e.g. maternal genetics might impact on a
woman's biological response to a pregnancy and so result in increased levels of
hormones. Therefore, teasing out environmental chemicals role in affecting male
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reproductive health is difficult, not only because there are other known risk factors
for each of these conditions but also that all can occur at various times before
manifestation of the condition.
Also, investigations to explain how these environmental chemicals affect the male
reproductive system are further complicated by the fact that most of these potential
toxicants are found at low concentrations within humans. For instance, the
oestrogenic potency of synthetic substances such as 4-octylphenol and bisphenol A
was more than 3,000 fold and 30,000 fold respectively, lower than that of
endogenous estradiol (Sonnenschein et al., 1996). It is unlikely that a toxicologically
relevant effect could occur as a result of low potency and currently, little evidence
has been provided to show that low concentrations of these environmental chemicals
are found to result in changes to humans either foetally or long term into adulthood
(Greim, 2004).
Furthermore, there are various factors that could affect an individual's susceptibility
to these potential toxicants (Brent, 2004). This makes it difficult to show that a
particular substance has teratogen properties i.e. produces abnormalities in the
embryo or foetus by disturbing maternal homeostasis or by acting directly on the
foetus in utero (Last, 2001). For instance, the timing of exposure in utero is crucial
as the type and risk of malformation caused will vary both by the chemical and when
the exposure occurred and at what dose. In addition, the physiological response of
the mother will influence the teratogenic effects of any exposure and while this will
be different between women it will also alter within a pregnancy.
This complexity has meant that describing how the exposure to these environmental
chemicals then develops into the various conditions of testicular dysgenesis
syndrome hypothesis is difficult and as yet has not been accomplished. Indeed,
several evaluations of the evidence for adverse health effects resulting from exposure
to endocrine disruptors have concluded that while temporal declines in the conditions
related to the male reproductive tract have been reported, no direct causative role for
low-level endocrine disrupters have been determined (Damstra et al., 2002;GDCh-
Advisory Committee on Existing Chemicals (Beratergremium fur Altstoffe: BUA),
2002).
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2.4 Conclusions of previous male reproductive health
research
From previous research there is strong evidence of a temporal increase in the
incidence of testicular cancer. There is also some evidence to show an increase in the
incidence of hypospadias, although this is not as strong as that provided for testicular
cancer due to quality issues surrounding the data used. However, the evidence
provided to show a decline in semen quality or an increase in cryptorchidism is the
least robust, and so it still unclear if temporal changes have occurred in these
conditions. Therefore as this evidence was used to argue that an environmental factor
is a result of these changes, the basis for this hypothesis could be seen as flawed.
Until these issues are resolved with robust data, questions will remain. For instance
any geographical differences found could be argued to be a result of differences in
data used. Therefore future research either looking at the temporal or geographical
differences in these conditions must address the concerns raised in relation to the
quality and collection of the data used.
So, in order to look at geographical differences and so explore if a geographically
varying environmental factor is associated with these conditions, consistently
collected high quality data must be used. Furthermore, as we have seen various other
risk factors unrelated to the proposed in utero environmental exposure are associated
with these conditions. Therefore, so as to fully examine the geographical differences
in these conditions and so investigate if a geographical varying in utero
environmental risk factor is associated with them, then these other factors must be
accounted for.
Finally, if these conditions are a result of one entity, TDS, we would expect to see
associations between them. In fact Skakkebaek et al., (2001) recommended that
future epidemiological studies on trends in male reproductive health should take into
account all aspects of TDS rather than focusing on only one symptom, as important
biological information could be lost. At this time this appears to have not been
carried out. Furthermore, no direct causative association between these
environmental chemicals and the various conditions of male reproductive health has
as yet been shown.
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Chapter 3 : Outline and Methods of Research Project
3.1 Introduction
The previous chapter has put the concerns in relation to male reproductive health into
context and highlighted unresolved issues. This chapter describes the research project
carried out and how it proposes to answer some of the outstanding issues raised by
previous research.
Firstly the aims of the research project are outlined, and the justifications and
hypothesises that underlie these aims are discussed. As a key theme of the research
project is spatial epidemiology, its concepts are then introduced and how they are
applied to the study is discussed. This introduction of the concepts of spatial
epidemiology is done before the data and methods are outlined as these concepts
have implications for the research project.
The datasets used in the research project are classified into four categories depending
on their use within the research project. As the datasets are from different time
periods and so different geographies the methods used to establish them at one
common geography is then described.
The methods used to achieve the aims of the research project can be found in three
sections. The first summarises the methods used to describe the geographical
variation of the three disease/conditions as counts per postcode sector; while the
second outlines the spatial analysis of information pertaining to the cryptorchidism
cases. The final methods section shows how the three disease/conditions were
analysed conjointly. As the analysis outlined in the methods sections was carried out
using the WinBUGs, this Bayesian analysis package and how it is used is also
described.
The final section gives a summary of the chapter to provide a synopsis of the
research project.
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3.2 Aims and Objectives of Research Project
The aims of the research project are to:
(i) Describe the geographical distributions of three indicators of male
reproductive health in Scotland (i.e. testicular cancer, cryptorchidism and
hypospadias).
(ii) Describe the conjoint geographical distribution of the three indicators
specified in (i).
(iii) Identify explanatory factors that might account for the geographical
distribution of male reproductive health in Scotland.
As discussed in Chapter 2, it is hypothesised that increasing in utero exposure in
environmental oestrogens and/or anti-androgens has resulted in a decline in male
reproductive health (Skakkebaek, Rajpert-De Meyts, and Main, 2001). If
geographically varying environmental factors are associated with these
diseases/conditions then we might see variations in the distributions of each of the
disease/conditions across areas in Scotland. Therefore, the first aim of the research
project aims to assess the geographical distributions of the disease/conditions across
Scotland, to establish whether spatial variations exist. If variations are found, it
would lend weight to the environmental exposure hypothesis, provided that the
environmental factor also varies geographically.
The second aim of the research project is to look at the geographical distribution of
the three indicators jointly. In a multi-indicator model, diseases have the potential to
'borrow strength' from each other and so reduce the variability of risk estimates
within a particular postcode sector. Furthermore, if these diseases/conditions are
believed to have one underlying environmental cause, as proposed by Skakkebaek,
Rajpert-De Meyts, and Main (2001), then it is likely their geographical variation
would be similar to each other. Therefore, the conjoint analysis of these
diseases/conditions would examine the relationships between the spatial distributions
of the three diseases/conditions. If a spatial relationship is found between them then
this would also provide evidence of geographically varying environmental factor(s)
being associated with all three conditions, i.e. a common aetiology.
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While the first two aims of the research project attempt to assess if there is a spatial
variation in these three disease/conditions, they do not attempt to explain these
variations. It is useful in itself to describe the spatial variation of the
disease/condition risk, and so indicate possible aetiology. However, the further
analysis of the geographical variation of the diseases/conditions, by including
potential covariates in the models, would not only identify possible explanatory
factors but might also account for any spatial variation due to non-environmental
factors. As discussed in Chapter 2, other risk factors unrelated to the intra-uterine
environment exposure hypothesis are also associated with these conditions.
Therefore, in order to fully examine the geographical differences of these conditions
and so begin to investigate if a geographical varying environmental risk factor is
associated with them, all known and available potential risk factors should be
examined.
Also discussed in Chapter 2 was that previous research on male reproductive health
anomalies have been inconclusive in part due to the quality of the data used,
particularly in relation to cryptorchidism and semen quality, and to a lesser extent
hypospadias. In contrast, data on testicular cancer, cryptorchidism and hypospadias
in Scotland have all been collected consistently over geography and time; further
details on these datasets are given in 3.4. The use of high quality data in this research
project aims to address one of the unresolved criticisms of previous research on male
reproductive health. With use of potentially consistently collected data, this research
project will be able to examine geographical differences without the potential bias of
differences in ascertainment over geography and time.
A further criticism of previous research on male reproductive health is that the
assessment of the geographical variations of these diseases/conditions has largely
been limited to comparisons of registries/countries, which are unreliable as there are
usually differences in ascertainment. While there does not appear to be any analysis
of the spatial variation of cryptorchidism and hypospadias, there has been spatial
analysis of testicular cancer in the Great Britain. As detailed further in the review of
testicular cancer research, this study only analysed two regions of Great Britain
rather than a larger region/country (Toledano et ah, 2001). Therefore, this research
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project aims to assess the geographical variation of the disease/conditions across a
larger region which will be more likely to include sub-regions that differ from each
other in terms of several potential risk factors, but not differ in terms of
ascertainment.
Finally, if these diseases/conditions are symptoms of one underlying entity, the
testicular dysgenesis syndrome (TDS), we would expect to see associations between
them. In fact Skakkebaek et al. (2001), recommended that future epidemiological
studies on trends in male reproductive health should take into account all aspects of
TDS rather than focusing on only one symptom. At present, no such research has
been published. Therefore, this research project would appear to be the first analysis
of some of the male reproductive health anomalies conjointly, thus addressing
another unresolved issue highlighted in previous research.
Therefore the research project aims to provide a complete picture of the spatial
variation of three indicators of male reproductive health in Scotland, both by
describing the geographical variation and attempting to explain the variation. The
research project also aims to address the two main unresolved issues highlighted in
previous research, namely the use of consistently collected high quality data for these
diseases/conditions data and the conjoint analysis of these indicators.
3.3 Spatial Epidemiology Concepts
This research project is a spatial epidemiological study. Therefore, before explaining
the data and the methods used to achieve the study aims the underlying concepts in
spatial epidemiology will be introduced in this section. In order to understand why
particular methods and data are used these concepts need to be elucidated.
Furthermore, how these concepts have implications for the research project are also
discussed.
Spatial epidemiology aims to describe and understand the spatial variation of disease.
There is a long tradition of the production and analysis of maps within public health
research, going back to the 19th century (Snow, 1854) . However in recent years the
use of this type of study has grown due to the availability and expansion of the
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following: geo-referenced health and population data; geographic information
systems (G.I.S); computing technology; and statistical methodology.
3.3.1 Types of Spatial Data
There are two types of geo-referenced data used within spatial epidemiology - case
event and count data. As with any other analysis the type of data available largely
determines the particular methodology used, therefore, in order to correctly analyse
the data used in the research project we need to identify its type.
For Case event data the point location is known for each individual with the
particular disease/condition. On a map a case would be presented as a cross or point
and the analysis of this type of data would be based on point process models. The
datasets within this research project do not contain this level of geographical
information. Therefore, further detail on this type of data and the methods used to
analyse it are not described.
The datasets used in this research project are count data. Within count datasets the
point location of cases is not known, but rather in the particular sub-region of the
study area in which they are located. Therefore the basis of the analysis is the
number of cases of the disease within each of the sub-regions. Figure 4 shows the
number of births with cryptorchidism in postcode sectors in Edinburgh from the
cryptorchidism dataset within the research project.
Figure 4 Example of case event data - births with cryptorchidism by postcode sector
Edinburgh: 1980-1995
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Increasingly, count data are the only geo-referenced data being made available to
researchers carrying out spatial epidemiological studies. Current interpretations of
data confidentiality legislation have meant that count data rather than case event data
are what are being provided to researchers. The current interpretation is that if the
exact location of a case was provided then it might be possible to identify the
individual. So the cases geographical information is provided at a higher spatial
resolution (i.e. postcode sector in the case of the datasets in this study). More detail
on the postcode system in the U.K and its spatial resolution is given in 3.5.
3.3.2 Types of spatial epidemiology studies
There are three main types of study in spatial epidemiology, which are largely
categorized by the aim of the research:
(i) Disease Mapping aims to illustrate the spatial variation of diseases via the
use of maps and is the first type of spatial analysis carried out. These maps,
along with corresponding maps of potential explanatory factors, may suggest
possible aetiology of the disease in question. The methods used within this
type of study have in recent years been developed further with advances in
computer technology and the application of Bayesian modelling methods; and
these methods have been utilised to address aim (i) of the project.
(ii) Disease Clustering studies aim to determine whether particular regions of a
map have a 'cluster' of elevated disease risk. There are two types of disease
clustering studies depending on the scale of the analysis and what is defined
as a 'cluster'. Non-focused clustering analyses look at the whole study region
to see if areas within the study region have clustering of sub-regions with
higher or lower risks. This is seen as a further refinement of disease mapping
and this method is also applied to the first aim of this research project.
Focused clustering analysis is more specific in the location, structure and
number of clusters within a study region. The majority of studies of this type
are looking at the effects on health of specific pre-defined putative sources
e.g. nuclear power stations, waste dumps, incinerators. This is one of the most
well known spatial analysis methods, both within the academic community
and among the general public. This is largely because it is associated with
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often high-profile potential sources of health hazard. Within this research
project this method of analysis is not used, so it is not detailed further,
(iii) Ecological analysis is an extension of disease mapping aiming to assess
whether the observed spatial variation of a disease can be explained by other
explanatory variables. In ecological analysis the association between disease
spatial variation and a possible explanatory variable can be quantified;
whereas in disease mapping analysis the maps of the disease and the potential
covariates are visually compared to assess if similar in spatial variation.
Ecological analysis is used to address the third aim of the research project, to
identify explanatory factors that might account for the geographical
distribution of the male reproductive health indicators.
Therefore, the analyses undertaken to achieve the three aims of the research project
are disease mapping, non-focused clustering and ecological analysis on disease count
data.
3.3.3 Maps and mapping
The visual assessment of maps of estimated risks by postcode sectors in Scotland
will be an important part of the study. While the maps presented in this research
project are as a descriptive/presentation tool, and any inferences made will stem from
formal statistical analysis, there are cartographic and visual cognition issues that
need to be considered. This section outlines introductory concepts on the use ofmaps
to assess geographical variations of diseases.
It is usual within epidemiology to use thematic maps, i.e. colour or shading schemes
represent the different relative risks in each sub-region. Figure 5 shows the data from
Figure 4 as a thematic map.
The common use of thematic maps within epidemiology is confirmed by cognitive
research, which found that epidemiologists prefer thematic maps and used them more
accurately than isopleth or dot maps (Pickle et al., 1994). However, the use of
thematic maps is not without problems, as the size and pattern of the sub-regions, in
this case postcode sectors, will have an impact on any inferences made. Larger
postcode sectors tend to draw the viewer's eye towards them even though another
smaller postcode sector might have the same category value (Pickle, 2000). Pickle
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recommends where possible that the sub-regions should be re-aggregated so that the
sub-regions are uniform in size.
Figure 5 Example of case event data thematic map - births with cryptorchidism by
postcode sector Edinburgh: 1980-1995
In Scotland, the postcode sectors areas are certainly not uniform as they are based on
population sizes. For instance the North is in the most part rural and so sparsely
populated, resulting in postcode sectors with large areas; while the South and
particularly the Central Belt is the most densely populated region of Scotland,
resulting in postcode sectors with small areas.
Although it would be ideal to re-aggregate, as recommended by Pickle (2000), it was
decided to leave the boundaries as they are in this research project. As the data have
been provided at the smallest spatial resolution, the re-aggregation to sub-regions of
uniform size would result in larger sub-regions. As noted by (Pickle, 2000)
aggregation to larger areas are more likely to soak up any variation, particularly if a
re-aggregated region contains postcode sectors with widely varying values.
Therefore the loss in spatial resolution could result in the potential loss of spatial
variation. This would be more likely within Scotland as the re-aggregation would be
driven by the largest postcode sectors, which are considerably larger in size than the
smallest and less populated.
Therefore, the postcode sectors as the spatial resolution has been retained. In order to
reduce the risk of over-emphasis on the larger-in-area postcode sectors, most maps
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will also have a close-up of the Central Belt so attention will be directed to the
smaller postcode sectors.
The primary use of a map is an important consideration for its production. Bertin
classified that there are three basic questions that could be asked using a map (Bertin,
1983). These have been adapted to the conditions of this research project as follows:
(i) what is the disease risk in a particular postcode sector?
(ii) are there geographical trends in the relative risks, or clusters of postcode
sectors with relatively high or low risks?
(iii) are the geographical variations of the relative risks different when produced
by different Bayesian models?
The aims of the research project mean that the maps produced will either be used to
ask (ii) or (iii). For a particular map the question type will determine the style and
colours used (Pickle, 2000). For instance, to compare different relative risk maps
produced by different Bayesian model for the same disease/condition the categories
within the thematic maps will have the same cut-off values.
Finally, the colour schemes used within the thematic maps are also crucial. For
cluster recognition, it has been found that one colour gradient is the most effective
(Lewandowsky et al., 1993). Blue was chosen as the colour gradient, as the same
authors found it had the least 'value judgement' associated with it when used in
maps. It was decided to use darker shades of blue for the higher values and lighter for
the lower, as it has been found that the performance of the map user was better when
this 'convention' was used (Carswell and Winslow, 1994). The boundaries of the
postcode sectors were not given an outline so as to aid in the visual assessment of
clustering. Distinct boundaries would over emphasise the difference between
postcode sectors which are to a certain extent an artificial construct.
3.3.4 Ecological Fallacy
The use of disease count data may introduce a bias known as ecological fallacy. This
is not pertinent to just spatial epidemiology but to epidemiological studies in general
where the data being analysed are based on aggregated or grouped data. Ecological
bias may occur when an association observed between variables on an aggregated
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level does not necessarily represent the association that exists at an individual level.
In spatial epidemiology this is taken as inferences made about the spatial variation of
the risk between postcode sectors might not translate to the individuals within those
postcode sectors.
The potential for this bias to occur is more acute when ecological analysis is carried
out. While potential area-specific explanatory variables might explain the spatial
variation of a disease it might be that information about the cases in a particular
postcode sectors, e.g. age, might explain the geographical variation.
In order to test for the possibility of ecological fallacy in this research project, an
individual level analysis of the cryptorchidism cases has been carried out. The
methods for this are outlined in 3.7; and aims to see if available information about
the individuals has a geographical variation which is similar to that of the
geographical variation of the condition's risk and so might explain that variation.
3.4 Datasets used within research project
The datasets used in the study can be classified into four categories of data
depending on its use within the research project;
> Male Reproductive Health Disease/Condition data are the three specific
diseases i.e. cryptorchidism, hypospadias and testicular cancer, that are
referenced by postcode sector to allow their geographical distributions to be
described;
> Denominator data are used to standardise, by the underlying population at
risk, the number of cases of particular male reproductive health
diseases/conditions within postcode sectors;
> Boundary spatial data are the geo-referenced border data for Scottish
postcode sectors, required to show the geographical distribution of the male
reproductive health disease/condition;
> Potential covariates are those datasets that will be explored to see if they
explain the geographical distributions of the male reproductive health
disease/condition data.
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As this is a spatial epidemiological study all the data needs to be geo-referenced, in
this case by postcode sector - further details on how this is done for each dataset, and
further information on the datasets, are given in the subsequent sections. Table 4
summarises all the datasets used in the research project and indicates which of the
next sections provides further details on each.
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The majority of the datasets are freely available either on-line or on request.
However, permissions and ethical approvals were required before access was given
to the three male reproductive health disease/condition datasets. The Privacy and
Advisory Committee (PAC) of the Information Statistics Division (ISD) who collect
and provide the datasets, would only give access to the datasets if the spatial
resolution was provided only at postcode sector rather than postcode unit level.
As first highlighted in 3.3.1, this was due to current interpretations of data protection
legislation, as it is believed that it would be more likely to identify individuals. This
interpretation was further confirmed when the ethical approval for the study from the
Northern & Yorkshire Multi-Centre Research Ethics Committee (MREC/2/3/40) was
given on the same proviso. The postcode system in the UK and the impact of this
spatial resolution on the spatial analysis are detailed in 3.5.
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3.4.1 Cryptorchidism and Hypospadias datasets
The data for both the cryptorchidism and hypospadias cases were extracted from the
same database. Therefore, information relevant to this database is outlined first
before details on the specific condition data are given.
The database from which these conditions datasets were created is known as the
maternity/neonatal linked database from the Information Statistics Division (ISD),
which collect and analyse information on NHS activity in Scotland. The maternity
/neonatal linked database holds data on maternity (SMR02), neonatal (SMR11) and
infant deaths/stillbirths records, and links these records pertaining to a woman and
her births. The database includes births from 1980 to 1999 and over this time
different data schemes and inclusions have applied. Table 5 shows the different data
schemes included in the maternity/neonatal linked database and what would have
been included over time.
Table 5 Overview of data schemes included in maternity/neonatal linked database
Scheme Description Time period
SMR2 All obstetric hospital discharges 1980-March 1997
COPPISH SMR02 All obstetric hospital discharges April 1997-1999
SMR11 All live births in hospital 1980- 1991
SMRI1 (UV) All live births in hospital 1992-March 1996
SMR 11 (EP) All discharges from SCBU/ITU 1992-March 1996
COPPISH SMRI 1 All discharges from SCBU/ITU April 1996- 1999
As will be shown the differences in inclusions over time will have an impact on the
completeness and quality of the data over time. Firstly, how the data was extracted
from the maternity/neonatal linked database is described.
The combined cryptorchidism and hypospadias data file was created using the
following selection criteria:
(i) All SMR2 and SMR11 records from 1980 onwards linked to the same mother
(known as patient record set) were selected. All patient record sets containing
at least one SMR11 record with a diagnosis of hypospadias or cryptorchidism
were selected.
(ii) A dataset with 8,930 cases was created which contains a baby's record and
the corresponding mothers' information. Table 6 shows the frequency within
Chapter 3: Methods 47
Spatial Epidemiology of Indicators of Male Reproductive Health in Scotland
this dataset of the two conditions. The fields selected from the database are
detailed in Appendix 1. These fields were included so as to potentially assess
if this information might also explain the spatial variation in the conditions.




Hypospadias & Cryptorchidism 71 0.8
Further notes were supplied with the data extract, and two of these have an impact on
the analysis of the data:
(i) From April 1996 only sick babies generated an SMR11 as can be seen from
Table 5. This change in ascertainment is further discussed in relation to each
of the two conditions in the next sub-sections.
(ii) There are 134 babies on the file for which ISD do not have the mother's birth
record so do not have information about the mother e.g. age of mother.
Therefore analysis of information pertaining to the cases' mother would not
be carried out on the complete dataset.
3.4.1.1 Cryptorchidism
This section outlines how the cryptorchidism cases used in the research project were
extracted from the combined cryptorchidism/hypospadias dataset. As can be seen
from Table 6 there were 3,223 births with cryptorchidism.
The varying frequency of births with cryptorchidism suggests a need to assess the
differences in ascertainment (Figure 6). There are a few cases in the dataset that
occurred in 1979. These were probably a run in to the data collection beginning in
1980, so these cases were removed from the dataset as an incomplete year. As
already highlighted, from April 1996 only 'sick babies' generated a SMR11 return. It
would appear that the numbers of births with cryptorchidism reduced from this time.
It might be a true reduction in cases or due to ascertainment. It is likely that
cryptorchidism would not be classified as a 'sick baby', so would only be recorded if
the baby had further mobidity serious enough to generate a SMR11.
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Figure 6 Cryptorchidism births by year
Therefore it was decided to only include births from 1980 to the end of 1995. The
first months of 1996 were also excluded so as to only include complete years. It is
likely that there are seasonal differences in the overall births; therefore to avoid
introducing potential bias in the numbers of cases only complete years will be
included in the data. Therefore the cryptorchidism dataset from which all subsequent
analyses will be carried out includes 2,635 cases.
3.4.1.2 Hypospadias
As we can see from Table 6 the joint datasets includes 5,778 births with hypospadias.
As with the cryptorchidism data there appear to be changes in ascertainment over
time (Figure 7).
Figure 7 Hypospadias births by year
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Again there are a few cases that occurred in 1979, and so these were removed from
the dataset. The same changes in data collection that applied to cryptorchidism also
apply to the hypospadias data, and as can be seen, the number of cases reduced from
1996 onwards. As it is not clear if this is 'real' or due to ascertainment, the
hypospadias analysis was based on the births between 1980 and 1995, resulting in
4,919 cases.
3.4.2 Testicular cancer dataset
This dataset was also provided by ISD although from another linked database which
holds data on non-maternity and non-psychiatric hospital discharges (SMR1), cancer
registrations (SMR6), mental health records (SMR4) and death records.
The testicular cancer data file was created using the following selection criteria:
(i) All cancer registration (SMR6) records where the incidence date is for 1975
to 1999 were selected, as at the time of extraction these were the complete
years of registration available.
(ii) All records containing a diagnosis code for testicular cancer were selected.
(iii) This resulted in 3,624 records and those fields included in the dataset are
shown in Appendix 2. Again these additional fields were requested to
potentially investigate if individual covariates explain the spatial variation of
testicular cancer.
3.4.3 Denominator data
In order to standardise by the underlying population the number of cases of the three
disease/conditions per postcode sector denominator data are required. How these are
used is described in 3.6.1, while this section describes the actual data. The
denominator used depends on the condition/disease. The population data was used as
the denominator data for the testicular cancer data. As detailed in Table 4, the
population data is freely available by postcode sector, age and sex from GRO. In
order to correspond with the boundary data, the population data was obtained for
1991 Census. However, the birth data had to be requested from ISD, and further
details are given here.
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3.4.3.1 Birth data
The birth data was used as the denominator data for both the cryptorchidism and
hypospadias datasets as these were ascertained at birth. It was created from the same
maternity/neonatal linked database used to create the cryptorchidism and
hypospadias data - see 3.4.1 for more detail. The birth data was created from the
linked database by aggregating particular events by postcode sector, year and month.
Table 7 shows the events requested from the birth dataset, although only the number
of live male births was used as the denominator data.





No. ofAll Male Births
No. of All Female Births
No. of Live Male Births
No. of Live Female Births
No. of Twins Both Male
No. of Twins Both Female
No. of Twins Both Sexes
3.4.4 Boundary data
In order to produce maps of the disease/conditions by postcode sector, one particular
time-frame would need to be used, as the postcode sector boundaries change with
time. Since the disease/condition datasets span 1975 to 1999 the postcode sector
boundary file valid at the 1991 Census was used. It was decided that the boundary
files from the Census would be used as they are based on postcode sectors, are
widely available, validated and can be cross referenced with population data. Figure
8 shows the boundaries of the postcode sectors as at 1991 Census, and as already
mentioned there are differences in sizes of the postcode sectors across Scotland. The
postcode sectors are larger in area in the North and South with smaller ones mainly
situated in the Central Belt.
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3.4.5 Postcode specific potential covariates
The third aim of the research project is to identify explanatory factors for the spatial
variation of the different disease/conditions. This section outlines the potential
covariates used that might explain any geographical variation, while 3.6.3 explains
how these will be analysed. While the data of the three disease/conditions contain
individual information on the cases there are no postcode sector specific covariates.
However, by using the postcode sector we can obtain other postcode specific
potential covariates from other datasets. The five postcode specific potential
covariates used in this research project are an urban/rural indicator, two deprivation
indices and two radon measurements.
Before outlining the potential covariates used in this research project, the process by
which these variables were selected needs to be discussed. The spatial variation of
the potential covariates is compared to those of the indicators of male reproductive
health in order to see if they have similarities. If there appear to be similarities, then
it is likely that there is a spatial association between the potential covariate and the
particular disease/condition. A more vigorous analysis is to include the potential
covariate into the Bayesian spatial models to see if it explains the spatial variation of
each of the indicators of male reproductive health, this method is outlined in 3.6.3.
For a potential variable to be compared to the spatial variation of the indicators of
male reproductive health, it would need to have a spatial component i.e. that its
values vary spatially.
A further consideration when selecting potential covariates is that while we will be
looking at possible risk factors of male reproductive health to investigate further
there are other generic variables which would also need to be considered. As
discussed in the review of the human exposure to endocrine disruptors (2.3.2) and
summarised in Table 3, the potential risk factors for the manifestation of the various
indicators of male reproductive health are numerous and include non-environmental
ones. One of the most important of these generic potential risk factors that also varies
geographically is deprivation, and two covariates that look at this risk factor have
been used and are described in 3.4.5.2.
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In terms of possible risk factors of male reproductive health that are specific to the
hypothesis that exposure to endocrine disruptors have resulted in these
disease/conditions, we need to look at the sources of human exposure to these
chemicals as reviewed in 2.3.2 and Table 2, and assess which of these would be
suitable to be included in a spatial analysis. As we have seen the primary source of
endocrine disruptors for humans is food, which might on first appearance not to be
the most appropriate for inclusion as a potential covariate. Food people eat is, in the
main, an individually varying covariate rather than a spatially varying one. In recent
times, food has generally been transported and consumed away from the area it was
produced and so where it was contaminated with the potential endocrine disruptors
(e.g. pesticides), and the spatial variation of particular food types (e.g. eggs, meat,
grain and vegetables) would be lost. Furthermore, the majority of endocrine
disruptors in food are naturally occurring phytoestrogens and the assessment of the
level of consumption of these chemicals would chiefly be related to the individual
rather than the area they lived.
However, particular chemicals that might enter the food chain may be present in the
area in which the food was produced, and so humans could be exposed to these
chemicals still present in the area. Therefore spatially varying potential covariates
that relate to human exposure of endocrine disruptors via food would stem from the
areas where the food was produced. For example, we would wish to obtain levels of
particular pesticides across Scotland. Another approach would be to use data that
identified if land was used for farming purposes. As pesticides and other endocrine
disruptors are used a great deal in this industry, then areas of farming could have
correspondingly high levels of these chemicals. As farming is carried out in rural
areas, data that can identify between rural and urban areas of Scotland could be a
proxy measure. This approach was taken in this research project and the data used
are described 3.4.5.1.
Two possible sources of human exposure to endocrine disruptors that are not pursued
further in this research project are those found in plastics, pharmaceuticals, cosmetics
and other consumer products (e.g. Bisphenol A and phthalates), and those exposed
via occupation (e.g. lead, manganese and mercury). As with food consumption, in the
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main exposure via these sources would vary by the individual rather than geography,
and any available data would be via individual exposure data rather than on a
geographical basis.
Two possible sources of human exposure that could be pursued further in this
research project are those via water and air.
As described in 2.3.2, exposure to endocrine disruptors via water could either be by
residing near contaminated water or by the consumption of such water. For data
pertaining to residing near to contaminated sources of water, we require levels of the
particular potential chemicals (e.g. hormones, pesticides, PCBs and APEs), with
geographical location of where the water sample was taken. It is believed that a more
significant source of human exposure via water is by consumption rather than
proximity. Therefore if it was possible to obtain water distribution data, i.e. from
which reservoir/water source particular areas of Scotland are supplied, then the
sample data showing levels of chemicals could be incorporated to potentially give
levels of exposure via water consumption.
Industrial pollution and combustion of materials could result in potential endocrine
disruptors being present in the air we breathe. Levels of these chemicals (e.g. dioxins
and PCBs) in the atmosphere across Scotland could provide the potential exposure of
these chemicals via air. Furthermore, reports of incidents of pollution by industrial
sites etc., which is a mandatory regulation, could be incorporated to indicate areas
where exposure to particular chemicals could have occurred.
While some of the potential data outlined above has been used in this project, some
have not been included. Those that were not included are summarised in Table 8 and
the reasons why have also been outlined.
Ideally the potential covariate data would be available at the same resolution as the
disease data, so as to make direct comparisons. If this was not the case, the next
possibility would be that the data could be converted into comparable data. This was
not always possible and so certain possible sources of exposure were not included.
As with any project there is a balance between time available and what can be done
in that time, and so the conversion of potential covariate data to correspond with the
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disease data would not always have been practical. Furthermore the lack of
availability to this researcher of particular potential covariates also impeded the
inclusion of some data. For example, water distribution data, while available, would
not be provided to this researcher by either the Scottish Executive or the water
companies even following several requests. And while geographically based data
might be available interactively via the internet, the underlying datasets needed for
the analysis, would not be provided.
Table 8 Potential Covariates not included in research project
Potential







Incidence of poisoning (by
chemical) of wildlife/animals
by year and region
Annual classification of land
use by agricultural regions
Samples across Scotland taken
annually from range ofwater
systems, chemical levels
identified
Areas served by particular
reservoirs etc.
Point data of specific sites of
pollution (e.g. industries) and
levels of chemicals
Regions could not be directly mapped to
postcode sector
Agricultural regions could not be directly
mapped to postcode sector, and refused data
at spatial resolution that would have
corresponded.
Data available interactively via website by
particular chemicals, year or location able
select sample but not able to download or
obtain complete dataset
Unable to obtain from water companies or
Scottish Executive
Data available interactively via website by
particular chemicals, year or location able
select sample but not able to download or
obtain complete dataset
Therefore the geographically based environmental data available to this researcher
was limited. So as to show, if available, how environmental data could be used in the
spatial models, radon data was included and is described in 3.4.5.3. A discussion of
what environmental data could be included if time and logistics permitted, and the
limitations of those used, are given in 8.3.1 and 8.2.1.5 respectively.
3.4.5.1 Rural/urban indicator
As discussed, it is hypothesised that the decline in male reproductive health is due to
increasing exposure to environmental oestrogens and one of the potential sources is
large scale pesticide use. As large scale pesticide use is a result of farming it could be
assumed that farming areas would have higher rates of these conditions. A proxy for
assessing if sub-regions are farming areas is the rural/urban indicator from the 1991
Census. This indicator is based on the population within postcode sectors as at the
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1991 Census. The frequencies of the five groups of the rural/urban indicator in the
895 postcode sectors in Scotland in 1991 Census are shown in Table 9.
Table 9 Rural/Urban indicator postcode sector frequency
Rural/Urban
p . . Number of
Indicator Code 0'5U 3 l0n postcode sectors (%)
1 > 1,000,000 160 (17.9)
2 100,000-999,999 140 (15.6)
3 10,000-99,999 203 (22.7)
4 1,000-9,999 205 (23.0)
5 <1,000 187 (20.9)
The spatial distribution of the rural/urban indicator within the postcode sectors is
shown in Figure 9. As would be expected there appears to be spatial clustering of
these indicators; most of the rural areas are grouped in the West and North while the
urban areas are in the Central Belt.
3.4.5.2 Deprivation indices
Deprivation is associated with several health indicators (Carstairs, 1995), and so
could have association with these anomalies of male reproductive health. Based on
1991 census information deprivation indices were developed (Carstairs and Morris,
1990). The indices are based on a combination of 4 socio-economic indicators from
the census - the percentage of people in an area; without a car; in overcrowded
housing; with head of household in social class IV or V; and men unemployed. The
spatial distributions of the two groupings used are shown in Figure 10 (quintiles of
Carstairs score) and Figure 11 (septiles) within the 895 postcode sectors in Scotland
as at 1991 Census.
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Figure 10 Deprivation Code (5 groups) from 1991 Census: Scotland and Central Belt
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There appears to be some clustering of both of the deprivation codes, low deprivation
in the North and North-East and high deprivation in the West, South West and the
conurbations of the Central Belt.
Figure 11 Deprivation Code (7 groups) from 1991 Census: Scotland and Central Belt
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3.4.5.3 Radon measurements
There are particular areas of the UK that have higher levels of radon exposure, one of
which is north-east Scotland. Some health conditions have been associated with
excessive exposure e.g. lung cancer (Bilello, Murin, and Matthay, 2002). While
radon has not been associated with male reproductive health it is a potential
environmental pollutant that might also impact on these anomalies. An estimated
84% of the exposure of the population to radiation comes from natural sources, with
radon being the greatest source (NRPB, 2003).
The radon data are currently not available at postcode sector level. The results are
aggregated to the first two letters of the postcode, although several measurements
have been carried out in the area, e.g. 'AB' known as a postcode area. There are two
measures of radon which will be assessed. Firstly, the mean radon level Bq/m3 within
each postcode area. Secondly, the proportion of measurements taken within a
postcode area that exceed 200 Bq/m3, the recommended action level for radon in the
home according to the National Radiological Protection Board (NRPB). Figure 12
shows the spatial distribution of these two measurements.
Each value has been given an individual colour so as to differentiate between areas,
as it must be remembered that the postcode areas are much larger than postcode
sectors. With this in mind, there does appear to be a pattern to the two measurements.
For the mean radon measurements (a) there appears to be high radon values in the
North, North-East and South with lower values in the Central Belt. For the excess
radon (b) there is a slightly different pattern. While the North and North-East have
higher proportions of areas with excess radon and the Central Belt have lower
proportions of areas with excess radon as like the mean radon, the South has lower
proportions of areas with excess radon.
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Figure 12 Radon measurements at Region level: Scotland (a) Mean radon (b)
Proportion of sub-regions with radon levels exceed 200
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3.5 Establishing a common geography
As outlined in 3.4, the data are geo-referenced based on postcode sector. The
boundaries of these postcode sectors have changed over time. This section describes
the postcode system in the UK in more detail; defines the postcode sector within this
system and describes how the changes over time have an impact on the production of
diseases/conditions maps and how this was resolved for this research project.
3.5.1 Postcode system
Postcodes were introduced by the Royal Mail so as to provide an accurate and
consistent method of delivering mail. It is made up of a combination of letters and
numbers which from left to right narrows the destination as illustrated in Table 10.
Table 10 Postcode system and levels
Postcode level Example Description
Identifies the main Royal Mail sorting office which will process
the mail
Tells the sorting office which delivery office the mail should
go to
Local area or neighbourhood usually consisting on average of
2,000 households
Identifies a group of up to 80 addresses and tells the delivery
office which postal route (or walk) will deliver the item
As the postcode sectors and units are based on number of households these have to
be changed and revised from time to time. For example, a housing development
might result in significantly more than 80 addresses in a particular postcode unit or
more than 2,000 in a postcode sector, requiring changes in the number of both an
area. Figure 13 illustrates these changes in relation to postcode sectors.





Postcode Sector EH8 9
Postcode Unit EH8 9AG
With changes over time in
household density the
boundaries were changed to
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In the three disease/condition datasets the postcode sector recorded for each case is
the postcode sector applicable at the time the case was registered. Therefore a case
recorded in the datasets in 1980 might have a postcode sector that does not exist in
1999, and the same addresses within that postcode sector at that time might be in a
different postcode sector(s). Therefore the postcode sectors recorded in the datasets
are not comparable over time. Furthermore, as already mentioned, in order to
produce maps one boundary system needed to be used, which was decided to be that
as at 1991 Census.
So in order to undertake spatial analysis and mapping to one boundary system it is
necessary to re-assign all postcode sectors to the 1991 postcode sector boundary
system.
3.5.2 Methods used to re-assign postcode sectors
Once the changes in postcode sectors were understood to impact on the spatial
analysis and mapping of the different disease/conditions, it was assumed that
information to match postcode sectors over time would be widely available. This is a
common requirement as previous disease maps have been produced from data
spanning a number of years.
The majority of previous spatial analyses were provided with the postcode unit rather
than postcode sector. Therefore the centre point (centroid) of the postcode unit could
be overlaid with the boundary system and so accurately locate in which postcode
sector a postcode unit would be. However as already discussed, due to changes in
data protection interpretations only postcode sector was provided for the
disease/condition datasets, therefore this solution could not be used; and no solution
was found for matching postcode sectors over time.
Matching postcode sectors to those postcode sector boundaries valid as at 1991 is not
straightforward due to the nature of the changing of boundaries. As we can see in
Figure 13 a new postcode sector might not directly overlay a previous postcode
sector i.e. be made of sections of more than one old postcode sector. However, the
linking of postcode units to a postcode sector boundary system, introduced in the
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previous paragraph, could be used as a basis to assign postcode sectors to those valid
Firstly, the centroids of all the postcode units ever used are overlaid with the
postcode sector boundaries as at 1991 within a geographical information system (in
this case ArcView), as shown in Figure 14. The centroids of all the postcode units
ever used were provided from the 'All Fields Postcode Directory' from the Office for
National Statistics. It contained 179,868 postcode units for Scotland, for which
179,662 (99.9%) had centroid co-ordinates.
Figure 14 Illustration of spatial linkage of all postcode units to postcode sectors valid
as at 1991 Census
This meant it was possible to spatially link every postcode unit ever used in Scotland
to the postcode sector they would have been located in as at 1991. As the postcode
sectors over time are required it was then necessary to aggregate the postcode units
to postcode sector level. This then produced a file for every postcode sector ever
used matched to a 1991 postcode sector.
In this file there are some of the postcode units that link to more than one 1991
postcode sector. This can happen for instance when a postcode sector splits into more
than one new postcode sector. When this occurred, the 1991 postcode sector to which
the majority of the postcode units are linked is used as the match.
Therefore a file was created that was able to match postcode sectors to one common
geography - postcode sectors as at 1991 - and appears to be the first complete file
produced. There are other files that have looked at this issue within Scotland,
however, each is for their own local needs and have their own particular problems.
Public Health Institute of Scotland (PHIS) - has produced a file that tracks census
as at 1991.
Centroid of postcode unit
Boundary of postcode sectors
valid as at Census 1991
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tracts from one Census to another. These census tracts are similar to postcode sectors
in Scotland but do alter in a number of areas. Furthermore the file was created to
proportionally assign populations to census tracts over time rather than match
particular census tracts; therefore there is no one-to-one match.
ISD and GROS have developed a file that provides a one-to-one match of postcode
sectors to the postcode sectors valid at the 1991 census. However, this information
was developed on a piece-meal fashion based on local knowledge rather than a
systematic linkage across Scotland.
Although the file used in the research project appears to be the first of its kind, the
methods used do have limitations that need to be discussed. The use of centroid of
the postcode units to link to those postcode sectors valid as at 1991 assumes that the
spatial distribution of the population within the units are uniform. This might not be
the case e.g. the north part of a postcode unit might be more densely populated than
the south, meaning that an individual could be assigned to a neighbouring postcode
sector incorrectly. However, as the postcode units are at a small spatial resolution the
effect should be minimal. Furthermore, as the assignment to a 1991 postcode sector
is based on where do the majority of the postcode units lie then this type of mis-
assignment is less likely.
But the assignment to 1991 postcode sectors based on the majority of postcode units
will have meant that some postcode sectors have been assigned to neighbouring
postcode sectors. However this mis-assignment is small. Of the 179,662 postcode
units 6,580 (3.7%) were found to be in one 1991 postcode sector but were assigned
to its neighbour as the majority of the other postcode units were within that sector.
Furthermore, it must be remembered that the spatial analysis is interested in the
general spatial distribution of the diseases rather than the particular numbers within
postcode sectors, so the small chance ofmis-assignment is unlikely to impact on the
overall aim of the analysis.
It might have also been possible to proportionally assign cases aggregated to
postcode sector to the 1991 postcode sectors. As particular postcode units aggregated
to postcode sector linked to more than one 1991 postcode sector we could have used
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the proportions of postcode units as a proportion to assign aggregated diseases cases.
However, this would have meant the loss of individual level information related to
the case as it would have not been possible to attach a postcode sector to each case.
And as we do have individual level information for each case, that might explain
spatial variation in the disease risk, we would not want to lose this level of
information.
With the disease/condition cases assigned to one common geography i.e. postcode
sector valid as at the 1991 Census, it would be now be possible to look at the spatial
variation of the different diseases/conditions.
3.6 Analysis of disease/conditions count data
This section summarises the methods used to describe the geographical variation of
the three disease/conditions as counts of cases per 1991 postcode sector. Each sub¬
section is a progression of the previous as the methods are developed.
3.6.1 Standard Morbidity Ratio (SMR) maps
Maps of the Standard Morbidity Ratios (SMRs) have long been used to look at the
geographical variation on a particular diseases/conditions or condition. Maps of the
number of cases within each postcode sector can result in misleading inferences, as
these values do not take account of the spatial variation in the underlying population
at risk. However, the SMR takes the size of the population at risk into account within
each postcode sector. The SMR is the maximum likelihood estimate (MLE) of the
relative risk for each postcode sector and is calculated as follows:
SMR — observed number of cases of disease in 1991 postcode sector
expected number of cases of disease in 1991 postcode sector
The postcode sector of all cases in each of the disease/conditions datasets were re¬
assigned to the 1991 postcode sectors using the methods described in section 3.5.
Summing these cases by the 1991 postcode sector gives the observed number of
cases.
The expected number of cases within each of 1991 postcode sectors involves
calculating national rates for each disease/condition which are then applied to the
underlying population at risk, as follows:
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Then these national rates are applied by standardised category to the underlying
population within each postcode sector to calculate the expected number of
diseases/conditions cases as follows:
For 1991 postcode sector j:
Population at risk in Ci and 1991 postcode sector j x Dl/Pl = elj
Population at risk in C2 and 1991 postcode sector j x D2/P2 = e2j
Population at risk in Cn and 1991 postcode sector j x Dn/ Pn = e 18j
Expected number of diseases/conditions cases in postcode sector j £e
Although the method is the same irrespective of disease/condition the population at
risk and the standardisation category are different for each. Table 11 shows those
used for each of the diseases/conditions to calculate the expected rates per 1991
postcode sector. Details on the Population at Risk datasets have been given earlier -
known as denominator data.
Table 11 Population at Risk and Standardisation Categories used to calculate
expected rates per postcode sector for each disease/condition
Disease/Condition Population at Risk
Standardisation
category
Cryptorchidism All births - maternity/neonatal linked database, ISD Year of birth
Hypospadias All births - maternity/neonatal linked database, ISD Year of birth
Testicular cancer Population - Census 1991 Age groups
Although the SMRs maps have long been used in spatial epidemiology to show the
spatial variation of a disease and do take into account the spatial variation of the
underlying population, they have a number of shortcomings, particularly when
carried out on areas with small number of cases.
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As the SMR is based on the ratio of observed and expected values per postcode
sector, any variation in the disease risk would be dominated by the uncertainty of the
estimates, particularly in areas with small number of cases. In order to see the
variability of the SMRs, the maps of the standard errors of these estimates are
compared to the actual SMR maps. If the standard errors of the SMRs show a similar
spatial variation as the SMRs then it is likely there are dominated by the uncertainty
of the estimates.
The standard error of the SMR for each postcode sector is calculated as:
Standard error (SMR) = -\°^serve<^ number of cases of disease in 1991 postcode sector
expected number of cases of disease in 1991 postcode sector
In order to account for the variability of the relative risk estimates, that might either
be random or spatially structured, Bayesian Hierarchical modelling is required.
3.6.2 Bayesian Hierarchical Modelling of disease/condition
count data
In general Bayesian hierarchical models attempt to remove the random variation or
random effects of the relative risk estimates from the map. Modelling random effects
attempt to quantify unobserved effects within a model. How this is done depends on
the assumptions made within each model and on the nature of the random effects.
This section outlines the three different Bayesian models used with the three
disease/condition datasets. Each model make different assumptions about the spatial
variation of the relative risks and have been used with all three disease/condition
datasets to assess which best describes the geographical variation of the
diseases/conditions and so give a better insight into their spatial variation. For each
disease/condition the posterior estimates and the resulting maps from each of the
three models were compared to see which terms best describe the spatial distribution
of each disease.
In order to understand the models an introduction to Bayesian modelling is required.
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3.6.2.1 Bayesian Theory
As noted by (Congdon, 2001), the general principle of Bayesian analysis is that prior
knowledge about the density of the parameters within a model are combined with
either sample data or previous experimental evidence to produce updated knowledge
about the parameters. Within a spatial Bayesian modeling context this translates as
the crude relative risks (i.e. SMRs) being combined with models that make
assumptions about the spatial variation of these risks to produce new estimates of the
relative risks which take into account the variability of the estimates.
In general, if we have data {y,} with parameters {0,} then its likelihood is denoted as
L(y|0) and the log-likelihood as l(y\6). The prior knowledge concerning the
parameters are assumed to have distributions known as prior distributions
represented as g(0j), where the joint distribution of the parameters is g(0). The
distributions of the updated parameters produced by taking into account the prior
distributions are known as the posterior distributions, and are the product of the
likelihood and the prior. So, if the posterior distributions is represented by p{6|y),
then,
my)« L(y|0) m
It is impossible to produce point estimates for the updated parameters from Bayesian
models as it assumed that the parameters occur from a distribution of possible values.
For simple models it is possible to find the exact form of the posterior distribution
and so any summaries of interest. However, for most realistic hierarchical models,
unless the posterior produced is of a closed form, it is not possible to find the exact
form. Classic estimation methods were used to estimate the maximum likelihood
estimates of the posterior for the parameter of interest e.g. the Newton-Raphson and
least squares methods. However they were impractical with large numbers of
parameters and only with very simple hierarchical models. Therefore the use of
Bayesian analysis was limited in its scope for a number of years due to the
constraints of producing estimates of the posterior distributions.
However with the introduction of higher performance computers, simulation
methods could be developed to estimate the entire posterior distribution of the
parameters. Samples could be taken from the posterior density, which could then be
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summarised to produce estimates of interest. Markov Chain Monte Carlo (MCMC)
based methods were used which simulated parameter values iteratively within a
Markov Chain. A number of MCMC based algorithms were developed to perform
these iterations: Metropolis updates, Metropolis-Hastings updates and Gibbs updates.
The most used of these algorithms within epidemiology is the Gibbs algorithms, as it
is the basis of the widely used Bayesian analysis packages MLwiN and the package
used for this research project WinBUGs. More information on the use of WinBUGs
in this research project can be found in 3.9.
3.6.2.2 Poisson-Gamma model
The first Bayesian hierarchical model used in the analysis, known as the Poisson-
Gamma model, is one of the first to have been used in spatial epidemiology.
If we denote the observed number of cases of a disease in 1991 postcode sector i as
yi, and the expected number of cases as e,. Then the SMR for 1991 postcode sector i,
which is the MLE estimate of the relative risk St is
4 = A
et
The binomial distribution typically applies when counting the number of cases of an
event occurring or not. However, within these datasets and with other
epidemiological data the key interest is the number of times when a disease occurs,
and do not know when it does not occur. In such a situation, and when the event is
rare, the Poisson distribution is a good approximate of the binomial. Therefore, if we
assume that the numbers of cases of a disease within each postcode sector are
independent then
y, ~ Poisson( et .9,) V/
A Gamma prior distribution for the crude relative risks combines conveniently with
the Poisson likelihood for the number of cases to give a gamma posterior distribution
for the estimates of the relative risks. Those postcode sectors with SMRs with high
variance will have a posterior mean relative risk smoothed towards the global mean
relative risk, while those with a small variance will have a posterior mean relative
risk close to the SMR.
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The WinBUGs code for the Poisson-Gamma model used for the three
diseases/conditions is shown in Figure 15. As a result of the posterior relative risks
having a gamma distribution Gamma(a ,b) then the overall mean relative risk is alb.
For a full Bayesian model these hyper-parameters a and b are also given prior
distributions. For these datasets an exponential distribution of mean 1 was given for
a and a gamma distribution with shape parameter 0.1 and scale parameter 1 was
given for b.
Figure 15 WinBUGs code for Poisson-Gamma model
model
{
for(i in 1 :m)
{









#Prior distributions for parameters
a~dexp(1)
b~dgamma(0.1,1.0)
# Population mean and variance
mean<-a/b
var<-a/pow(b,2)}
It is possible to give these hyper-parameters different priors, and in fact it is
recommended to undertake a sensitivity analysis of any Bayesian hierarchical models
by comparing posterior estimates from models with different hyper-parameters priors
(O'Hagan, 2003). However, the aim of the analysis is large scale disease mapping i.e.
looking at large-scale spatial variation rather than specific relative risk estimates and
it was not practical in terms of time to carry out this level of analysis on all the
Bayesian hierarchical models described. It was therefore decided to carry out
sensitivity analysis only on the Besag, York and Mollie (BYM) model for each
disease/condition. How this was done and why is described in 3.6.2.4. However, all
priors specified have been taken from WinBUGs examples in either textbooks
(Lawson, Browne, and Vidal Rodeiro, 2003;Congdon, 2001) or the WinBUGs
manual.
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Also included in the WinBUGs code is the calculation of posterior probabilities of
the relative risk being greater than 1. A map of these values will show the probability
that the posterior relative risk within each postcode sector is greater than 1. This
value gives an indication of which areas have a higher disease risk, while accounting
for the variability of the relative risk estimate. All the Bayesian hierarchical disease
count models will include this calculation and subsequent maps.
The Poisson-Gamma model smoothes the posterior relative risks towards the overall
mean relative risk, and so decreases the range of their values and variability.
However, it does not account for spatial correlation i.e. that a postcode sector will be
similar to its neighbours. Furthermore, the inclusion of other covariates is not
possible within a Poisson-Gamma model.
3.6.2.3 Log-Normal model
A more flexible model which could include other covariates was then developed
(Clayton and Kaldor, 1987). This model known as the Log-normal model, again
assumes a Poisson likelihood for the observed number of diseases/conditions per
1991 postcode sector. However, rather than gamma priors for the crude relative risks
this model uses a normal prior distribution on the logarithm of the relative risk
i.e. y, ~ Poisson( e;9i),
log 5, =ct+vn
vi~N(0, rv2)
Therefore unlike the Poisson-Gamma model, the Log-Normal model can include
covariate information. However as with the Poisson-Gamma model it includes a
component that assumes that the random effects vary between areas in an
unstructured way, known as uncorrelated heterogeneity v,. Uncorrelated
heterogeneity assumes that within the model that any extra variation is not correlated
with the location of the disease, i.e. the location of any clustering of diseases is a
random effect. Therefore the SMRs are smoothed towards the overall mean relative
risk, where a represents the overall relative risk within the model. Figure 16 shows
the WinBUGs code for the Log-Normal model which was used on the three
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disease/condition datasets. As with the Poisson-Gamma model the same priors for
the hyper-parameters were used for each disease dataset, for the same reasons given
in 3.6.2.2.
Figure 16 WinBUGs code for Log-Normal model
model
{
for (i in 1 :m)
{





#Posterior probability of theta>1
PP[i]<-step(theta[i]-1 +eps)




#Vague distribution for the mean relative risk in the study region
alpha~dflat()
mean<-exp(alpha)
#Hyperprior distributions on inverse variance parameters of random effects
tau.v~dgamma(0.5,0.0005)}
3.6.2.4 Besag, York and Mollie (BYM) model
As already mentioned both the Poisson-Gamma and the Log-Normal models do not
take into account that there might be spatial correlation in the relative risks. Spatial
correlation is the assumption that the relative risk value of a postcode sector would
tend to be similar to the neighbouring postcode sectors.
An extension to the Log-normal model that also included a spatially correlated
heterogeneity term was first introduced in 1987 (Clayton and Kaldor, 1987) and was
further developed in 1991 (Besag, York, and Mollie, 1991) and will be referred to as
the Besag, York and Mollie (BYM) model. This spatially correlated heterogeneity
term assumes that there is a correlation between any extra variation and the spatial
unit (in this case postcode sector) and its neighbours. This could be because the
disease is naturally clustered or brought about because of unobserved effects.
Therefore the estimation of the relative risk for each postcode sector will depend on
the neighbouring postcode sectors.
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So, as with the log-normal model
y>i~ Poisson(e,&,),
but, log =a +u,+vl,
where, as with the Log-normal model, a represents the overall relative risk and v, is
the uncorrelated heterogeneity which has the same normal prior. For the spatial
correlated heterogeneity term uh Besag, York and Mollie proposed that a conditional
autoregressive models (CAR) prior was specified (Besag, York, and Mollie, 1991).
As detailed by Lawson, Browne, and Vidal Rodeiro (Lawson, Browne, and Vidal
Rodeiro, 2003) this is
So the distribution of the log relative risk in postcode sector i is normal with mean
given by the mean of the log of the relative risks in the neighbouring postcode
sectors and the variance being proportional to the number of neighbouring postcode
sectors.
Figure 17 shows the implementation of the BYM model in WinBUGs as suggested
by Lawson, Browne, and Vidal Rodeiro (2003). This is similar to the WinBUGs code
for the Log-normal model but with an additional spatial correlated heterogeneity
term. The CAR model proposed by Besag, York and Mollie (1991) is available from
GeoBUGs, an add-on spatial module of WinBUGs, via the car.normal distribution
and requires the following terms to be specified:
(i) adj[] is a vector containing the adjacent postcode sectors for each postcode
[w, \Uj, i * j, r,2 ] ~ N(ut, t?)
where U' NT" ^jUJCOir2,% j
and
(Oy = 1, if i,j are neighbours (0 if they are not).
sector
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(ii) weights[] is a vector containing weights associated with each pair of postcode
sectors - within this model the weights are 1 for all pairs
(iii) num[] contains the number of neighbours for each postcode sector
(iv) tau.u represents the inverse-variance of the spatial correlated heterogeneity.
While tau.u is assigned a prior gamma distribution, the other terms are specified and
so have to be added as data. Within GeoBUGs these terms can be generated by the
Adjacency Tool using the 1991 postcode sector boundary file.
Figure 17 WinBUGs code for BYM model
model
{
for (i in 1 :m)
{





#Posterior probability of theta>1
PP[i]<-step(theta[i]-1 +eps)




#CAR distribution for the spatial correlated heterogeneity
u[1:m]~car.normal(adj[], weights!], num[], tau.u)
#Weights




#Vague distribution for the mean relative risk in the study region
alpha~dflat()
mean<-exp(alpha)
#Hyperprior distributions on inverse variance parameters of random effects
tau.u~dgamma(1,1)
tau.v~dgamma(0.5,0.0005)}
As previously discussed in relation to the Poisson-Gamma and Log-Normal models,
sensitivity analysis is recommended so as to assess the performance of the hyper-
priors specified. Unlike the two other Bayesian models it was decided to carry out
sensitivity analysis on the inverse-variance of the spatial correlated heterogeneity
(tau.u), because as will be seen in Chapters 4, 5 and 6 there were concerns that the
spatially correlated heterogeneity term over-smoothes the relative risk estimates.
The sensitivity analysis was carried out by comparing the relative risks estimated for
each postcode sector by the model shown in Figure 17 and by this model with tau.u
specified as Gamma{0.5, 0.0005) which has been suggested for the precision
parameter of the spatial random effects in a CAR model (Kelsall and Wakefield,
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1999). The comparison of the two sets of relative risks were compared by looking at
the correlations and carrying out paired t test to see if there are significant difference
between the estimated values. If a significant difference is found then the spatial
variation of the two sets of relative risks estimated are compared.
3.6.3 Inclusion of covariates into Bayesian Hierarchical
models of diseases/conditions count data
After estimating the spatial variation of the disease risk through the different
Bayesian hierarchical disease count models and assessing which best explain the
data, the logical next step is to seek to explain the spatial variation. The initial way to
accomplish this is to include in the Bayesian hierarchical disease count models,
covariates which are postcode sector specific i.e. deprivation, rural/urban indicator
and radon.
To see if the spatial distribution of these indicators explains the spatial variation of
the cryptorchidism cases we need to include each covariate separately within the
BYM and log-normal models. How these covariates are included in the two models
is dependent on the nature of the factor.
Both deprivation indices and urban/rural indicator are category variables. Figure 18
(bold) gives an example of the WinBUGs code for the urban/rural indicator being
included to the BYM model, and the same coding is used to include all three
covariates within the BYM and log-normal models. The covariates are included by
eliminating the grand mean and calculating the contrasts between the 5 groups
separately.
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Figure 18 WinBUGs code of BYM model plus rural/urban indicator
model
{
for (i in 1 :m)
{





#Posterior probablity of theta>1
PP[i]<-step(theta[i]-1 +eps)




#CAR distribution for the spatial correlated heterogenity
u[1 :m]~car.normal(adjO, weightsO, num[], tau.u)
#Weights




#Vague distribution for the mean relative risk in the study region
alpha~dflat()
mean<-exp(alpha)
for (j in 1:5) {
beta[j] - dnorm(0.0, 0.0001)}
for(j in 2:5) {
contrast[j-1] <- beta[j]-beta[1]}
#Hyperprior distributions on inverse variance parameters of random effects
tau.u~dgamma(1,1)
tau.v~dgamma(1,1)}
The two radon measurements are continuous measurements. Figure 19 (bold) shows
the WinBUGs code for the inclusion of the mean radon measurement within the
BYM model. This is the method used to include both radon measurements within the
BYM and log-normal models.
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Figure 19 WinBUGs code of BYM model plus mean radon
model
{
for (i in 1 :m)
{





#Posterior probablity of theta>1
PP[i]<-step(theta[i]-1 +eps)




#CAR distribution for the spatial correlated heterogenity
u[1:m]~car.normal(adjQ, weightsQ, num^, tau.u)
#Weights




#Vague distribution for the mean relative risk in the study region
alpha~dflat()
mean<-exp(alpha)
beta ~ dnorm(0, 2)
#Hyperprior distributions on inverse variance parameters of random effects
tau.u~dgamma(1,1)
tau.v~dqamma(1,1)>
3.7 Bayesian Hierarchical Modelling of Individual
level data
As discussed earlier (3.3.4), in order to assess the possibility of ecological fallacy, an
individual level analysis was to be carried out. An individual analysis would see if
information about the cases has a geographical variation similar to that of the
geographical variation of the disease risk. If this is the case then it is possible that
this individual information explains the geographical variation in the relative risk.
However the failure to explain the geographical variation with the individual analysis
will not mean that the potential for ecological fallacy is eliminated. Rather that it if is
present then it is not due to the information known about the individuals in the
datasets.
The individual level analysis described below was carried out only on the
cryptorchidism dataset. Ideally, the individual level models would have been carried
out on all three disease/conditions and on all the information known about the cases.
However, due to time constraints it was decided to use the cryptorchidism datasets as
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an example of the potential of such analysis. Furthermore this analysis gives an
indication whether information about the individuals might explain the spatial
variation in the disease risk rather than geographical based covariates. The results do
not give direct associations between disease risk and individual covariates.
Development of such models has yet to emerge in this relatively new field of
statistical analysis. Therefore the individual analysis was limited in what conclusions
could be made from it, consequently it was decided to illustrate the methods with one
disease i.e. cryptorchidism; and individual level models were developed for only
three key individual level covariates: year of birth, year of mother's birth and co¬
morbidity.
The year of birth was modelled as will be seen from the cryptorchidism incidence
rates in Scotland have increased over time. The age of the mother might explain
some spatial variation in cases as previous research proposed that older women
might have a higher risk of congenital malformations (Baldwin and Nord, 1984).
From the diagnosis fields it was possible to identify which of the cryptorchidism
cases were also born with hypospadias. As both these conditions are hypothesised to
be caused by the same environmental exposure, these babies may have the same
spatial variation as the overall disease risk of cryptorchidism.
3.7.1 Models
The overall approach taken to analyse these three covariates (year of birth, year of
mother's birth and co-morbidity) spatially is to regard them as outcome variables. As
the individual analysis is within a given population (i.e. cryptorchidism cases) then
differentiation is based on the outcome variables and their different levels e.g. year of
birth grouping. Then these individual models could include spatial and heterogeneity
terms to ascertain the extent to which these effects are required to explain any
differences between the groups of individuals.
Unlike the disease count models, we are looking at the locations of individual cases.
Therefore the underlying population at risk is not accounted for as was done in the
count models. However, if we use polytomous regression models i.e. category based
outcomes, the underlying population is controlled within the model. As both the year
of birth and age of mother are continuous variables they were converted into
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category variables as outlined in Table 12. These categories were selected so that the
sub-groups were equal in population size and the number of categories was kept to a
minimum.
Table 12 Conversion of Year of Birth and Mother's Year of Birth to category
variables
Variable Categories
Year of Birth 1 = 1980-1983, 2=1984-1987, 3=1988-1991, 4=1992-1995
Age of Mother (years) 1 = 14-21, 2=22-29, 3=30-37, 4=38-45
The WinBUGs code for the categorical models for the Year of Birth and Age of
Mother are shown in Figure 20. From each model we obtain the probability for each
individual of being within each of the categories. The code shows the model with all
terms included i.e. coordinates and heterogeneity terms. Each of these terms were
added individually to the models to assess which terms best described the variation in
probabilities, e.g. does the x co-ordinates of the case location explain the
categorisation of the cryptorchidism cases by year of birth.
As there were only two outcomes for the co-morbidity model a logistic regression
model was performed i.e. cryptorchidism cases or cryptorchidism and hypospadias
cases. As this is a reduction of the polytomous regression model it can also control
for the underlying population. The WinBUGs code for the full model is shown in
Figure 21 which produces the probability of that individual having both
cryptorchidism and hypospadias. As with the year of birth and age of mother models
the terms in the model were added individually and the different models compared to
assess which terms explain the variation in probabilities between the two groups of
cases.
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Figure 20 WinBUGs code for categorical models for Year of Birth and Age of Mother
# Year of Birth group model
model
{ for (i in 1:n) {DOByr[i] ~ dcat( P[i,1 :J])
xc1[i]<-Xcoord[i]-mean(Xcoord[ij)
yc1[i]<-YCoord[i]-mean(YCoord[i])
for (j in 1: J) {
log(PHI[i,j]) <- betaO + v[i,j]+beta1*xc1[i]+beta2*yc1[i]+W[area[i]]
P[i,j] <- PHI[i,j] / sum(PHI[i,1 :J])
v[i,j] ~ dnorm(0, tau.v[j])}}
#CAR distribution for the spatial correlated heterogenity
W[1:regions] ~ car.normal(adj[], weights[], num[], tau.u)
W.mean <- mean(W[])
#Weights









# Age of Mother group model
model
{ for (i in 1 :n) {MAgecat[i] ~ dcat( P[i,1 :J])
xc1[i]<-Xcoord[i]-mean(Xcoord[i])
yc1[i]<-YCoord[i]-mean(YCoord[i])
for (j in 1 :J) {
log(PHI[i,j]) <- betaO + v[i,j]+beta1*xc1[i]+beta2*yc1[i]+W[area[i]]
P[i,j] <-PHI[i,j]/sum(PHI[i,1:J])
v[i,j] ~ dnorm(0, tau.v[j])}}
#CAR distribution for the spatial correlated heterogenity
W[1:regions] ~ car.normal(adj[], weights[], num[], tau.u)
W.mean <- mean(W[])
#Weights









Figure 21 WinBUGs code for Cryptorchidism/Hypospadias model
model




#CAR distribution for the spatial correlated heterogenity
W[1:regions] ~ car.normal(adj[], weights!], num[], tau.u)
W.mean <- mean(W[])
#Weights
for (i in 1 :sumNumNeigh) { weights[i]<-1}
beta0~dnorm(0,2)
for(j in 1:2) {betaO] ~ dnorm(0.0, 1000)}
tau.v~dgamma(1,1)
tau.u ~ dgamma(1, 1)}
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3.8 Bayesian Hierarchical Multi-indicator model
As it is hypothesised that an environmental factor is associated with the
disease/conditions then, if the environmental factor varied across Scotland, it would
be expected that the number of cases would also vary geographically. Furthermore, if
these disease/conditions are believed to have one underlying environmental cause
then it would be expected to find an association between their geographical
variations. A multi-indicator model could examine the similarities and differences in
the spatial variation in risk between the disease/conditions. It could therefore
examine the relationships between the spatial variations of the different
disease/conditions.
Another advantage of a multi-indicator model is the potential to reduce the
variability of the relative risks estimated. This is particularly applicable with rare
conditions, which is the case with these disease/conditions. As seen previously, the
random variability of the relative risks estimates is largely due to the sparse counts
within postcode sectors. However, a multi-indicator model has the potential for a
particular disease to 'borrow-strength' from the other indicators. Considering more
than one indicator in the model results in an increase in the cases potentially
associated with the underlying geographically varying factor, which would reduce
the random variability of the estimates within a particular postcode sector. However,
in order for this potential reduction in the variability of estimates to occur, the spatial
pattern of the relative risks of the indicators included must be similar.
Furthermore, as discussed in Chapter 2, since the start of this research project a
multi-indicator approach has been proposed for the analysis of male reproductive
health, that compliments the above statistical argument (Skakkebaek, Rajpert-De
Meyts, and Main, 2001). The authors recommended that future epidemiological
studies on trends in male reproductive health should take into account all aspects of
TDS rather than focusing on only one symptom, as important biological information
could be lost. As the proposed in utero exposure to environmental chemicals occurs
at low-doses and the manifestation of some of the symptoms take place several
decades since the potential exposure, the strength of the potential association is
'diluted'. In addition, all the disease/conditions are associated with other risk factors
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unrelated to environmental exposure, so potentially further diluting any associations.
Therefore Skakkebaek and colleagues are suggesting that taking into account all
aspects of TDS would counteract some of this dilution. The combined analysis of
various symptoms of TDS, as proposed here with the multi-indicator model, could
increase the strength of association between the indicators and the underlying
geographically-varying risk factor.
Therefore, while the development of a multi-indicator model is statistically attractive
for such data, it is also pertinent to the health problem being investigated.
3.8.1 Model
The multi-indicator model is a multivariate extension of the BYM model (3.6.2.4)
and the WinBUGs code for this is shown in Figure 22. This model was developed
from the two disease model outlined by (Knorr-Held and Best, 2001), so as to
include three diseases. A Poisson likelihood is assumed for the observed number of
diseasej (j=l,..M, M=3) in area i (i=l,..N, N=895) i.e.
y,j ~ Poisson( etj&v),
so, log &v = a j + Uy + Vy
where a . represents the disease specific overall relative risk. The heterogeneity
terms are multivariate extensions of those specified in the BYM model i.e. Vy is the
uncorrected heterogeneity with independent multivariate normal priors,
Vy ~ mvN(0,rj) ,
therefore the precision of the multivariate priors (tau[ , ] in WinBUGs code) have to
be specified and are assumed to have a Wishart(Q, M) distribution.
For the spatial correlated heterogeneity term uip there is multivariate extension of the
conditional autoregressive model (CAR) prior used in the BYM model
[Uy | ulk,u2k,u3k,i*k,t]]~ mvN(uIJ Ty)
where 17 ==1— Jka>,k
2-®* *
k
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Figure 22 WinBUGs code for multi-indicator model
model
{
for(i in 1:N) {













#MV CAR distribution for the spatial correlated heterogeneity
u[1:M,1:N] - mv.car(adj[], weights[], num[], omega[, ])
# Bivariate normal prior for spatial uncorrected heterogeneity
for (i in 1:N) { v[i,1:M] ~ dmnorm(zero[],tau[, ])}
#Weights
for (i in 1:sumNumNeigh)
{ weights[i]<-1}
eps<-1.0E-6
#area specific relative risk for
#area specific relative risk for
#area specific relative risk for
#first part of deviance calc for
#second part of deviance calc
#first part of deviance calc for
#second part of deviance calc
#first part of deviance calc for
















omega[1:M, 1:M] ~ dwish(R[, ], M)
sigma2.u[1 :M, 1:M] <- inverse(omega[, ])
sigma.u[1] <- sqrt(sigma2.u[1, 1])
sigma.u[2] <- sqrt(sigma2.u[2, 2])
sigma.u[3] <- sqrt(sigma2.u[3, 3])
corrl .u <- sigma2.u[1, 2] / (sigma.u[1] * sigma.u[2])
corr2.u <- sigma2.u[1, 3] / (sigma.u[1] * sigma.u[3])
corr3.u <- sigma2.u[2, 3] / (sigma.u[2] * sigma.u[3])
tau[1:M, 1:M] - dwish(Q[, ], M)
sigma2.v[1:3, 1:3] <- inverse(tau[, ])
sigma.v[1] <- sqrt(sigma2.v[1, 1])
sigma.v[2] <- sqrt(sigma2.v[2, 2])
sigma.v[3] <- sqrt(sigma2.v[3, 3])
corrl.v <- sigma2.v[1, 2] / (sigma.v[1] * sigma.v[2])
corr2.v <- sigma2.v[1, 3] / (sigma.v[1] * sigma. v[3])
corr3.v <- sigma2.v[2, 3] / (sigma.v[2] * sigma.v[3])
#deviance calc for disease 1
#deviance calc for disease 2
#deviance calc for disease 3
#log likelihood
# Precision matrix of MVCAR
# Covariance matrix of MVCAR
# conditional SD of u[1,] (cryp)
# conditional SD of u[2,j (hypo)
# conditional SD of u[3,] (tc)
# within-area conditional correlation
# between spatial component of
#variation in the three diseases.
# Precision matrix of MV Normal
# Covariance matrix of MV Normal
# conditional SD of v[,1] (cryp)
# conditional SD of v[,2] (hypo)
# conditional SD of v[,3] (tc)
# within-area correlation between
# unstructured component of
# variation in the three diseases
# within-area conditional correlation between total random effects
# (i.e. spatial+unstructured components) for between disease correlation
corr.suml <- (sigma2.u[1,2]+sigma2.u[1,2]) /
(sqrt(sigma2.u[1,1]+sigma2.v[1,1])*sqrt(sigma2.u[2,2]+sigma2.v[2,2]))
corr.sum2 <- (sigma2.u[1,3]+sigma2.v[1,3]) /
(sqrt(sigma2.u[1,1]+sigma2.v[1,1])*sqrt(sigma2.u[3,3]+sigma2.v[3l3]))
corr.sum3 <- (sigma2.u[2,3]+sigma2.v[2,3]) /
(sqrt(sigma2.u[2,2]+sigma2.v[2,2])*sqrt(sigma2.u[3,3]+sigma2.v[3,3]))
}
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and rf, = —, colk = 1, if i,k are neighbours (0 if they are not).
L0J.k
k
So the distribution of the log relative risk in postcode sector i for disease j is normal
with mean given by the mean of the log of the relative risks in the neighbouring
postcode sectors for that disease and the variance being proportional to the number of
neighbouring postcode sectors.
In WinBUGs the multivariate CAR is specified as mv.car for the M x N matrix of
random variables U, where columns of U represent the postcode sectors and rows
represent the diseases (i.e. opposite from the other specified terms). The syntax for
this distribution is as follows:
u[l:M, 1 :N] ~ mv.car(adj[], weights[], num[], omega[, ])
where adj[], weights[], num[] are the same outlined for the BYM model. The only
difference is the precision matrix of the multivariate intrinsic Gaussian CAR prior
omega[ , ]. As with the uncorrelated heterogeneity, the precision of the multivariate
priors for the spatially correlated heterogeneity are assumed to have a Wishart(R, J)
distribution.
Table 13 describes the other parameters specified in the multivariate model detailed
in Figure 22. The comparison of indicators' relative risks is done by comparing one
with another so as to investigate which of the three indicators have a between
postcode sector correlation and whether it is spatially or randomly structured. The
correlation of the spatially structured heterogeneity between two particular diseases
is estimated by corr#.u, while the correlation of the spatially unstructured
heterogeneity between two diseases is estimated by corr#.v. The correlation of the
total heterogeneity between two diseases is estimated by corr#.sum. These three
terms are compared to see if the two diseases have a between area correltion and
whether this is due to geographically-varying unexplained risk or a non
geographically-varying unexplained risk.
The intercept terms for the three diseases (a[#]) represent the logarithm of the overall
disease-specific relative risk.
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Table 13 Descriptions of parameters included in Multi-Indicator model
Parameter Description of parameter
a[ 1 ] Intercept term for Cryptorchidism model
a[2] Intercept term for Hypospadias model
a[3] Intercept term for Testicular Cancer model
corr.suml Within-area correlation between total heterogeneity ofCryptorchidism and Hypospadias
corrl .u Within-area correlation between spatial heterogeneity of Cryptorchidism and Hypospadias
corrl .v Within-area correlation between random heterogeneity of Cryptorchidism and Hypospadias
corr.sum2 Within-area correlation between total heterogeneity of Cryptorchidism and Testicular Cancer
corr2.u Within-area correlation between spatial heterogeneity ofCryptorchidism and Testicular Cancer
COrr2.v Within-area correlation between random heterogeneity ofCryptorchidism and Testicular Cancer
corr.sum3 Within-area correlation between total heterogeneity of Hypospadias and Testicular Cancer
corr3.u Within-area correlation between spatial heterogeneity of Hypospadias and Testicular Cancer
corr3.v Within-area correlation between random heterogeneity ofHypospadias and Testicular Cancer
sigma.u[ 1 ] Standard Deviation of spatial heterogeneity of Cryptorchidism
sigma.u[2] Standard Deviation of spatial heterogeneity ofHypospadias
sigma. u[3] Standard Deviation of spatial heterogeneity of Testicular Cancer
sigma.v[ 1 ] Standard Deviation of random heterogeneity for Cryptorchidism
sigma.v[2] Standard Deviation of random heterogeneity for Hypospadias
sigma.v[3] Standard Deviation of random heterogeneity for Testicular Cancer
For each of the diseases, the variability of the heterogeneity estimates is summarised
by the standard deviation. In the WinBUGs code, the standard deviations are
estimated by sigma.u(#) (spatially correlated heterogeneities) and sigma.v(#)
(spatially uncorrelated heterogeneities).
As will be detailed later (3.9.3) an overall goodness of fit measure (D.I.C) is
calculated in WinBUGs for all the models in this project. However, this tool is
currently not available when the mv.car distribution is used. Therefore, this measure
had to be calculated in the model. The D.I.C is calculated as,
DIC = Z)-pD = 2*D-D
where D is the deviance which is pre-defined in WinBUGS and so can be estimated
from the posterior distribution like other parameters. D is the conditional log
likelihood, and needs to be specified in the model. In the case of a Poisson model it is
D = 2 XT (Ln(y,) - Ln(mul)) (yt -mu,)
. <=i <=i
which needs to be calculated for each indicator and then summed to provide the
overall model's conditional log likelihood.
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3.9 Bayesian Modelling Software -WinBUGs
As already mentioned the analysis of these data has been done using the package
WinBUGs. WinBUGs was developed by the Medical Research Council Biostatistics
Unit at Cambridge University. The program is currently free to download at
http://www.mrc-bsu.cam.ac.uk/bugs/ and comes with a wide range of documentation
and examples. This section describes the basics of the package - what data are
required to run models; the checks required and how the results produced by the
models were assessed.
3.9.1 Running a model in WinBUGs
There are three pieces of information required by WinBUGs to run a Bayesian
model:
(i) The model file specifies the likelihood and priori distributions and the
accompanying data. It can be developed graphically via DoodleBUGs which
allows the user to describe the models in terms of graphs. However, as many
features of BUGs language cannot be expressed using the graphical interface,
all models within the research project were specified via the text-based BUGs
language and have been shown for each stage of analysis.
(ii) The data is specified in the model file but is introduced as a separate file and
there are particular formats in which WinBUGs reads data.
(iii) Initial values are required for those priors for whom no data are known nor
provided e.g. hyper-parameters. They can either be entered in the same
format as the data file or WinBUGs will generate initial values from the
specified prior or an approximation to it. If initial values are given this can
sometimes help convergence occur sooner.
3.9.2 Checking convergence
In order to produce posterior estimates, samples are taken from the posterior
distribution. Before samples can be taken it is necessary to assess if the iterative
simulations have reached an equilibrium distribution - known as convergence. To
check for convergence in WinBUGS, it is recommended to use a combination of
diagnostics and visual inspection of trace plots (Lawson, Browne, and Vidal Rodeiro,
2003).
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The visual inspection of trace plots consists of running parallel chains and looking at
the histories of the parameters produced by the model. The history plots the value of
the parameters against the number of iterations. If the parameter is converged then







The convergence diagnostic produced in WinBUGs is the Gelman-Rubin diagnostic
(Brooks and Gelman, 1998). It is based on running parallel chains from different
initial values. The Gelman-Rubin plot shows three values over the iterations: a green
line represents the width of the central 80% interval of the pooled runs; a blue line
represents the average width of the 80% intervals within the runs; and the red line
represents the ratio of the pooled/within runs. Convergence is believed to be reached
when the ratio converges to 1, while the pooled and within values have reached
stability (Brooks and Gelman, 1998). Figure 24 shows the Gelman-Rubin plot
produced by WinBUGs for a converged parameter, the red line has converged on 1
and the blue and green line have stabilised.





1001 2500 5000 7500
iteration
Therefore before any posterior samples were taken from any of the models described
previously, convergence was tested by visual assessment of the history plot and the
Gelman-Rubin plot on running two parallel chains. On convergence, further
iterations were run from which samples were taken to obtain posterior inferences.
Example of a history plot for which a parameter has converged
contrasts ] chains 1:2
—i 1 1 1 1—
1001 2500 5000 7500 10000
iteration
contrast[1] chains 1:2
T 1 1 1 r
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The number of further iterations required for accurate posterior estimates was
assessed by using the Monte Carlo standard errors (MC error) of the parameters
which is produced by WinBUGs when posterior samples are requested. It is
recommend that the MC error, i.e. the standard deviation of the difference between
the mean of the sampled values and the true posterior mean, should be small
compared to the posterior standard deviation (Lawson, Browne, and Vidal Rodeiro,
2003). For all the models reported, the estimates were assessed to be accurate when
the MC error was at least 5% of the posterior standard deviation.
3.9.3 Assessment of models
As three Bayesian Hierarchical disease count models were run to attempt to explain
the spatial variation of the relative risks these models performance need to be
compared and assessed. Indeed with any modelling, an assessment of the models via
an analysis of the residuals should be carried out. The standardised residuals r, were




where y, is the observed count, y( is the fitted values due to the model i.e. expected
count x estimated relative risk and ^/var(y, - y(.) is the standard deviation of the
standardised residuals.
There are assumptions placed on the standardised residuals which require testing and
these have been shown for each of the disease count models. The normal plot of the
standardised residuals should follow the x=y line; and when the standardised
residuals are plotted against the fitted values, the standardised residuals should be
evenly scattered at all the fitted values.
Also shown for each of the disease count models are the maps of the standardised
residuals by postcode sectors. These maps are used to visually assess if there is any
spatial correlation of the standardised residuals i.e. are there clusters. Furthermore,
the spatial correlation of the standardised residuals can be tested formally using the
Moran's I, which is also included for the residuals of each disease count model.
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As previously mentioned several models have been compared in the analysis, either
to see which models fits the data better or to see if the inclusion of possible
covariates within a particular model might explain any spatial variation. The
Deviance Information Criterion (DIC) diagnostic is the overall goodness of fit
measure developed for WinBUGs (Spiegelhalter et al., 2002), and is used for all the
comparison of models. The values produced by the diagnostic are the deviance and
the DIC which is the deviance value that takes into account the number of parameters
within the model. For a model to be a significantly better fit to data than another
model, it is recommended that there is a difference of 2 between the DIC values.
3.10 Summary of Research Project
This chapter has outlined the research project and this final section aims to
summarise this.
Firstly the aims of the research project were outlined and discussed in relation to
current research. These aims of the study attempt to:
> give a complete picture of the spatial variation of three indicators of male
reproductive health in Scotland.
> explain any geographical variation found in these disease/conditions; and so
investigate the possible underlying environmental exposure hypothesised to be
associated with male reproductive health.
> overcome the two unresolved issues highlighted in previous research, namely
the quality of the diseases/conditions data and the conjoint analysis of these
indicators.
Before describing the research project in more detail it was necessary to introduce
some key concepts of spatial epidemiology, as these would determine the data used
and its subsequent analysis.
> To achieve the aims of the research project the following types of analyses
would be carried out on disease count data: disease mapping, non-focused
clustering and ecological analysis.
> There are cartographic and visual cognition issues that have consequences on
the maps presented in this research project, namely;
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(i) thematic maps are produced;
(ii) for maps of the same disease/condition the same cut-off values are used;
(iii) a close-up of the Central Belt is produced for most maps;
(iv) blue is chosen as the colour gradient with darker shades for higher values
and lighter for lower;
(v) the boundaries of the postcode sectors are not illustrated.
> The use of disease count data may introduce ecological bias where inferences
made about the spatial variation of the risk between postcode sectors does not
necessarily translate to the individuals within those postcode sectors.
The datasets used in the study were described and classified into four categories
depending on its use within the research project;
> the three specific diseases for which the geographical distributions are to be
described are cryptorchidism, hypospadias and testicular cancer. In Scotland
these Male Reproductive Health Disease/Condition datasets are of a high
quality i.e. consistently collected across geography and time, therefore
potentially overcoming unresolved issues highlighted in previous research;
> birth and population data are used to standardise particular male reproductive
health diseases/conditions by the underlying population at risk;
> the 1991 Census postcode sector boundary data are used in all maps to show
the geographical distribution of the male reproductive health disease/condition
in Scotland;
> a rural/urban indicator, 2 deprivation indices and 2 radon measurements are
used to explore if they explain the geographical distributions of the male
reproductive health disease/condition data.
> all data are geo-referenced on postcode sector and as these change over time
they need to be assigned to one common geography; the methods used to
assign all postcode sector to those postcode sector boundaries valid as at 1991
census are described and discussed.
There are four analyses carried out on the disease count data separately to estimate
the relative risk per postcode sector in Scotland. The first is the calculation of the
Standardised Morbidity Ratios (SMRs). Although the SMRs take into account the
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size of the population at risk within each postcode sector, they can be dominated by
the uncertainty of the estimates, particularly in areas with small number of cases. In
order to account for the variability of the relative risk estimates, that might either be
randomly or spatially structured, Bayesian Hierarchical modelling was used.
Three Bayesian Hierarchical Models were used to estimate the relative risks per
postcode sectors in Scotland. Each model makes different assumptions about the
spatial variation of the relative risks and the following table summaries these three
models in terms of these assumptions.
Table 14 Summary of the 3 Bayesian Hierarchical disease count models
Model
Likelihood Prior on SMRs (crude










Poisson Normal on log of SMRs
Poisson Normal on log of SMRs
Global Mean RR
Global Mean RR






> The potential covariates (a rural/urban indicator, 2 deprivation indices and 2
radon measurements) were included to the Log-Normal and BYM models to
see which factors explain the spatial variation of the different
disease/conditions.
> To compare the success of all the Bayesian Hierarchical models, an analysis of
the residuals would be conducted and a comparison of the DIC diagnostics.
> The BYM model was extended so as to analyse the three disease/conditions
conjointly. This conjoint model potentially would reduce the variability of the
estimates but also explore the spatial relationships between the three
disease/conditions relative risks.
To assess the possibility of ecological fallacy in these disease count models,
individual level Bayesian models were developed.
> The spatial analysis was conducted on particular individual level information
concerning the cryptorchidism cases (Year of Birth, Age of Mother and co¬
morbidity), to give an example of the potential of such analysis due to time
constraints.
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> A number of Bayesian models for each particular individual level information
are required to ascertain the extent to which effects (spatial and non-spatial)
explain any differences between the groups of individuals in each of these
individual level covariates.
> If the geographical variation of these groups of individuals were similar to that
of the geographical variation of the cryptorchidism risk, then it is possible that
this individual information explains the geographical variation in the relative
risk rather than area-specific risk factors.
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Chapter 4 : Cryptorchidism Analysis
4.1 Introduction
This chapter details the analysis of the cryptorchidism dataset described in Chapter 3,
where the methods used are also outlined. Specific methods sections of that chapter
are referred to at the relevant points within the results.
The results of the analysis are detailed in seven sections, the first summarises the
cryptorchidism dataset. The next five sections contain the area-specific spatial
analysis of cryptorchidism in Scotland. The first is a summary of the initial spatial
analysis - the SMRs, while the next three summarise the results of applying the three
Bayesian spatial models to the cryptorchidism dataset. The final area-specific spatial
analysis section outlines the results of including potential covariates within the
Bayesian models to explain the spatial variation of the relative risks. The final results
section shows the results of the individual level analysis carried out on the
cryptorchidism data to investigate the possibility of ecological bias.
The chapter is completed with a summary of the conclusions of the cryptorchidism
analysis and highlights points for further discussion.
4.2 Summary of cryptorchidism dataset
Further information pertaining to each of the cryptorchidism cases was requested as
part of the dataset (Appendix 1). This was done as the geographical variation of
cryptorchidism may be explained by this information rather than area-specific
factors. This section summarises those factors that will be included in the individual
level models (4.8).
4.2.1 Incidence over time
The incidence of births with cryptorchidism appears to increase with time in
Scotland (Figure 25), a pattern which has been found in previous research (Ansell et
al., 1992). The changes over time in incidence might also vary geographically.
Therefore a spatial model would assess if the year of birth of the cryptorchidism
cases varies geographically, and so might explain any geographical variation in
cryptorchidism.
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4.2.2 Mothers' year of birth
For those cryptorchidism cases that had accompanying details on their mother
(n=2,600) we would be able to see if information about these mother's might have an
association with any spatial variation. Firstly, the year of birth of the mother ranged
from 1935 to 1978, with a mean of 1960 and its distribution is approximately
normally distributed (Figure 26).
Figure 26 Histogram ofMothers' Year of Birth
1935 1939 1943 1947 1951 1955 1959 1963 1967 1971 1975
Year of birth of mother n=2.600
As the month and year of birth of the mother's are known it would be possible to
calculate the mother age when their son was born. Figure 27 shows the distribution
of the mothers' ages, which range from 14 to 45 with a mean of 26.5 years.
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Figure 27 Histogram of mother's age at son's birth
Age of mother at birth
4.3 Standardised Morbidity Ratio (SMR) maps
The methods used to calculate the SMRs for each 1991 postcode sector are outlined
in 3.6.1. The following gives the results of these calculations in relation to the
cryptorchidism dataset.
4.3.1 Observed number of cryptorchidism cases per 1991
postcode sector
Of the 2,635 cases of cryptorchidism, 12 records did not have postcode sector
recorded. Therefore 2,623 cases were linked to the database created that matches all
valid postcode sectors to where this would have been in 1991 (detailed in 3.5). Of the
691 postcode sectors recorded in the cryptorchidism dataset, only 679 were linked to
records within the 1991 database. The remaining 12 postcode sectors were not valid
postcode sectors; and are detailed in Table 15.
Table 15 Description of invalid postcodes in cryptorchidism dataset
Description of invalid
postcode sector
Number of postcode sectors (number of cases of cryptorchidism)
Mistyped postcode sector 4 postcode sectors (4 cases)
English postcode sector 1 postcode sectors (4 cases)
Local Council code 7 postcode sectors (92 cases)
Of those postcode sectors mistyped, 1 (1 case) could be corrected. However none of
the remaining postcode sectors could be geographically referenced resulting in 99
cases being excluded from further analysis. This exclusion was valid for those cases
with English postcode sectors, which probably resulted from cross-boundary
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attendance at a maternity hospital. However, the high number of cases lost in some
areas due to local council codes being used instead of postcode sectors does impact
on subsequent spatial analysis. Local council codes are used instead of postcode
sectors when an address is not known and are at much lower spatial resolution.
Therefore, those cases with local council codes can not be assigned to postcode
sectors as local councils cover several postcode sectors. When further investigation
was carried out on which local council codes were used it would appear that a
particular area of Scotland predominately used these codes. While most local
councils were only used once or twice in the dataset, 3 are used considerable more;
Kirkcaldy (40 cases), North East Fife (14 cases) and Dunfermline (34 cases). These
are in the same locality and furthermore, it would appear that these cases all
originated from two hospitals in the locality. It is not clear why this has occurred in
both the cryptorchidism and hypospadias datasets, but the result is that these areas of
Scotland will have under-reported cases of both diseases; which should be
remembered in subsequent assessment of the maps.
Therefore, of the 2,635 cases of cryptorchidism 2,524 could be assigned to a 1991
postcode sector. The distribution of the number of cryptorchidism cases per 1991
postcode sector is shown in Figure 28. As can be seen, the distribution is highly
skewed - the number of cases in each postcode sector ranges from 0 to 19 with a
median of 2 cases.
Figure 28 Histogram of the number of cryptorchidism cases per 1991 postcode
sectors
0 5 10 15 20
Number of cryptorchidism cases per 1991 postcode sector
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4.3.2 Expected number of cryptorchidism cases per 1991
postcode sector
The expected numbers of cryptorchidism cases per 1991 postcode sector have been
calculated using the methods described in detail in 3.6.1. The cryptorchidism
expected numbers were standardised by year of birth and the underlying population
used was all births within the linked maternity database.
The distribution of the expected cryptorchidism cases in the 1991 postcode sectors is
shown in Figure 29. While the distribution is skewed, it is not as extreme as the
observed values - The range of expected cases within the postcode sectors is 0 to
12.04, with a median of 2.52 cases.
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Expected number of cryptorchidism cases per 1991 postcode sector
4.3.3 SMRs of cryptorchidism cases per postcode sector
With the observed and expected values for each 1991 postcode sector calculated, the
SMR for each could be calculated. The distribution of the SMRs is highly skewed
(Figure 30).
There are three values that are very extreme - 235.61, 179.65 and 106.35.
Comparison of these values with the third quartile of 1.77 shows how skewed the
distribution is. These extreme values are a result of small expected values. The mean
SMR is 3.78 (standard deviation 14.8) while the median is 0.78.
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Figure 30 Histogram of cryptorchidism SMRs per 1991 postcode sector
0 50 100 150 200
SMRs for cryptorchidism cases per 1991 postcode sector
There are geographical variations in the SMRs across Scotland (Figure 31) shows the
maps of these values. There appears to be clustering of higher SMRs in the North-
East and South-West of Scotland and clustering of the lower SMRs in the North-
West and South East.
As discussed in 3.6.1, SMRs are prone to high variability especially when used with
areas with small number of cases. Cryptorchidism is the lowest incidence of the three
conditions studied in the research project so SMR variability will be particularly
pertinent here. The variability of the estimates of the SMRs is assessed by calculating
the standard error of each SMR, the methods for which are also detailed in 3.6.1. The
distribution of the standard errors is, as the SMR distribution, very skewed. The
maximum value is 235.62 with a medium of 0.92. The maximum SMR (235.62) has
the same standard error value, as the observed count within this postcode sector is 1.
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Figure 31 SMRs per 1991 postcode sectors for Cryptorchidism: Scotland and Central
Belt 1980-1999
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The maps of the standard errors of the SMRs are shown below.
Figure 32 Standard error of SMRs per 1991 postcode sector for Cryptorchidism:
Scotland and Central Belt 1980-1999
It would appear that the clustering of the standard errors is similar to that of the
SMRs. Therefore the SMRs appear to reflect the random variation of the estimates
rather than any variation in disease risk. This variability in the standardised rates
reflects both the small number of cases and the variation in population density across
the postcode sectors. Therefore this initial analysis is limited in being able to show
the spatial variation of the cryptorchidism SMRs over Scotland. Therefore it looks
important to take into account this variability when calculating the cryptorchidism
disease risk, which can be done with Bayesian models.
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4.4 Bayesian Hierarchical Models of cryptorchidism
count data - Poisson-Gamma
As discussed in more detail in 3.6.2.2, the Poisson-Gamma model smoothes the
relative risks towards the overall mean relative risk and so decreases the range of
their values and variability. The model was run with the cryptorchidism dataset using
WinBUGs and converged following 4,000 iterations. To produce robust posterior
estimates a further 20,000 iterations were run.
4.4.1 Posterior estimates from model
The distribution of the posterior expected relative risks for each of the 1991 postcode
sectors as produced by the Poisson-Gamma model is shown in Figure 33.
Figure 33 Histogram of Cryptorchidism posterior expected Relative Risk estimated
from the Poisson-Gamma model
0.6 0.8 1.0 1.2 1.4 1.6 1.8
Posterior expected relative risks for cryptorchidism cases per 1991 postcode sector
The distribution is less skewed than that for the SMRs (median 0.97 and mean 0.99)
and as expected the range of values has been reduced (0.53, 1.8) towards the overall
mean. As the population mean relative risk is 0.99 with a standard deviation 0.026,
the variability of this estimate has also been reduced compared to the SMR (Table
16).
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a 5.94 0.774 0.05189 4.593 5.88 7.703
b 5.98 0.7943 0.05329 4.615 5.912 7.79
mean 0.9947 2.57E-02 4.71E-04 0.9455 0.9942 1.046
var 0.1693 0.0232 0.001475 0.1266 0.1683 0.2186
With the change in the variability of the estimates of the relative risks, the spatial
variation of the relative risks has been smoothed compared to the SMRs (Figure 34).
Even with the reduction in the variability of the estimates, the clustering of the higher
relative risks remains in the North-East of Scotland.
The probabilities of the relative risks being greater than 1 show a similar spatial
pattern to the relative risks map, so confirming those areas with high and low relative
risks while taking into account the variability of these estimates (Figure 35).
Chapter 4: Cryptorchidism Analysis 104
Spatial Epidemiology of Indicators of Male Reproductive Health in Scotland
Figure 34 Posterior mean relative risks per 1991 postcode sector for Cryptorchidism
from the Poisson-Gamma model: Scotland 1980-1999
Legend
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Figure 35 Posterior probabilities of relative risks per 1991 postcode sector for
Cryptorchidism from the Poisson-Gamma model: Scotland 1980-1999
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4.4.2 Assessment of model
The relative risk estimates have been smoothed by the Poisson-Gamma model, but is
the model successful at fitting the cryptorchidism data? In order to assess the model
an analysis of the standardised residuals is undertaken, as outlined in 3.9.3, and is
shown in Figure 36. The Normal Plot of the residuals (a) should follow the x=y line,
which is not the case for the extreme cases in particular the high relative risks. For
the residuals plotted by the fitted values (b), the residuals should be evenly scattered
at all the fitted values, this is not the case. Therefore the Poisson-Gamma model is
not a successful fit of the higher relative risk values of the cryptorchidism data.
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Furthermore, there appears to be some spatial correlation of the residuals in
particular in the North-East of Scotland (Figure 37).
Figure 37 Standardised Residuals of Poisson-Gamma model for Cryptorchidism:
Scotland and Central Belt 1980-1999
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The spatial correlation of the residuals can be tested formally using the Moran's I test
(Table 17).
Table 17 Moran's I test result for residuals from Poisson-Gamma model
Statistic Result
Number of permutations 100
Correlation (95% CI) 0.19 (0.15, 0.23)
Correlation Normal p-value (2-sided) 4.4 x 10"4
Mean Permutation correlations (Inter-quartile range) -0.002 (-0.016, 0.0113)
Permutation p-value <0.00001
There does appear to be a statistically significant (p=4.4 x 10"4) spatial correlation of
the residuals, although it is not a very strong one (r=0.19). Furthermore, as the
permutations do not appear to be correlated (r=-0.002), then the test is valid.
Therefore as the residuals appear to cluster in areas where high relative risks are
estimated, then the models does not fully explain the variability of these estimates.
4.4.3 Conclusions for Poisson-Gamma Model
While the Poisson-Gamma model smoothes the relative risks and so decreases the
range of their values, it does not fully take into account the variability of the
cryptorchidism estimates. In particular, the model is least successful for those areas
with high relative risks. As there appears to be some clustering of the residuals, it
might be that a term that accounts for spatially correlated heterogeneity should be
included within a model for the cryptorchidism data.
4.5 Bayesian Hierarchical Models of cryptorchidism
count data - Log-Normal
The Log-Normal model smoothes the relative risk estimates towards the overall
mean relative risk as with the Poisson-Gamma, but unlike the Poisson-Gamma it is
possible to include additional terms. As detailed further in 3.6.2.3, a spatially
uncorrelated heterogeneity term is the only term added to this model. This term
assumes that any variability in the relative risk estimates is random and not spatially
structured; a spatially structured heterogeneity term will be added in the BYM model
which is detailed in 4.6. The Log-Normal model converged following 2,000
iterations with a further 10,000 were run to produce robust posterior estimates.
Chapter 4: Cryptorchidism Analysis 109
Spatial Epidemiology of Indicators of Male Reproductive Health in Scotland
4.5.1 Posterior estimates from model
The distribution of the cryptorchidism posterior expected relative risks for each of
the 1991 postcode sectors as produced by the Log-Normal model is shown in Figure
38. It has a similar distribution of relative risks as the Poisson-Gamma model
(median 0.97 and mean 0.99), although has a narrower range of values (0.65-1.75)
compared to the Poisson-Gamma (0.53, 1.8).
Figure 38 Histogram of Cryptorchidism posterior expected Relative Risk estimated
from the Log-normal model
0.6 0.8 1.0 1.2 1.4 1.6 1.8
Posterior expected relative risks for cryptorchidism cases per 1991 postcode sector
Therefore, the Log-Normal model reduces the range of values compared to the SMRs
and those produced by the Poisson-Gamma model. As already mentioned the Log-
Normal smoothes the relative risk estimates towards the overall mean relative risk,
which for the cryptorchidism data is 0.93 with a standard deviation of 0.02 (Table
18).
Table 18 Posterior estimates for parameters in Log-Normal model
Parameter Mean
Standard MC 2.5% credible
Median
97.5% credible
Deviation error interval interval
alpha -0.07081 0.02635 5.22E-04 -0.1238 -0.07066 -0.02095
mean 0.932 0.02454 4.85E-04 0.8836 0.9318 0.9793
tau.v 8.59 1.744 0.07418 5.96 8.315 12.64
So the population mean relative risk produced by the Log-Normal is lower than that
produced by the Poisson-Gamma model but higher than the median SMRs. The
variability of this estimate has been reduced compared to the SMR and to the same
extent as that done by the Poisson-Gamma model. The spatial variation of the
Chapter 4: Cryptorchidism Analysis 110
Spatial Epidemiology of Indicators of Male Reproductive Health in Scotland
relative risk estimates produced by the Log-Normal model is very similar to that
produced by the Poisson-Gamma model (Figure 39). Again we can see the North-
East has a cluster of elevated cryptorchidism risk, although they are only slightly
elevated.
Figure 39 Posterior mean relative risks per 1991 postcode sector for Cryptorchidism
from the Log-normal model: Scotland 1980-1999
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As with the Poisson-Gamma model, the probabilities of the relative risks being
greater than 1 show a similar spatial pattern to the relative risks map, so confirming
the areas with high and low relative risk while taking into account the variability of
the estimates (Figure 40).
Figure 40 Posterior probabilities of relative risks per 1991 postcode sector for
Cryptorchidism from the Log-normal model: Scotland 1980-1999
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The uncorrelated heterogeneity term within the Log-Normal model attempts to
account for the extra variation of the relative risk estimates. The map of this term by
postcode sector will show if there is a spatial clustering of the extra variation (Figure
41).
Figure 41 Posterior mean uncorrelated heterogeneity term v, per 1991 postcode sector
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It would appear that those areas with high relative risks also have high extra
variation. Therefore the heterogeneity does appear to vary in a spatially structured
way, so this term should be included within the model. This is carried out in the
BYM model in section 4.6. However, before doing this the residuals of the Log-
Normal model need to be fully assessed so as to fully evaluate the model.
4.5.2 Assessment of model
To firstly assess the model an analysis of the residuals is done, as shown in Figure
42.
Figure 42 Log-normal Model residuals analysis - (a) Normal Plot (b) Residuals v
Fitted
Quantiles of Standard Normal
(a)
(b)
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It would appear that the Log-Normal model is not any more successful at fitting the
cryptorchidism data than the Poisson-Gamma model. The normal plot (a) shows that
although most of the residuals follow the x-y line, the larger extreme values do not fit
the Log-Normal model and, as with the Poisson-Gamma model, the residuals are not
evenly scattered across all fitted values (b). Therefore, as with the Poisson-Gamma
model, the Log-Normal is not a completely successful fit to the cryptorchidism data,
particularly for the higher relative risk values.
Figure 43 shows the maps of the residuals produced by the Log-Normal model for
each of the postcode sectors.
Figure 43 Standardised Residuals of Log-normal model for Cryptorchidism:
Scotland and Central Belt 1980-1999
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As with the Poisson-Gamma model, there might be a spatial correlation of the
residual particularly in the North-East of Scotland where the higher relative risks
occur. This can be tested formally using the Moran's I (Table 19).
Table 19 Moran's I test result for residuals from Log-normal model
Statistic Result
Number of permutations 100
Correlation (95% CI) 0.19 (0.15, 0.23)
Correlation Normal p-value (2-sided) 4.4 x 10"4
Mean Permutation correlations (Inter-quartile range) -0.003 (-0.014, 0.016)
Permutation p-value <0.00001
As with the Poisson-Gamma model, there appears to statistically significant (p= 4.4 x
10~4) spatial correlation of the residuals, although it is not a strong one (r=0.19).
Therefore as the residuals appear to cluster in areas where high relative risks are
estimated, then the models does not fully explain the variability of these estimates.
4.5.3 Conclusions for Log-Normal model
The Log-Normal model does not appear to be an improvement on the Poisson-
Gamma model for estimating the relative risks for the cryptorchidism dataset. Both
show a similar spatial variation of the relative risk of cryptorchidism. However, from
the residual analysis of the Log-Normal model it does not appear to fit the
cryptorchidism dataset any better than the Poisson-Gamma model. Also from the
residual analysis it would appear that there is a spatial component to the
heterogeneity of the relative risk estimates.
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4.6 Bayesian Hierarchical Models of cryptorchidism
count data - Besag, York and Mollie (BYM) model
As shown in the previous sections neither the Poisson-Gamma nor the Log-Normal
models are adequately successful at fitting to the cryptorchidism dataset. While the
Log-Normal model includes a random heterogeneity term, neither model takes into
account the spatial correlation i.e. that a postcode sector will be similar to its
neighbours. It would appear that there is a spatial correlation of the residuals
produced by the Poisson-Gamma model residuals and clustering of high relative risks
in the North-East of Scotland. The BYM model does include a spatially correlated
heterogeneity term. When the model was run in WinBUGs it converged following
10,000 iterations, and a further 20,000 iterations were run to produce robust posterior
estimates.
4.6.1 Posterior estimates from model
Figure 44 shows the distribution of the posterior expected relative risks estimated
from the BYM model. It is similar in shape to the distributions of the relative risks
estimated by the Poisson-Gamma and Log-normal models. However the BYM
21relative risks estimates have a wider range of values (1.77 x 10" , 2.60) compared to
the Log-Normal (0.65-1.75) and the Poisson-Gamma models (0.53, 1.8).
Figure 44 Histogram of Cryptorchidism posterior expected Relative Risk estimated
from the BYM model
0.0 0.5 1.0 1.5 2.0
Posterior expected relative risks for cryptorchidism cases per 1991 postcode sector
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It is possible to compare the non-postcode-specific parameter estimates produced by
the BYM model to those produced by the Log-Normal to see if the inclusion of the
spatially correlated heterogeneity term has an impact on the estimates. The
population mean relative risk is 0.63 which is considerably lower than that produced
by the other Bayesian models and the median SMR (Table 20).







alpha -0.4528 0.1079 0.008776 -0.6529 -0.4674 -0.2199
mean 0.6396 0.07019 0.005719 0.5206 0.6266 0.8026
tau.u 5.265 1.005 0.0421 3.64 5.16 7.61
tau.v 1652 1598 123.1 110.3 1114 6046
The intercept term alpha has decreased and the precision of the non-spatial
heterogeneity term has deteriorated, compared to the Log-Normal model. Therefore
the inclusion of the spatially correlated heterogeneity term appears to have weakened
the intercept term and the precision of the non-spatial heterogeneity term.
The maps of the posterior expected relative risks from the BYM model show the
same spatial variation as those produced by the other Bayesian models; however it is
more distinct (Figure 45). Therefore the inclusion of the spatially correlated
heterogeneity term within the model has meant that the relative risk appears to have a
more distinct spatial correlation than the other models - higher relative risks in East
and South-West of Scotland. This spatial pattern of the relative risks is repeated in
the probabilities of the relative risks being greater than 1, therefore confirming the
spatial variation of the relative risks produced by the BYM model while taking into
account the variability of the estimates (Figure 46).
The spatial variation of the heterogeneity terms in the BYM model will show in more
detail the heterogeneity of the relative risk estimates. As with the Log-Normal
model, the non spatial heterogeneity does appear to have some spatial correlation
(Figure 47). The spatially correlated heterogeneity term does show spatial correlation
similar to that of the relative risks (Figure 48). Therefore the variability of the
random effects appears to have a spatial component.
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Figure 45 Posterior mean relative risk per 1991 postcode sector for Cryptorchidism
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Figure 46 Posterior probabilities of relative risks per 1991 postcode sector for
Cryptorchidism from the BYM model: Central Belt 1980-1999
Legend
Posteiioi Piol>Utilities of Relative Risks
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b
Chapter 4: Cryptorchidism Analysis 120
Spatial Epidemiology of Indicators of Male Reproductive Health in Scotland
Figure 47 Posterior mean uncorrected heterogeneity term v, per 1991 postcode sector
for Cryptorchidism from the BYM model: Scotland and Central Belt 1980-
1999
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Figure 48 Posterior mean spatial correlated heterogeneity term «, per 1991 postcode
sector for Cryptorchidism from the BYM model: Scotland and Central
Belt 1980-1999
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The spatial variation of the heterogeneity terms in the BYM model might be because
there is a spatially correlated variability in the estimates of the relative risks.
However, it could be that the CAR model used in the BYM model for the spatially
correlated heterogeneity term over-smoothes the relative risks and so soaks up all
extra variation. This might explain the deterioration in the precision value for the
non-spatially correlated heterogeneity term between the Log-Normal and BYM
model.
4.6.2 Sensitivity Analysis
As discussed in 3.6.2.4 it was decided to carry out sensitivity analysis on the inverse-
variance of the spatial correlated heterogeneity (tau.u) in the BYM model, because of
concerns that the spatially correlated heterogeneity term over-smoothes the relative
risk estimates.
Table 21 shows the results of the comparison of the relative risks estimated by the
BYM model outlined (Model 1) and those from the BYM model where the prior for
tau.u is changed to gamma(0.5, 0.0005). While there appears to be a strong
correlation between the two sets of estimated relative risks, those estimated by Model
1 appear to be significantly lower than those estimated from Model 2 for the same
postcode sector. However does that change the spatial variation of the relative risks
estimated for cryptorchidism?
Table 21 Comparison tests of Relative Risks estimated from BYM models using
prior for tau.u gamma(l,l,) (model 1) and gamma(0.5, 0.0005) (model 2)
Correlation co-efficient of Mean difference in relative risks
Paired t-test - p valuerelative risks (95% CI) (Model 1-2)
0.989 -0.004 (-0.007,-0.001) 0.0038
If we compare the spatial variation of the relative risks estimated from Model 2
(Figure 49) with those estimated from Model 1 (Figure 46) there is very little
difference in the spatial variation of the two. Therefore, while the relative risks
estimated by the BYM model with a less specific prior for tau.u (gamma(0.5,
0.0005)) are significantly lower than those produced by the BYM model with a more
specific prior (gamma(0.5, 0.0005)), this does not alter the distinct spatial variation
of the estimated relative risks for cryptorchidism.
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Figure 49 Posterior probabilities of relative risks per 1991 postcode sector for
Cryptorchidism from the BYM model with prior of tau.u gamma(0.5,
0.0005): Central Belt 1980-1999
Legend
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4.6.3 Assessment of model
An analysis of the residuals of the BYM model might suggest if the BYM model is a
better fit of the data and so does the spatially correlated heterogeneity term help
model the relative risk estimates (Figure 50).
Figure 50 BYM Model residuals analysis - (a) Normal Plot (b) Residuals v Fitted
Quantiles of Standard Normal
(a)
*x **», * *
I o ; ■.,«■
0 5 10 15
Fitted values
(b)
The BYM model is not any more successful at fitting the cryptorchidism data than
the other two Bayesian models according to the residual tests. The Normal Plot of the
residuals (a) does not follow the x=y line for the extreme values. As with the other
two Bayesian models, the residuals are not evenly scattered when plotted by the
fitted values (b), and shows that for the extreme fitted values the models is an
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unsuccessful fit. Therefore, as with the other Bayesian models the BYM model is not
a complete success at fitting the cryptorchidism data.
From the maps of the residuals, there might again be some spatial correlation in
particular in the North-East of Scotland (Figure 51).
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13From the Moran's I test results there is a statistically significant (p=8.7 x 10" )
spatial correlation of the residuals, although it is not strong correlation (r=0.15)
(Table 22). Therefore as the residuals appear to cluster in areas where high relative
risks are estimated, then the model does not fully explain the variability of these
estimates.
Table 22 Moran's I test result for residuals from BYM model
Statistic Result
Number of permutations 100
Correlation (95% CI) 0.15 (0.11, 0.19)
Correlation Normal p-value (2-sided) 8.7 x 10"lj
Mean Permutation correlations (Inter-quartile range) -0.004 (-0.019, 0.011)
Permutation p-value 0
As well as comparing residual analysis results, we can compare the three Bayesian
models fit to the cryptorchidism data by comparing the DIC diagnostics results
(Table 23).
Table 23 Model fitting results of the three disease count models
Model D d{§) pD DIC
Poisson-Gamma model 2856.57 2618.22 238.342 3094.91
Log normal model 2910.16 2711.38 198.777 3108.93
BYM model 2851.36 2720.96 130.406 2981.77
From the deviance D , it would appear that the BYM model is the best fit of the three
models. Furthermore it would also appear to be the best model from the DIC results,
as this takes into the number of parameters (pD) used within each model. The
Poisson-Gamma model is a better model than the Log-Normal model for the
cryptorchidism data. Therefore the inclusion of the spatially correlated heterogeneity
term within the BYM model compared to the Log-Normal model has greatly
improved the fit of the model to the data. Is this because the spatially correlated
heterogeneity term is a successful fit to the cryptorchidism data or is this term too
successful and 'soaks up' all extra variation?
4.6.4 Conclusions for BYM Model
Therefore the BYM model appears to produce relative risk estimates that show the
spatial variation of the cryptorchidism data more acutely than the other Bayesian
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models. Furthermore, in the comparison of the DIC diagnostics it would appear to be
the better model in terms of fit to the cryptorchidism data.
However, there are concerns about the performance of the BYM model. The
improvement of the BYM compared to the Log-Normal model in terms of the DIC
results shows that the inclusion of the spatially heterogeneity term has a considerable
impact on the model performance. As already mentioned is this because the spatially
correlated heterogeneity term is a successful fit to the cryptorchidism data or is this
term too successful and 'soaks up' all extra variation. This is not clear from the
analysis currently shown.
4.7 Inclusion of covariates into Bayesian hierarchical
models of disease count data
None of the Bayesian models have included other covariates that might explain the
spatial variation in the relative risks of the cryptorchidism data. Both the Log-Normal
and BYM models can include other covariates and as it is unclear of the impact of
the spatially con-elated heterogeneity on modelling the extra variation, both models
have been used in this section to see if the potential covariates explain the variation
in the relative risks.
The potential explanatory variables have been described in 3.4.5 and how they were
included to the models in WinBUGs is detailed in 3.6.3. These covariates have been
included separately to both the Log-Normal and BYM model so as to assess the
impact on the inclusion of the covariates with and without the spatially correlated
heterogeneity term. Given that the spatially correlated heterogeneity term can soak
up any extra variation, then the inclusion of another variable to explain any variation
might not be successful.
4.7.1 Comparison of Models
Table 24 shows the different models ran in WinBUGs and the DIC diagnostics
results for each. These results are the primary analysis used to assess which model is
the most successful at fitting the cryptorchidism data.
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Table 24 Model fitting results of the Bayesian Hierarchical disease count models
with covariates
Model D 4?) pD DIC
1 Poisson-Gamma model 2856.57 2618.22 238.342 3094.91
2 Log normal model 2910.16 2711.38 198.777 3108.93
3 BYM model 2851.36 2720.96 130.406 2981.77
4 Log normal model plus urban/rural indicator 2922.11 2746.22 175.889 3098.00
5 Log normal model plus deprivation (5 groups) 2911.92 2713.14 198.773 3110.69
6 Log normal model plus deprivation (7 groups) 2909.85 2709.26 200.584 3110.43
7 Log normal model plus radon (mean) 2923.39 2763.39 159.999 3083.39
8 Log normal model plus radon (% >200) 2916.86 2741.27 175.592 3092.45
9 BYM model plus urban/rural indicator 2802.45 2592.09 210.365 3012.82
10 BYM model plus deprivation (5 groups) 2798.43 2591.2 207.229 3005.66
11 BYM model plus deprivation (7 groups) 2798.43 2590.55 207.879 3006.31
12 BYM model plus radon (mean) 2800.98 2593.78 207.198 3008.18
13 BYM model plus radon (% >200) 2800.84 2593.86 206.986 3007.83
Comparing deviances D shows that, the log-normal model is not improved, i.e. not a
better fit to the cryptorchidism data, for any of the potential covariates that have been
included. However from the DIC results, which are the deviances with the number of
parameters (pD) is taken into account, the log-normal model fit to the cryptorchidism
data is improved by the inclusion of either of the radon measurements and the
rural/urban indicator.
According to the deviances D of the various BYM models, the BYM model is
improved by the inclusion of any of the potential covariates. However, according to
the DIC results none of the BYM models with potential covariates are an
improvement on the basic BYM model. Therefore, when the number of parameters is
taken into account the fit of the BYM model is not improved by the inclusion of any
of the covariates.
The improvement of the Log-Normal model with the inclusion of either of the radon
measurements and the urban/rural indicator is not replicated in the BYM models.
This difference is probably due to the inclusion of the spatially correlated
heterogeneity term within the BYM model soaking up any of the extra variation.
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4.7.2 Posterior estimates from the models
There is evidence that the spatial variation of the cryptorchidism data is partly
explained by the rural/urban indicator and radon measurements of the areas.
However, in order to fully assess the models, the posterior estimates of parameters
within the models should also be compared so as to indicate which terms within the
various models might be explaining the spatial variation in the cryptorchidism risk.
The spatial variations of the relative risks produced by the different Log-Normal
models were different dependent on how successful the particular covariate was at
improving the model (Figure 52). The deprivation covariates (models 5 and 6) did
not improve the Log-Normal model and did not change the spatial variation of the
relative risks. Conversely the radon measurement covariates (model 7 and 8) that
were the most effective at improving the Log-Normal altered the spatial variation of
the relative risks. The maps of the relative risks produced by these two models show
more clustering of higher values in the North East of Scotland than in the basic Log-
Normal model (model 2). Furthermore, the rural/urban indicator (model 4) which did
improve the Log-Normal model, but to not as much extent as the radon
measurements has slightly altered the spatial variation of the relative risks. The
clustering of the relative risks produced by this model is similar to that of the basic
Log-Normal model (model 2). However the values of the areas with the lower
relative risks has increased. Therefore, these maps suggest that the radon
measurements do explain some of the spatial variation of the relative risks of
cryptorchidism and so does the rural/urban indicator to a lesser extent.
Do the BYM models produce the same spatial variation for the different potential
covariates? Figure 52 shows the spatial variation of the relative risks for the different
BYM models outlined in Table 24. There is very little change in the spatial variation
of relative risks between the different models. Therefore the inclusion of potential
covariates does not alter the spatial variation of the relative risks of cryptorchidism
produced by the BYM model. The differences between Figure 52 and Figure 53
suggest that the spatial heterogeneity term soaks up the extra variation so the
inclusion of selected covariates is redundant.
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Figure 52 Posterior Mean relative risks per 1991 postcode sector for Cryptorchidism
from the Log-Normal plus covariates: Scotland 1980-1999
Legend
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Figure 52 continued
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Figure 52 continued
Model 8 (LN+%radon >200)
Model 7 (LN+mean
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Figure 53 Posterior Mean relative risks per 1991 postcode sector for Cryptorchidism
from the BYM plus covariates: Scotland 1980-1999
Model 9 (BYM+rural)
Model 3 (BYM model)
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Figure 53 continued
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In order to assess if the BYM model is altered by the inclusion of covariates the
geographical variation of the spatially correlated heterogeneity term within the
models should be compared (Figure 54).
Figure 54 Posterior Mean Spatial Correlated Heterogeneity term per 1991 postcode












Model 11 (dep7) Model 12 (mean radon) Model 13 (max radon)
The maps of the spatially correlated heterogeneity term for some of the different
BYM models are altered by the inclusion of the potential covariates. For those
covariates that did not improve the Log-Normal model (i.e. the BYM without the
spatially correlated heterogeneity term) the geographical variation of the spatially
correlated heterogeneity term is largely unaltered. However, those covariates that did
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improve the Log-Normal model the most (i.e. the radon measurements - BYM
Models 12 and 13) have removed the larger values of the spatially correlated
heterogeneity term.
These covariates appear to have accounted for some of the spatially correlated
heterogeneity in the BYM model. So there is evidence that the radon measurements
and to a lesser extent the rural/urban indicator have been successful at explaining
some of the spatial variation of the relative risks in the BYM model, even though this
is not underlined by the DIC results. This could be because the spatially correlated
heterogeneity term soaks up the extra variation.
Both the Log-Normal and BYM model also have a spatially uncorrelated
heterogeneity term. This term may also be affected by the inclusion of potential
covariates and so indicate which covariates explain the non-spatial heterogeneity.
The distributions of the estimates of the spatially uncorrelated heterogeneity term for
the Log-Normal models are shown in Figure 55.
Figure 55 Posterior Mean Uncorrelated Heterogeneity term per 1991 postcode sector
from the Log-Normal model plus covariates: Scotland 1980-1999
Key ofModels
2 Log-Normal (LN)
4 LN plus rural/urban
5 LN plus deprivation 5
6 LN plus deprivation 7
7 LN plus mean radon
8 LN plus max radon
-0.2 0.0 0.2 0.4
Uncorrelated Heterogeneity
Although very similar, the distributions of estimates of the uncorrelated
heterogeneity do alter slightly with the inclusion of the potential covariates. For those
covariates (both deprivation terms - models 5 and 6) that did not improve the Log-
Normal model the distribution of the spatially uncorrelated heterogeneity term is
Chapter 4: Cryptorchidism Analysis 138
Spatial Epidemiology of Indicators of Male Reproductive Health in Scotland
largely unaltered compare to the basic Log-normal model (model 2). Those
covariates that did improve the Log-Normal model (i.e. the radon measurements -
Models 12 and 13 and the rural/urban indicator - Model 4) have narrowed the
distribution of the spatially uncorrelated heterogeneity term. Therefore the inclusion
of those covariates that improved the Log-normal model has reduced the non random
heterogeneity of the relative risk estimates.
The spatially uncorrelated heterogeneity term was altered by the inclusion of
potential covariates to the BYM model to the same degree for model (Figure 56).
The distribution of the spatially uncorrelated heterogeneity is widened for all the
potential covariates model compared to the basic BYM model. Therefore the
inclusion of the covariates to the BYM model has increased the non random
heterogeneity of the relative risk estimates
Figure 56 Distributions of Posterior Mean Uncorrelated Heterogeneity term per 1991









Apart from the postcode-specific posterior estimates produced by the models, there
are model parameters that might provide more information on how successful the
inclusion of potential covariates have been in explaining the spatial variation of the
testicular cancer risk. Figure 57 shows the posterior estimates of the parameters for
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The estimates of the intercept term (alpha) and the population mean relative risk
(mean) have been altered in similar ways due to the inclusion of potential covariates
to the Log-Normal model. For those covariates that improve the Log-Normal model
the most (radon measurements - Models 7 and 8), both terms have been reduced.
The alpha terms have increased in negative value while the mean term has got closer
to zero. The remaining models have produced wider credible intervals on both the
alpha and mean terms. Therefore any difference between these values and that
produced by the Log-Normal model are not conclusive. The estimate of the precision
of the uncorrected heterogeneity (tau.v) is largely unaltered by the inclusion of
potential covariates
Do any of these parameter estimates alter with the inclusion of the spatially
correlated heterogeneity term? Figure 58 shows the posterior estimates of the non-
postcode specific parameters for the different BYM models.
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The parameters in the BYM models have been altered differently to those in the Log-
Normal models. The intercept term is largely unaltered by the inclusion of the
potential covariates except for the model which includes the rural/urban indicator.
This model has produced a positive intercept term while the others have a negative
value. The population mean relative risk has been altered in a similar way. The
model including the rural/urban indicator has increased the population mean relative
risk, while the others are comparatively similar. Unlike the Log-Normal models,
including the potential covariates has altered the precision of the uncorrelated
heterogeneity. The BYM models with covariates have improved the precision of the
uncorrelated heterogeneity. Finally, the precision of the correlated heterogeneity is
largely unaltered with the inclusion of the potential covariates.
tau.u
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4.7.3 Conclusions of Inclusion of Covariates
Therefore, from the analysis of including covariates into the Log-Normal and BYM
model the spatial variation of the cryptorchidism cases can be partly explained by the
two radon measurements and the rural/urban indicator. The DIC results for the Log-
Normal model show that the model is improved by the inclusion of any of these three
covariates. Also, the posterior estimates produced by these Log-Normal models
indicate that the spatial variation of the relative risks is partly accounted for and that
the heterogeneity of the estimates is decreased. Although the BYM model is not
improved by the inclusion of the covariates when comparing DIC results, there is
evidence that these three covariates also decrease the heterogeneity of the estimates
in the BYM model as with the Log-Normal model.
4.8 Individual Level Models
4.8.1 Introduction
The inclusion of area level covariates into disease count data could have led to
ecological bias i.e. associations found at the postcode level could in fact be
associations at the individual level. Information about the individual cryptorchidism
cases might explain the spatial variation shown.
To assess if information about the individual cases might explain the spatial variation
rather than the covariates at the postcode sector, an individual level analysis has been
carried out on the cryptorchidism data. As discussed in more detail in 3.7, the spatial
distribution of particular individual level information has been modelled to see if
they have similar geographical variation as the relative risks of cryptorchidism. If
this is the case, it would be suggestive that covariates about the individuals rather
than area specific covariates explain the spatial variation in cryptorchidism. If
different spatial variation in the relative risks is found in the individual level
information, then it would appear that these covariates do not explain the spatial
variation of cryptorchidism. However, it does not mean that other individual level
information does not explain the spatial variation in cryptorchidism.
Three potential individual level covariates were modelled - co-morbidity, year of
birth and age of mother. The models developed and why these covariates were
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chosen is detailed in 3.7. The next three sections show the results of the models
developed for each covariate.
4.8.2 Co-morbidity Models
As shown in 3.4.1 there were babies born diagnosed with cryptorchidism and
hypospadias. Of the 2,524 cryptorchidism cases that were geo-referenced to the 1991
postcode sectors, 47 babies were also born with hypospadias.
The logistic regression model developed for the co-morbidity covariate was run with
different terms in order to assess which best explains the variation of those
cryptorchidism cases. Table 25 shows the different co-morbidity models ran and the
corresponding DIC results, where v, represents the spatially uncorrelated
heterogeneity term and u, represents the spatially correlated heterogeneity term.
Table 25 Co-morbidity Model fitting results
Model D 49) pD DIC
1. Basic model - just betaO term 469.557 468.590 0.967 470.524
2. Model 1 plus v, 445.668 419.803 25.865 471.533
3. Model 1 plus v, and x co-ordinates 451.037 423.365 27.671 478.708
4. Model 1 plus v, and y co-ordinates 463.562 444.996 18.566 482.128
5. Model 1 plus v, and x and y co-ordinates 397.074 330.266 66.808 463.882
6. Model 1 plus v, and x and y co-ordinates, and u, 407.026 358.259 48.767 455.793
Vj spatially uncorrelated heterogeneity term
Uj spatially correlated heterogeneity term
These changes in the DIC results show that the distribution of those cryptorchidism
cases who also have hypospadias is explained with the inclusion of both x and y co¬
ordinates and the heterogeneity terms.
To see if the spatial distribution of co-morbidity is similar to that of the relative risks
of the cryptorchidism cases, the posterior estimates of the probabilities produced by
models 5 and 6 are looked at in more detail. The probabilities produced by the co¬
morbidity model give the probability that a particular cryptorchidism case is also
diagnosed with hypospadias. The spatial variation of the individual probabilities can
be shown by mapping the average probability within a postcode sector. This is
calculated by aggregating the individual probabilities to the 1991 postcode sectors
and then dividing by the number of individuals within each postcode sector.
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The average probabilities per 1991 postcode sector for models 5 and 6 are shown in
Figure 59. The spatial distribution of the average probabilities produced by model 5
(all terms except spatially correlated heterogeneity) appear to be the reverse of the
cryptorchidism relative risks, i.e. those areas with higher average probabilities of
having cryptorchidism and hypospadias cases are those areas with lower relative
risks of cryptorchidism. When the spatial correlated heterogeneity term is added to
the model (model 6) then the spatial distribution of the average probabilities follows
a similar pattern to the relative risks of the cryptorchidism cases. So this map
provides some evidence to support the hypothesis that co-morbidity of the
cryptorchidism cases may explain their spatial variation. However, there is such
difference in the spatial distribution between Models 5 and 6 due to the inclusion of
one term. This raises suspicions that this term might over-smooth the relative risks.
In conclusion, the coordinates and the heterogeneity terms explain the distribution of
those cryptorchidism cases with hypospadias. Therefore there is a spatial variation to
these cases. However, it is inconclusive that the spatial variation of those with both
conditions follows the same variation as all cryptorchidism cases. While the
probabilities estimated from the model with all the terms found to explain the spatial
variation were found to have a similar spatial variation to the cryptorchidism relative
risks. The model which excluded the spatially correlated heterogeneity did not have
the same spatial variation. Therefore it is uncertain if the co-morbidity explains the
spatial variation of the cryptorchidism relative risks. So it is not possible to exclude
this covariate from explaining the spatial variation of the cryptorchidism rather than
the area-specific covariates therefore the possibility of ecological fallacy is still
relevant.
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Figure 59 Average posterior expected probabilities per 1991 postcode sector
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Model 5 (both co- ordinates and non
spatially correlated heterogeneity)
Model 6 (both co-ordinates
and heterogeneity terms)
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4.8.3 Year of Birth Models
The modelling of the year of birth could assess if there is temporal association to the
spatial variation of cryptorchidism. As with the co-morbidity model, the polytomous
regression model developed for the Year of birth categories was run several times
with different terms in each to assess which best explain the variation of the different
year of birth groups.
Table 26 shows the different models run and the DIC results.
Table 26 Year of Birth category Model fitting results
Model d d(s) pD DIC
l. Basic model - just betaO term 6998.010 6998.010 0.000 6998.010
2. Model 1 plus v, 6956.210 6906.010 50.199 7006.410
3. Model 1 plus v, and x co-ordinates 6883.990 6755.380 128.605 7012.590
4. Model 1 plus v, and y co-ordinates 6866.910 6724.760 142.146 7009.050
5. Model 1 plus v, and x and y co-ordinates 6912.440 6807.650 104.792 7017.240
6. Model 1 plus v, and x and y co-ordinates, and u, 6868.670 6720.650 148.024 7016.700
From comparison of the DIC results, neither coordinates nor the heterogeneity terms
improve the model compared to the one with just an intercept term. Therefore, it
would appear that the incidence year of the cryptorchidism cases does not have a
spatial variation and so unlikely to explain the spatial variation of the relative risks.
As this covariate does not appear to have a spatial variation no maps were generated.
4.8.4 Age of Mother Models
The age of the mother might explain any spatial variation in cases as previous
research has shown that older women have a higher risk giving births to babies with
congenital malformations. The different polytomous regression models ran for the
Age ofMother categories and corresponding DIC results are shown in Table 27.
Table 27 Age of Mother Category model fitting results
Model D 49) pD DIC
1. Basic model - just betaO term 934.240 6934.240 0.000 6934.240
2. Model 1 plus v, 6895.840 6847.450 48.388 6944.230
3. Model 1 plus v, and x co-ordinates 304.840 1758.270 546.569 2851.410
4. Model 1 plus v, and y co-ordinates 2304.840 1758.270 546.569 2851.410
5. Model 1 plus v, and x and y co-ordinates 2305.940 1884.350 421.592 2727.530
6. Model 1 plus v, and x and y co-ordinates, and u, 2243.210 1723.060 520.147 2763.360
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From the comparison of the DIC results the Mother's Age groups do appear to be
associated with the coordinates and the spatially uncorrelated heterogeneity term.
The spatially correlated heterogeneity term does not appear to improve the Mother
Age group model.
To see if the spatial distribution of Mother Age is similar to that of the relative risks
of the cryptorchidism cases, the average posterior estimates of the probabilities per
postcode sector produced by model 5 are looked at in more detail.
Figure 60 shows the average probabilities for each Age of Mother categories. Unlike
previous maps the cut-off values for the categories are different for each Age of
Mother group. This is because the aim of each of the maps is to show the spatial
distribution of the probabilities within each of the Age of Mother group; and each of
the groups has a different range of probabilities.
For all four Age of Mother groups there does appear to be a similarity in the spatial
variation of the probabilities and the relative risks for the North of Scotland, i.e. the
East has high probabilities while the West has low probabilities. However, the spatial
variation of the probabilities in the South of Scotland does not show the same spatial
variation as estimated for the relative risks. Therefore, these maps suggests that the
age of the mother might partly explain the occurrence of the cluster of high relative
risks in North East Scotland but does not explain the region of low relative risks in
the South of Scotland.
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Figure 60 Average posterior expected probabilities per 1991 postcode sector
produced model 5 by Mother's Age Category
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The differences in the range of probabilities between the four Mother of Age groups
gives an insight into the role of this covariate in explaining the variation of the
relative risks of cryptorchidism. Those women in the two older age groups have the
lower range of probabilities, which contrary to previous research, appears to indicate
that the cryptorchidism cases are less likely to be born to these women. Those
women in the two younger age groups have a higher range of probabilities; in
particular those women aged 22 to 29. So it would appear that the cryptorchidism
cases are more likely to be born to younger women, in particular those women in
their 20's.
In conclusion, the co-ordinates and the non-spatially correlated heterogeneity explain
the variation in the cryptorchidism cases by Age of Mother group. Therefore the
grouping of cryptorchidism cases by Age of Mother does have a spatial variation.
Furthermore, the spatial variation of the probabilities of being in these groups is
similar to the cryptorchidism relative risks in the North of Scotland. This similarity
in spatial variation suggests that the age of the mother might partly explain the
occurrence of the cluster of high relative risks in North East Scotland but does not
explain the region of low relative risks in the South of Scotland. Finally the
differences in probability values between the four Age of Mother groups suggests
that the cryptorchidism cases are more likely to be born to younger women, in
particular those in their 20's.
4.8.5 Conclusions for Individual Models
From the individual models it would appear that the spatial variation of the
cryptorchidism cases could also be explained by information known about the
individual cases. Therefore the presence of ecological bias cannot be ruled out in the
disease count models. From the individual analysis, the age of the mother is
associated with the spatial variation of the cryptorchidism relative risks. The co¬
morbidity of hypospadias for the cryptorchidism cases may also explain the spatial
variation although it is not conclusive.
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4.9 Summary of Cryptorchidism Analysis
There does appear to be a spatial variation in the cryptorchidism cases, with a cluster
of high relative risks in the North-East and generally lower relative risks in the South
and West. Although this spatial variation was shown by all three Bayesian
Hierarchical models, each had varying success at fitting the data.
Both the Poisson-Gamma and Log-Normal model smoothed the relative risks
towards the overall mean and so decreased the range of their values. From the
comparison of the DIC results the Poisson-Gamma was actually a better fit to the
cryptorchidism data, although neither fully accounted for the variability of the
relative risk estimates. From the residual analysis, neither model was successful at
fitting those postcode sectors with high relative risks. Furthermore, the residuals
produced by both models appear to show some spatial correlation, so there is
evidence that there is a spatial component to the heterogeneity of the cryptorchidism
relative risk estimates.
The BYM model did include a spatially correlated heterogeneity term and, in the
comparison of the DIC results, it would appear to be the better model in terms of fit
to the cryptorchidism data. However concerns were raised from the analysis about
the performance of the BYM model. The residual analysis did not show an
improvement on the other two models and there was still spatial correlation of the
residuals.
Furthermore, two other outcomes of the BYM model mean it is unclear if the
spatially correlated heterogeneity term explained the relative risk estimates variation,
or that this term over-smoothes this heterogeneity. Firstly, the relative risk estimates
produced by the BYM model show a considerably more distinct spatial variation of
cryptorchidism than those produced by the other two Bayesian models. It is
surprising to see such a difference in the Log-Normal and BYM models results, only
due to the inclusion of the spatially correlated heterogeneity. Secondly, the sizable
improvement of the DIC results for the BYM compared to the Log-Normal model,
shows that the inclusion of the spatially heterogeneity term has a considerable impact
on the model's performance.
Chapter 4: Cryptorchidism Analysis 150
Spatial Epidemiology of Indicators of Male Reproductive Health in Scotland
With the cryptorchidism cases showing a spatial pattern, can the inclusion of possible
area-specific covariates explain this variation? From the analysis of including
covariates into the Log-Normal and BYM models the spatial variation of the
cryptorchidism cases can be partly explained by the two radon measurements and the
rural/urban indicator. The DIC results for the Log-Normal models show that the
model is improved by the inclusion of any of these three covariates. Furthermore, the
posterior estimates produced by the Log-Normal models including these covariates
indicate that the spatial variation of the relative risks is partly accounted for and that
the heterogeneity of the estimates is decreased.
Although the BYM model is not improved by the inclusion of any of the covariates,
when comparing DIC results, there is evidence that the same three covariates
decrease the heterogeneity of the estimates in the BYM model as with the Log-
Normal model. The difference in conclusions made from the DIC diagnostics and the
heterogeneity estimates could be because the spatially correlated heterogeneity term
is 'soaking up' any extra variation, so making the inclusion of potential covariates
redundant within the BYM model.
From the individual-level models the presence of ecological bias cannot be ruled out
in the Bayesian Hierarchical disease count models of cryptorchidism. The spatial
variation of the cryptorchidism cases could be explained by information known about
the individual cases. In particular, the individual models were able to show that the
age of the mother is associated with the spatial variation of the cryptorchidism
relative risks. There is also evidence that the co-morbidity of hypospadias for the
cryptorchidism cases may also explain the spatial variation although it is not
conclusive. As will be discussed in more detail in Chapter 8 this individual analysis
only indicates if the individual level information might explain the spatial variation
of the cryptorchidism cases rather than showing direct relationships. The individual
level analysis was done to explore if there was a possibility of ecological fallacy in
the disease count models.
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Chapter 5 : Testicular cancer Analysis
5.1 Introduction
This chapter details the analysis of the testicular cancer dataset. The testicular cancer
data has been analysed as disease count data and uses the same methods outlined for
the cryptorchidism data in sections 4.3-4.7. Therefore the methods are not described
in this chapter and the reader is referred to the previous chapter for further
explanation of the analysis.
5.2 Incidence overtime
Unlike the cryptorchidism chapter there has not been a spatial analysis of the
individual level covariates. Therefore, the only summary of the variables included in
the testicular cancer data (further details Appendix 2) is the temporal changes of
incidence. This was included as the proposed environmental factor being associated
with testicular cancer stem from reported increases over time in particular
conditions/diseases, including testicular cancer. Unless this is found in the three
disease/conditions datasets, then the environmental exposure might not have
occurred in Scotland. It would appear that the increase in the incidence of testicular
cancer has occurred in Scotland (Figure 61). Furthermore, there also appears to be
differences in the incidence and rate of increase of incidence between age groups,
which correspond with previous data outlined in 2.2.1.
The age groups with the highest incidence (20-40) correspond with previous
research, and show the greatest increase in incidence over time. Those that are in the
youngest age group have the lowest incidence and also show relatively little change
in incidence over time. Those that are in the oldest age groups have a slightly higher
incidence than the youngest age group and show some increase over time in
incidence. If individual level models were to be developed for the testicular cancer
data it would appear that age at incidence might be one to investigate further.
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Figure 61 Annual incidence rate by age group for testicular cancer in Scotland






5.3 Standardised Morbidity Ratio (SMR) maps
The following gives the results of these calculations in relation to the testicular
cancer dataset.
5.3.1 Observed number of testicular cancer cases per 1991
postcode sector
Of the 3,624 cases of Testicular Cancer, 5 did not have postcode sector recorded. The
remaining 3,619 cases were linked to the database created that matches all valid
postcode sectors to where this would have been in 1991. All these 3,619 cases were
successfully linked to a 1991 postcode sector.
The distribution of the number of cases within each of the postcodes sectors is shown
in Figure 62. As can be seen from the figure, the distribution is highly skewed - the
number of cases in each postcode sector ranges from 0 to 18 with a median of 3
cases.
5.3.2 Expected number of Testicular Cancer cases per 1991
postcode sector
The expected numbers of Testicular Cancer cases per 1991 postcode sector were
standardised by age and the underlying population used was the Census 1991
population. The distribution of the expected number of Testicular Cancer cases
within each of the 1991 postcode sectors is also skewed Figure 63. The distribution
1975 1977 1979 1981 1983 1985 1987 1989 1991 1993 1995 1997 1999
Year
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appears to be not as skewed as that for the observed cases per postcode sector. While
the range of values is less (0-15), the median expected value is larger (3.96) and the
mean numbers of cases per postcode sectors are similar (4.05 expected; 4.04
observed).
Figure 62 Histogram of the number of Testicular Cancer cases per 1991 postcode
sectors
Figure 63 Histogram of the expected number of Testicular Cancer cases per 1991
postcode sectors
5.3.3 SMRs of Testicular Cancer per 1991 postcode sector
The distribution of the Testicular Cancer SMRs for the 1991 postcode sectors is
skewed; the maximum SMR is 18.9 while the third quartile is 1.32 (Figure 64). The
mean SMR is 1.02 (standard deviation 3.4) and the median is 0.92. There is no strong
evidence of spatial clustering of the testicular cancer SMRs across Scotland (Figure
65).
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Figure 64 Histogram of Testicular Cancer SMRs per 1991 postcode sector
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SMRs for testicular cancer cases per 1991 postcode sector n=895
Figure 65 Testicular Cancer SMRs per 1991 postcode sectors: Scotland 1975-1999
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The variability of the estimates of the SMRs can be assessed by standard error of
each SMR. The distribution of the standard errors of the SMRs per postcode sector is
skewed - range 0-15.6, median 0.45 and mean 0.58. The spatial variation of the
standard errors is similar to the SMRs i.e. the SMRs may reflect the random variation
of the estimates rather than any variation in disease risk (Figure 66). Therefore it is
important to take into account this variability when calculating the Testicular Cancer
disease risk, which can be done with Bayesian models.
Figure 66 Testicular Cancer standard error of SMRs per 1991 postcode sector:
Scotland 1975-1999
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5.4 Bayesian Hierarchical Models of testicular cancer
count data - Poisson-Gamma
The Poisson-Gamma model was run with the Testicular Cancer dataset in WinBUGs
and converged following 20,000 iterations, a further 10,000 were run to produce
robust posterior estimates.
5.4.1 Posterior estimates from model
The distribution of the Testicular Cancer posterior expected relative risks for each of
the 1991 postcode sectors as produced by the Poisson-Gamma model is normally
distributed unlike that for the SMRs (Figure 67).
Figure 67 Histogram of Testicular Cancer posterior expected Relative Risk estimated
from the Poisson-Gamma model
The range of values has been greatly reduced (0.67, 1.44) towards the population
mean relative risk (1.004, standard deviation 0.02), whose variability has been
reduced compared to the SMR (Table 28).













a 12.53 1.701 0.1267 9.844 12.35 16.21
b 12.48 1.704 0.1266 9.785 12.29 16.18
mean 1.004 0.01987 4.13E-04 0.9658 1.004 1.044
var 0.08191 0.01097 7.86E-04 0.06174 0.08163 0.1033
So with the change in the variability of the estimate of the relative risks, has there
been a change in their spatial variation? While the range of values of the relative
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risks produced by the Poisson-Gamma model are greatly reduced compared to the
SMRs there does not appear to be any spatial pattern to the estimates (Figure 68).
Figure 68 Testicular Cancer posterior expected relative risk per 1991 postcode sector
from the Poisson-Gamma model: Scotland 1975-1999
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The probabilities of the relative risks being greater than 1 also show no spatial
correlation, and that no areas of Scotland with probabilities greater than 0.95 (Figure
69). Therefore confirming there appears to be no spatial pattern to the relative risks
produced by the Poisson-Gamma model, while taking into account the variability of
the estimates.
Figure 69 Testicular Cancer posterior probability for expected relative risk greater
than 1 per 1991 postcode sector from the Poisson-Gamma model: Scotland
1975-1999
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5.4.2 Assessment of model
Although the relative risk estimates are smoothed by the Poisson-Gamma model, is
the model successful at fitting the Testicular Cancer data? The analysis of the
standardised residuals is shown in Figure 70.




It would appear that the Poisson-Gamma model is only partly successful fit to the
Testicular Cancer dataset. The normal plot (a) follows the x-y line, except for the
extreme values of relative risks. Finally, the residuals are not evenly scattered across
all fitted values (b), with more residuals above the y=0 line which is increasingly the
case with the larger fitted values. Therefore, while the Poisson-Gamma model
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appears to smooth the relative risk estimates it does not appear to fit the testicular
cancer dataset successfully, in particular for larger relative risks.
There might be a slight spatial correlation of the residuals, which would indicate that
the unexplained variation is slightly spatially correlated (Figure 71).
Figure 71 Testicular Cancer residuals of Poisson-Gamma model: Scotland 1975-1999
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From the formal test there does not appear to be statistically significant (p=0.085,
r=0.035) spatial correlation of the residuals (Table 29). So there is little indication
that the heterogeneity of the relative risk estimates is spatially correlated.
Table 29 Moran's I test result for residuals from Poisson-Gamma model
5.4.3 Conclusions for Poisson-Gamma model
The relative risks estimated from the Poisson-Gamma model showed no spatial
pattern, as with the SMRs. While the model smoothes the relative risks and so
decreases the range of their values, it does not provide an adequate fit to the
testicular cancer data. In particular those areas with high relative risks do not fit well
within the model.
5.5 Bayesian Hierarchical Models of testicular cancer
count data - Log-Normal
The Log-Normal model was run with the Testicular Cancer dataset in WinBUGs,
convergence occurred following 3,000 iterations, and a further 10,000 were run to
produce robust posterior estimates.
5.5.1 Posterior estimates from model
The distribution of the Testicular Cancer posterior expected relative risks for each of
the 1991 postcode sectors as produced by the Log-Normal model is similar to those
produced by the Poisson-Gamma model (Figure 72). The range of relative risks
produced by the Log-Normal model (0.74, 1.41) is slightly narrower than those
produced by the Poisson-Gamma (0.67, 1.44). Therefore, the Log-Normal model
reduces the range of reltive risks to a similar extent as the Poisson-Gamma model




Correlation Normal p-value (2-sided)
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Figure 72 Histogram of Testicular Cancer posterior expected Relative Risk estimated
from the Log-Normal model
The Log-Normal smoothes the relative risk estimates towards the overall mean
relative risk, is 0.97 with a standard deviation of 0.02 (Table 30). So the population
mean relative risk produced by the Log-Normal is lower than that produced by the
Poisson-Gamma model (1.004) and the SMRs (1.02) and the variability of this
estimate has been reduced compared to the SMR and reduced to the same extent as
that done by the Poisson-Gamma model.







alpha -0.03119 0.01972 2.92E-04 -0.07034 -0.03108 0.007648
mean 0.9695 0.01911 2.83E-04 0.9321 0.9694 1.008
tau.v 16.02 2.524 0.1024 11.66 15.82 21.57
The spatial variation of the relative risk estimates produced by the Log-Normal
model is very similar to that produced by the Poisson-Gamma model (Figure 73), i.e.
there does not appear to spatial correlation of the relative risks.
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Figure 73 Testicular Cancer posterior expected relative risk per 1991 postcode sector
from the Log-Normal model: Scotland 1975-1999
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The probabilities of the relative risks being greater than 1 show a similar pattern to
the relative risks with no areas of Scotland with probabilities greater than 0.95
(Figure 74). Therefore some evidence that there is no spatial pattern to the relative
risks produced by the Log-Normal model, as with the Poisson-Gamma model, while
taking into account the variability of the estimates.
Figure 74 Testicular Cancer posterior probability of relative risk being greater than
1 per 1991 postcode sector from the Log-Normal model: Scotland 1975-
1999
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The map of the uncorrelated heterogeneity term of this term will show if there is a
spatial clustering of the extra variation of the relative risks estimates (Figure 75). It
does not appear to be any spatial correlation of the heterogeneity terms, so it does not
appear to vary in a spatially structured way.
Figure 75 Testicular Cancer posterior probability of uncorrelated heterogeneity per
1991 postcode sector from the Log-Normal model: Scotland 1975-1999
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5.5.2 Assessment of model
The analysis of the standardised residuals produced for each relative risk estimate
from the Log-Normal model is shown in Figure 76.







Quantiles of Standard Normal
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It would appear that the Log-Normal fits the Testicular Cancer slightly better than
the Poisson-Gamma model; however it is not adequate. The normal plot (a) shows
that most of the residuals follow the x-y line, except again for the extreme values
although they are nearer the line than the Poisson-Gamma results. As with the
Poisson-Gamma model the residuals are not evenly scattered across all fitted values
(b), with more residuals above the y=0 line which is increasingly the case with the
larger fitted values.
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The spatial variation of the residuals produced by the Log-Normal model is similar to
those produced by the Poisson-Gamma model i.e. there appears to be no spatial
correlation (Figure 77). So it would appear that the Log-Normal model, like the
Poisson-Gamma model, there dos appear to be a spatial component to the
heterogeneity of the relative risks.
Figure 77 Testicular Cancer residuals of Log-Normal model: Scotland 1975-1999
Legend
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From the formal test there does not appear to be statistically significant (p=0.094,
r=0.034) spatial correlation of the residuals Table 31. There is no evidence of a
spatial correlation of the residuals, so the heterogeneity does not appear to vary in a
spatially structured way.







5.5.3 Conclusions for Log-Normal model
The Log-Normal model only seems to be a slight improvement on the Poisson-
Gamma model for estimating the relative risks for the Testicular Cancer dataset.
Both show no spatial variation of the relative risk of testicular cancer. However, the
residual analysis of the Log-Normal model shows that is a better fit to the Testicular
Cancer dataset than the Poisson-Gamma model, although it is not completely
adequate. From assessing the spatial variation of the residuals the heterogeneity of
the relative risk estimates does not vary in a spatially correlated way.
5.6 Bayesian Hierarchical Models of testicular cancer
count data - Besag, York and Mollie (BYM) model
The BYM model was run with the Testicular Cancer dataset in WinBUGs which
converged following 8,000 iterations and a further 10,000 were run to produce robust
posterior estimates.
5.6.1 Posterior estimates from model
Figure 78 shows the distribution of the posterior expected relative risks estimated
from the BYM model. The distribution of the estimates is very similar in shape to
both the Poisson-Gamma and Log-Normal models. The maximum relative risk (1.55)
is the largest produced by any of the three Bayesian models, while the minimum
value (0.68) is between the other two models.
Number of permutations
Correlation (95% CI)
Correlation Normal p-value (2-sided)
Mean Permutation correlations (Inter-quartile
range)
Permutation p-value
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Figure 78 Histogram of Testicular Cancer posterior expected Relative Risk estimated
from the BYM model
The population mean relative risk is 0.97 is similar to that produced in the Log-
Normal model and slightly lower than the SMR and that produced by the Poisson-
Gamma model (Table 32). The intercept term alpha has decreased and the precision
of the non-spatial heterogeneity term has deteriorated, compared to the Log-Normal
model. Therefore the inclusion of the spatially correlated heterogeneity term has
weakened the intercept term and the precision of the non-spatial heterogeneity.







alpha -0.02895 0.02188 0.001037 -0.07281 -0.0286 0.01329
mean 0.9717 0.02124 0.001005 0.9298 0.9718 1.013
tau.u 12 2.328 0.1224 7.837 11.8 17,16
tau.v 988.7 983.3 92.66 112.8 625.2 3773
The map of the posterior expected relative risks produced by the BYM model shows
a very different spatial pattern than the Poisson-Gamma and Log-Normal models
(Figure 79). The inclusion of the spatially correlated heterogeneity term within the
model has meant that the relative risk have a spatial correlation - low relative risks in
the central belt area with higher risk areas in the other areas, almost a rural/urban
difference.
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Figure 79 Testicular Cancer posterior expected relative risk per 1991 postcode sector
from the BYM model: Scotland 1975-1999
Legend
Posteiioi expected leLtrve Msks - BYM model
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This spatial pattern of the relative risks is repeated in the probabilities of the relative
risks being greater than 1 (Figure 80). However those areas with the highest relative
risks no not all have probabilities greater than 0.95. Therefore the probabilities do not
confirm the spatial variation of the relative risks produced by the BYM model while
taking into account the variability of the estimates.
Figure 80 Testicular Cancer posterior probability for expected relative risk greater
than 1 per 1991 postcode sector from the BYM model: Scotland 1975-1999
Legend
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As with the Log-Normal model, the non spatial heterogeneity does not appear to
have any spatial correlation (Figure 81).
Figure 81 Testicular Cancer posterior expected uncorrelated Heterogeneity term v,
per 1991 postcode sector from the BYM model: Scotland 1975-1999
Legend
Uncoiieloted heterogeneity
HI -0.0133 - -0 0050
H -0.0049 - -00020
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The spatially correlated heterogeneity term does show spatial correlation similar to
that of the relative risks (Figure 82). Therefore from the BYM model the variability
of the random effects might have a spatial component.
Figure 82 Testicular Cancer posterior expected correlated Heterogeneity term m, per
1991 postcode sector from the BYM model: Scotland 1975-1999
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The spatial variation shown in this map could be because there is a spatially
correlated variability to the estimates of the relative risks, which is now accounted
for by this term within the BYM model. However, it could be that the CAR model
used in the BYM model for the spatially correlated heterogeneity term over-
smoothes the relative risks. This might explain the deterioration in the precision
value for the non-spatially correlated heterogeneity term between the Log-Normal
and BYM model. Furthermore, in the previous models, no spatial correlation of the
relative risk estimates, the heterogeneity or the residuals was found.
5.6.2 Sensitivity Analysis
Table 33 shows the results of the comparison of the relative risks estimated by the
BYM model outlined (Model 1) and those from the BYM model where the prior for
tau.u is changed to gamma(0.5, 0.0005). There appears to be a strong correlation
between the two sets of estimated relative risks, and no significant differences in the
relative risks estimated for the same postcode sector. Therefore the distinct sptail
pattern of the realive risks estimated by the BYM are not due to specific prior for the
precision of the spatially correlated heterogeneity.
Table 33 Comparison tests of Relative Risks estimated from BYM models using
prior for tau.u gamma(l,l?) (model 1) and gamma(0.5, 0.0005) (model 2)
Correlation co-efficient of Mean difference in relative risks
Paired t-test - p valuerelative risks (95% CI) (Model 1-2)
0. 996 0.00014 (-0.0005, 0.0008) 0. 6756
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5.6.3 Assessment of model
The residual analysis for the BYM model is shown in Figure 83.
Figure 83 BYM Model residuals analysis - (a) Normal Plot (b) Residuals v Fitted
-3-2-10 1 2
Quantiies of Standard Normal
(a)
(b)
It would appear that the BYM model is a very slight improvement than the other two
Bayesian model from the residual analysis. For the Normal Plot of the residuals (a)
most of the residuals follow the x-y line, except again for the extreme values
although they are nearer the line than the other models results. For the residuals
plotted by the fitted values, (c), there is slight improvement.
There does appear to be a little spatial correlation of the residuals (Figure 84). The
apparent correlation of low residuals is seen in the North-West of Scotland, where
the relative risks are high.
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Figure 84 Testicular Cancer residuals of BYM model: Scotland 1975-1999
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According to the Moran's I test there is a statistically significant (p=0.001) although
small spatial correlation (r=-0.069) of the residuals (Table 34). Therefore the
unexplained variation is spatially correlated.
Table 34 Moran's I test result for residuals from BYM model
Statistic Result
Number of permutations 100
Correlation (95% CI) -0.069 (-0.110, -0.028)
Correlation Normal p-value (2-sided) 0.001
Mean Permutation correlations (Inter-quartile range) -0.0023 (-0.0147, 0.0140)
Permutation p-value 1
It is possible to compare the DIC diagnostics of the three Bayesian Hierarchical
models to assess which is the best fit to the testicular cancer data (Table 35). These
results mirror the conclusions found from the residual analysis, i.e. the BYM model
fits the Testicular Cancer datasets the best and the Poisson-Gamma model is the least
successful.
Table 35 Model fitting results of the three disease count models
Model D D(a) pD DIC
Poisson-Gamma model 3263.34 3066.11 197.23 3460.57
Log-Normal model 3285.66 3116.47 169.184 3454.84
BYM model 3342.79 3237 105.787 3448.57
5.6.4 Conclusions for BYM model
The BYM model is slightly better model and fit to the data compared to the Poisson-
Gamma or Log-Normal model, when comparing the residuals analysis and the DIC
results. However, it like the other two models is not fully successful in accounting
for the unexplained variation in the relative risks. While the other two models did not
find spatial correlation of the relative risk estimates, the heterogeneity or the
residuals, they were found in the BYM model. The spatial correlation of the
unexplained variation lends credence to the possibility that the spatially correlated
heterogeneity term over-smoothes the spatial correlation.
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5.7 Inclusion of covariates into Bayesian hierarchical
models of disease count data
The inability of any of the three Bayesian Hierarchical Models to fully account for
the spatial variation of the testicular cancer risks might not be just due to the terms
used within the models, but that other explanatory variables might explain the
variation. This section assesses if the inclusion of potential explanatory variables
explains the variation of relative risks.
5.7.1 Comparison of models
Table 36 shows the different models run in WinBUGs and the results for each of the
DIC diagnostics. These results are the primary analysis used to assess which model is
the most successful at fitting the Testicular Cancer dataset.
Table 36 Model fitting results of the Bayesian Hierarchical disease count models
with covarites
Model D 4?) pD DIC
1. Poisson-Gamma model 3263.34 3066.11 197.23 3460.57
2. Log-Normal model 3285.66 3116.47 169.184 3454.84
3. BYM model 3342.79 3237 105.787 3448.57
4. Log-Normal model plus deprivation (5 groups) 3284.74 3113.89 170.844 3455.58
5. Log-Normal model plus deprivation (7 groups) 3284.51 3113.67 170.837 3455.35
6. Log-Normal model plus urban/rural indicator 3280.81 3115.38 165.436 3446.25
7. Log-Normal model plus radon (mean) 3283.04 3117.88 165.158 3448.2
8. Log-Normal model plus radon (% >200) 3287.77 3116.36 171.41 3459.18
9. BYM model plus deprivation (5 groups) 3260.85 3043 217.852 3478.71
10. BYM model plus deprivation (7 groups) 3260.17 3041.23 218.937 3479.11
11. BYM model plus urban/rural indicator 3347.56 3241.59 105.976 3453.54
12. BYM model plus radon (mean) 3286.18 3115.46 170.717 3456.89
13. BYM model plus radon (%>200) 3263.25 3050.35 212.892 3476.14
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The inclusion of the mean radon levels or the rural/urban indicator explain some of
the spatial variation in the Testicular Cancer risk in the Log-Normal model.
However, when the spatially correlated heterogeneity is added to the models, as is
the case in the BYM model, no model with the inclusion of potential covariates are
an improvement on the BYM model. This conclusion is made from comparing DIC
results; however, it would appear that the deviances are improved in the BYM model
when all the covariates, except the rural/urban indicator, are included. Therefore the
data fits the Testicular Cancer risk better with the inclusion ofmost of the covariates,
but they are not better models when the number of parameters is taken into account.
Could this be because the extra variation is soaked up by the spatially heterogeneity
term and so could not be accounted for by the potential covariates? A comparison of
the posterior estimates produced by these models might indicate what terms are
accounting for the spatial variation in the Testicular Cancer risk.
Figure 85 shows the relative risks produced by the six Log-Normal models described
in Table 36. In order to compare the spatial variation of the different models the
same categories are used in the maps and it would appear that most show the same
spatial pattern as the Log-Normal model i.e. no spatial correlation. However, the
spatial pattern of the relative risks the Log-Normal plus the two radon measurements
(models 7 and 8) appear slightly different. There does appear to be some clustering
of high relative risks in the North-East of Scotland. The mean radon model (7) is an
improvement on the Log-Normal model when comparing DIC results, so there might
be an association between the relative risk and mean radon.
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Would the inclusion of the spatially correlated heterogeneity term to these models
alter the spatial pattern of the relative risks? Figure 86 shows the relative risks
produced by the six BYM models described in Table 36. The inclusion of covariates
in the BYM model has reduced the spatial correlation of the relative risks, except
with the urban/rural indicator (Model 11). This model has a similar spatial variation
of relative risk to the model without covariates and is in fact the best model of those
with covariates when comparing DIC results.
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The difference the heterogeneity terms produced in the models might show what
variation is accounted for by the inclusion of potential covariates. The distribution of
the non-spatially correlated heterogeneity term is unaffected by the inclusion of
covariates within the Log- Normal model (Figure 87). So the random heterogeneity
produced by the Log-Normal model is not altered, even with the inclusion of
possible covariates. Therefore none of the possible covariates appear to account for
any of the random extra variation within the Log-Normal model.
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Figure 87 Testicular cancer posterior spatially uncorrected heterogeneity term from
Log-normal plus variable models
Uncorrelated Heterogeneity
The same conclusion can be made when comparing the distributions of the non-
spatially correlated heterogeneity term produced by the BYM models, except for the
urban/rural indicator model (Figure 88).
Figure 88 Testicular cancer posterior spatially uncorrelated heterogeneity term from















The BYM model without a covariate included and the BYM model with the
urban/rural indicator have a smaller range of values than the other models.
Furthermore, the model with the rural/urban indicator has a narrower distribution
compared to the BYM without a covariate model. Therefore, the rural/urban
BYM plus rural/urban
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indicator appears to account for some of the random extra variation within the BYM
model.
The spatial variations of the spatially correlated heterogeneity term produced by the
BYM models have similar patterns, except the model including mean radon (Figure
89). This model (Model 12) shows much less variation of values for the spatially
correlated heterogeneity term than the other models. Therefore it would appear that
the mean radon accounts for some of the spatially correlated extra variation within
the BYM model.
Figure 89 Testicular cancer posterior spatially correlated heterogeneity term from
BYM plus variable models
4
Model 3 Model 9 Model 10
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The comparison of the posterior estimates and the DIC results indicate that the
relative risks of testicular cancer are associated with the urban/rural indicator and
mean radon. The DIC results from the Log-Normal models appear to indicate that the
model is improved with the inclusion of these covariates. However, the DIC results
of the BYM mode did not confirm this. The changes in the spatial variation of the
heterogeneity terms for these models could mean that they have explained some of
the extra variation; but the CAR model used as the spatial heterogeneity term over-
smoothes the extra variation which we wish to account for.
Apart from the postcode specific posterior estimates produced by the models, there
are model parameters that might provide more information on how successful the
inclusion of potential covariates have been in explaining the spatial variation of the
testicular cancer risk. Figure 90 shows the posterior estimates of the parameters for
the different Log-Normal models.
Figure 90 Posterior estimates for non postcode specific parameters in Log-Normal
models
Log Normal LN + dep5 LN ♦ dep7 LN + radonl LN + radon2 LN + urban
Model





Log Normal LN + dep5 LN + dep7 LN + radonl LN + radon2 LN + urban
Model
tau.v
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The inclusion of both radon measurements has resulted in the mean intercept term
becoming more negative compared to the basic Log-Normal model. These terms had
also changed the spatial variation of the relative risks. The models with the other
covariates have not altered their estimates of the mean intercept term although their
credible intervals have widened. Therefore for those models with covariates that
have changed the spatial variation of the relative risk the strength of the intercept
term has increased. However, those models that did not change the spatial variation
of the relative risk have not changed the intercept term but diminished the precision
of its estimate.
The population mean relative risk (mean) estimates show as similar pattern to the
intercept estimate. Therefore the models with covariates (i.e. radon measurements)
that have changed the spatial variation of the relative risks have reduced the overall
population relative risk. Furthermore, those models that did not alter the spatial
variation of the relative risk estimates have increased the population relative risk,
although the precision of these estimates are such that it inconclusive that there are
changes.
Finally, the precision of the non-spatially correlated heterogeneity term (tau.v) is
unaltered by inclusion of the possible covariates.
Do any of these parameter estimates alter with the inclusion of the spatially
correlated heterogeneity term? The intercept term and the population relative risk
estimates are largely unaltered by the inclusion of the spatially correlated
heterogeneity term (Figure 91). However the precision of the non-spatially correlated
heterogeneity term (tau.v) has been altered. As seen previously the precision has
been diminished in the BYM model, but also in the model including the urban/rural
indicator which is the most successful of the models with potential covariates. The
precision of the spatially correlated heterogeneity term is the same in the models
except for that including the mean radon measurement which diminishes it.
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Figure 91 Posterior estimates for non postcode specific parameters in BYM models
BYM BYM plus dep5 BYM plus dep7 BYM plus radon 1 BYM plus raflon2 BYM pi
Model
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5.7.2 Conclusions of Inclusion of Covariates
Therefore a number of issues have been highlighted by the inclusion of these
potential covariates to the two Bayesian models. The results from the DIC and the
comparison of posterior estimates from the models indicate that the variation in the
relative risks testicular cancer within postcode sectors might be associated with the
rural/urban indicator and the mean radon measurement of that area. The inclusion of
these two covariates improved the Log-Normal model. This improvement was not
replicated in the inclusion of covariates within the BYM model. However, from the
comparison of the spatial variation of the heterogeneity terms and the changes in the
parameters estimates it would appear that the inclusion of the spatially correlated
heterogeneity soaks up any extra variation which we want to explain.
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5.8 Summary of Testicular Cancer analysis
It is inconclusive that there is a spatial variation in the relative risk of testicular
cancer in Scotland. The estimates produced by the Log-Normal and Poisson-Gamma
model showed no spatial correlation. However the relative risk estimates produced
by the BYM model appeared to show spatial correlation - low relative risks in urban
areas and high ones in relatively rural areas. This spatial variation in the relative risk
might be accurate; the BYM model was the best of the three models when comparing
DIC results and so might best describe the spatial correlation of the relative risks.
However, there are indications that the spatially correlated heterogeneity term might
over-smooth the spatial correlation of the relative risk estimates where none exists.
The performance of the BYM model is also highlighted when the potential covariates
were included to explain the extra variation in the relative risks. The inclusion of the
rural/urban indicator and the mean radon measurement improved the Log-Normal
model and so might explain the variation in the relative risks. However the inclusion
of these covariates in the BYM model did not improve the model. With further
assessment of the posterior estimates of the different BYM models it would appear
that although there is an association between these two covariates and the relative
risks the inclusion of the spatially correlated heterogeneity soaks up the extra
variation we wish to account for.
Therefore, in general there might be a slight spatial correlation of the relative risks of
testicular cancer within Scotland, although it is not a strong spatial variation. The
variation in relative risks appears to be associated with the rurality and mean radon
measurement of the area.
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Chapter 6 : Hypospadias Analysis
6.1 Introduction
This chapter details the analysis of the hypospadias dataset. As the hypospadias data
has been analysed as disease count data only, the chapter has a similar format as the
previous testicular cancer analysis chapter.
6.2 Summary of hypospadias dataset
As with the testicular cancer data, there has not been a spatial analysis of the
individual covariates from the hypospadias data. However the summary carried out
for the cryptorchidism cases is repeated here for the hypospadias data for comparison
purposes, as both are congenital anomalies and originate from the same dataset,.
6.2.1 Incidence over time
Unlike both the cryptorchidism and testicular cancer cases, the hypospadias
incidence has not increased over time (Figure 92). It would appear that after an
increase in the incidence for the first third of the time period of the hypospadias
dataset, the incidence has fallen since with a slight increase for the last few years of
the interval.
Figure 92 Hypospadias incidence rate per 1,000 births (3 year moving average)
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6.2.2 Mothers' year of birth
The distribution of the mother's year of birth for the hypospadias cases is similar to
the cryptorchidism cases (Figure 93). The mother's of the hypospadias cases had a
year of birth ranging from 1937 to 1979 and mean of 1960, compared to 1935 to
1978 (mean 1960) for the mothers' of the cryptorchidism cases.
Figure 93 Histogram ofMothers' Year of Birth
1937 1943 1949 1955 1961 1967 1973 1979
Year of birth of mother n«4.84i
Figure 94 shows the distribution of the mothers' ages of the hypospadias cases.
Again the distribution is similar to the cryptorchidism cases. The range of the
mothers' age of the hypospadias cases is 15 to 43 with a mean of 26.4 years,
compared to 14-45, mean 26.5 years for the cryptorchidism cases.













15 19 23 27 31 35 39 43
Age of mother at birth n=4.839
So even though the hypospadias incidence over time is different from the
cryptorchidism cases, this cannot be explained by differences in the mothers' of these
cases.
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6.3 Standardised Morbidity Ratio (SMR) maps
The following gives the results of these calculations in relation to the hypospadias
dataset.
6.3.1 Observed number of hypospadias cases per 1991
postcode sector
Of the 4,919 cases of hypospadias, 25 records did not have postcode sector recorded.
Therefore 4,894 cases were linked to the database created that matches all valid
postcode sectors to where this would have been in 1991 (detailed in 3.5). Of the 801
postcode sectors within the hypospadias dataset, only 777 were linked to records
within the 1991 database. The remaining 24 postcode sectors were not valid postcode
sectors; and are detailed in Table 37.
Table 37 Description of invalid postcodes in hypospadias dataset
Description of invalid postcode Number of postcode sectors (number of cases of
sector hypospadias)
Mistyped postcode sector 5 postcode sectors (6 cases)
English postcode sector 3 postcode sectors (6 cases)
Local Council code 16 postcode sectors (226 cases)
Of those postcode sectors mistyped, 4 (5 cases) could be corrected. However none of
the remaining postcode sectors could be geographically referenced resulting in 233
cases being excluded from further analysis. This was valid for those cases with
English postcode sectors, which probably resulted from cross-boundary attendance at
a maternity hospital.
However, as with the cryptorchidism dataset a high number of cases were lost
because particular hospitals have used local council codes instead of postcode sectors
- Kirkcaldy (97 cases), North East Fife (16 cases) and Dunfermline (93 cases). This
has the same impact on the analysis as discussed with the cryptorchidism dataset.
Therefore of the 4,919 cases of hypospadias 4,661 could be assigned to a 1991
postcode sector. The distribution of the number of cases within each of these
postcodes sectors is shown in Figure 95.
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Figure 95 Histogram of the number of hypospadias cases per 1991 postcode sectors
As can be seen the distribution is highly skewed - the number of cases in each
postcode sector ranges from 0 to 43 with a median of 4 cases. Comparing the
hypospadias values to the other two conditions, there is a wider range of hypospadias
cases than found for either cryptorchidism (0-19) or testicular cancer (0-18) datasets,
and has a higher median (cryptorchidism - 2; testicular cancer - 3). Therefore it has
the highest incidence of the three conditions.
6.3.2 Expected number of hypospadias cases per 1991
postcode sector
The expected numbers of hypospadias cases per 1991 postcode sector were
standardised by year of birth and the underlying population used was all births.
The distribution of the expected number of hypospadias cases within each of the
1991 postcode sectors is shown in Figure 96. While the distribution is skewed it is
not as wide a range of values as those observed for hypospadias - 0-21.4 compared
to 0-43. Furthermore the median expected value (4.73) is larger than the median
observed (4) while their mean values are similar (5.3 expected; 5.2 observed),
therefore the expected distribution does not appear to be a skewed as the observed.
These differences in the distributions of the expected and the observed values are
also comparable to the other two conditions within the research project.
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Figure 96 Histogram of the expected number of hypospadias cases per 1991 postcode
sectors
6.3.3 SMRs of hypospadias per 1991 postcode sector
The distribution of the hypospadias SMRs for the 1991 postcode sectors is skewed;
the maximum SMR is 18.11, the third quartile is 1.39, mean SMR is 0.98 (standard
deviation 1.08) and the median is 0.82 (Figure 97).
Figure 97 Histogram of hypospadias SMRs per 1991 postcode sector
Comparing the hypospadias SMRs with those for the other two conditions, all three
have skewed distributions. While the hypospadias distribution is similar to the
testicular cancer distribution (range 0-18.9; median 0.9), the cryptorchidism
distribution has a longer tail (range 0-235.6; median 0.78).
There does appear to be a spatial pattern to the hypospadias SMRs across Scotland
(Figure 98).
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Figure 98 Hypospadias SMRs per 1991 postcode sectors: Scotland 1980-1999
Legend
In particular, there does appear to be a cluster of higher relative risk in the east and
south-west of Scotland and lower relative risks in the area from the central border to
the west of Scotland.
The variability of the estimates of the SMRs can be assessed by the standard error of
each SMR. The distribution of the standard errors is skewed - range 0-7.8, median
0.37 and mean 0.46. Compared to the other conditions the variability of the
hypospadias standard errors of the SMRs is not as great (cryptorchidism 0-235.6,
mean 0.92; testicular cancer 0-15.6, mean 0.58).
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The spatial variation of the standard errors is similar in some areas to the SMRs i.e.
the SMRs may reflect the random variation of the estimates rather than any variation
in disease risk (Figure 99). Therefore it looks important to take into account this
variability when calculating the hypospadias disease risk, which can be done with
Bayesian models.
Figure 99 Hypospadias standard error of SMRs per 1991 postcode sector: Scotland
1980-1999
Legend
Standout enoi of SMRs
0.00
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6.4 Bayesian hierarchical modelling of hypospadias
data - Poisson-Gamma model
The Poisson-Gamma model was run with the hypospadias dataset in WinBUGs
which converged following 3,000 iterations, a further 10,000 were run to produce
robust posterior estimates.
6.4.1 Posterior estimates from model
The distribution of the hypospadias posterior expected relative risks for each of the
1991 postcode sectors as produced by the Poisson-Gamma model is shown in Figure
100.
Figure 100 Histogram of Hypospadias posterior expected Relative Risk estimated from
the Poisson-Gamma model
0 1 2 3 4 5
Posterior expected relative risks for cryptorchidism cases per 1991 postcode sector
The distribution is less skewed that that for the SMRs (median 0.99 and mean 1.004)
and the range of values has been reduced (0.25, 4.76) towards the population mean
relative risk of 1.006 (Table 38). As the standard deviation of the population mean
relative risk is 0.02 then the variability of this estimate has been reduced compared to
the SMR.
Compared to the spatial variation of the SMRs, the spatial pattern of the relative risks
produced by the Poisson-Gamma is the same although smoothed (Figure 101).
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a 3.386 0.3013 0.01915 2.844 3.369 4.018
b 3.369 0.3159 0.02012 2.801 3.354 4.039
mean 1.006 0.02563 4.81E-04 0.956 1.006 1.057
var 0.3013 0.0316 0.001871 0.2442 0.2995 0.3673
Figure 101 Hypospadias posterior expected relative risk per 1991 postcode sector from
the Poisson-Gamma model: Scotland 1980-1999
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The probabilities of the relative risks being greater than 1, show a similar spatial
pattern to the relative risks map, so confirming the areas with high and low relative
risk while taking into account the variability of the estimates (Figure 102).
Figure 102 Hypospadias Posterior probabilities for expected relative risk per 1991
postcode sector from the Poisson-Gamma model: Scotland 1980-1999
Legend
Posteiioi piolmhility of lelatrve lisks >1 - Poisson-Goiniim model
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6.4.2 Assessment of model
The analysis of the standardised residuals is shown in Figure 103.
Figure 103 Poisson-Gamma Model residuals analysis - (a) Normal Plot (b) Residuals v
Fitted
Quantiles of Standard Normal
(a)
(b)
The Poisson-Gamma model is not an adequate fit to the hypospadias dataset. The
normal plot (a) does not follow the x-y line, in particular the extreme values of
relative risks. The residuals are not evenly scattered across all fitted values (b), again
the larger fitted values appear to the least successful, although a number of small
fitted value also appear to not fit the Poisson-Gamma model. Therefore, while the
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Poisson-Gamma model appears to fit to those fitted values around the mean, it is
unsuccessful at fitting the extreme values.
There is also spatial correlation of the residuals, in particular in the North-East of
Scotland (Figure 104). So the Poisson-Gamma model does appear to the least
successful in those areas with high relative risks.
Figure 104 Hypospadias residuals of Poisson-Gamma model: Scotland 1980-1999
Legend
St. residuals - Poissoii-Gamma model
B -1.91 - -1.50
| -1.49- -0.50
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Furthermore, the Moran's I test shows that there is a statistically significant (p=4.03
x 10"80) spatial correlation (r=0.4) of the residuals (Table 39).
Table 39 Moran's I test result for residuals from Poisson-Gamma model
There is evidence that the residuals appear to cluster in areas where high relative
risks are estimated, so the Poisson-Gamma model does not fully explain the
variability of these estimates. It might be appropriate to include a term in any models
that attempt to describe the spatial variation of hypospadias that accounts for the
spatially correlated heterogeneity.
6.4.3 Conclusions for Poisson-Gamma model
The Poisson-Gamma model is not a complete appropriate fit to the hypospadias data.
The model smoothes the relative risks, decreases the range of their values and so
produces a smoother spatial pattern. However, it does not take into account the
variability in the estimates, in particular those areas with high relative risks. This
might be due to the model not taking into account spatial correlation i.e. that a
postcode sector will be similar to its neighbours.
6.5 Bayesian Hierarchical Models of hypospadias
count data - Log-Normal
The Log-Normal model was run with the hypospadias dataset in WinBUGs and
converged following 2,000 iterations. To produce robust posterior estimates a further
10,000 iterations were run.
6.5.1 Posterior estimates from model
The distribution of the hypospadias posterior expected relative risks for each of the
1991 postcode sectors as produced by the Log-Normal model is shown in Figure
105. While the distribution is similar to that for the relative risks produced by the
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those from the Poisson-Gamma (0.25-4.76). The distribution of relative risks is less
skewed (median 0.96 and mean 0.99) for the Log-Normal compared to the Poisson-
Gamma model (median 0.99 and mean 1.004).
Figure 105 Histogram of Hypospadias posterior expected Relative Risk estimated from
the Log-Normal model
0 1 2 3 4 5 6
Posterior expected relative risks for cryptorchidism cases per 1991 postcode sector
Therefore, the Log-Normal model smoothes the relative risk estimates towards the
population mean relative risk (0.87 standard deviation 0.02 (Table 40).







alpha -0.1372 0.02694 6.01E-04 -0.1906 -0.1372 -0.08533
mean 0.8721 0.02348 5.24E-04 0.8265 0.8718 0.9182
tau.v 3.476 0.3156 0.006938 2.901 3.463 4.137
While this is a reduction in the range of relative risks compared to the SMRs, it not
to the same extent as those produced by the Poisson-Gamma model. Furthermore, the
population mean relative risk produced by the Log-Normal is much lower than that
produced by the Poisson-Gamma model (1.006) and the SMRs (0.98). And the
variability of this estimate has been reduced compared to the SMR and to the same
extent as that done by the Poisson-Gamma model.
The spatial variation of the relative risk estimates produced by the Log-Normal
model is very similar to that produced by the Poisson-Gamma model (Figure 106).
Again we can see two regions with an elevated hypospadias risk in the East and
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South-West of Scotland, and an area with a reduced risk from the central Borders to
the West of Scotland.
Figure 106 Hypospadias posterior expected relative risk per 1991 postcode sector from
the Log-Normal model: Scotland 1980-1999
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The probabilities of the relative risks being greater than 1, show a similar spatial
pattern to the relative risks map, so confirming the areas with high and low relative
risk while taking into account the variability of the estimates (Figure 107).
Figure 107 Hypospadias posterior probability of relative risk being greater than 1 per
1991 postcode sector from the Log-Normal model: Scotland 1980-1999
Legend
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The map of the uncorrelated heterogeneity term from the Log-Normal model shows
that those areas with high relative risks also have high extra variation (Figure 108).
This provides some evidence that the heterogeneity of the relative risks appear to
vary in a spatially structured way.
Figure 108 Hypospadias posterior probability of uncorrelated heterogeneity per 1991
postcode sector from the Log-Normal model: Scotland 1980-1999
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6.5.2 Assessment of model
The analysis of the standardised residuals produced for each relative risk estimate
from the Log-Normal model is shown in Figure 109.
Figure 109 Log-normal Model residuals analysis - (a) Normal Plot (b) Residuals v
Fitted
Quantiles of Standard Normal
(a)
(b)
The Log-Normal fits the hypospadias dataset better than the Poisson-Gamma model,
although it is still not completely appropriate for the higher relative risks. The normal
plot (a) shows the residuals follow the x-y line better than those from the Poisson-
Gamma model; in particular the lower values now follow the line. However the
higher relative risks still do not fit the model as well as the other values. The
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residuals are more evenly scattered across all fitted values than the Poisson-Gamma
residuals (b), however again the larger fitted values appear not to follow this pattern.
The spatial variation of the residual produced by the Log-Normal model is similar to
those produced by the Poisson-Gamma model i.e. spatial correlation of high residuals
values in the North-East and South West of Scotland and lower residuals in the
North-West and South-East (Figure 110). Therefore, as with the Poisson-Gamma
model, the Log-Normal model does not successfully account for the heterogeneity in
those areas with high relative risks of hypospadias.
Figure 110 Hypospadias residuals of Log-Normal model: Scotland 1980-1999
Legend
St. Residuals - Lo<j-Noim<il model
HI -2.ee- -1.50
-149- -o-50
mm -o.48 - o.oo
m 0.01-0.50
0.51 - 1.50
■I 1.51 • 6.19
Not available
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From Table 41, there is a statistically significant (p<0.001) correlation of the
residuals, although it is a small negative one (r=-0.083). Furthermore, the
permutation correlation is not statistically significant at the 95% level. Therefore it is
inconclusive that there is spatial correlation of the residuals.
Table 41 Moran's I test result for residuals from Log-Normal model
Statistic Result
Number of permutations 100
Correlation (95% CI) -0.083 (-0.124, -0.062)
Correlation Normal p-value (2-sided) 9.85 x 10~5
Mean Permutation correlations (Inter-quartile range) -0.004 (-0.0196, 0.0125)
Permutation p-value 1
6.5.3 Conclusions for Log-Normal model
The Log-Normal model is a slight improvement on the Poisson-Gamma model for
estimating the relative risks for the hypospadias dataset. The same spatial variation of
the disease risk was found i.e. higher risk in East and South-West of Scotland with
lower risk in the region between the Central Borders and West of Scotland. And, like
the Poisson-Gamma model, there was some evidence of spatial correlation of the
residuals, so neither model fully explained the variability of the high relative risk
estimates. However, from the residual analysis the Log-Normal model fitted the
hypospadias dataset slightly better than the Poisson-Gamma model.
Finally, as there was some evidence that the heterogeneity was spatially correlated, a
term should be include to accounts for this so as to fully describe the spatial variation
of the hypospadias relative risks.
6.6 Bayesian Hierarchical Models of cryptorchidism
count data - Besag, York and Mollie (BYM) model
The BYM model was run with the hypospadias dataset in WinBUGs and converged
following 14,000 iterations. To produce robust posterior estimates a further 25,000
iterations were run.
6.6.1 Posterior estimates from model
Figure 111 shows the distribution of the posterior expected relative risks estimated
by the BYM model.
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Figure 111 Histogram of Hypospadias posterior expected Relative Risk estimated from
the BYM model
0 2 4 6 8 10
Posterior expected relative risks for cryptorchidism cases per 1991 postcode sector
The distribution of the estimates is very similar in shape to the SMRs i.e. skewed,
although the range of values (0.34-9.46) is reduced compared to the SMRs (0-18.1).
The BYM estimates have a higher maximum relative risk than both the Poisson-
Gamma (4.76) and Log-Normal (5.92) but also a higher minimum (0.25 and 0
respectively), so it would appear that the distribution of the estimates has shifted to
the right compared to the previous models.
As the distribution of the relative risk estimates produced by the BYM model is so
skewed this has resulted in a population mean relative risks of 0.5, considerably
lower than produced by SMRs or the other two Bayesian models (Table 42).
Furthermore, the intercept term alpha has increased, while the precision of the non-
spatial heterogeneity term has deteriorated compared to the Log-Normal model.
Therefore the inclusion of the spatially correlated heterogeneity term appears to have
strengthened the intercept term but weakened the precision of the non-spatial
heterogeneity.
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alpha -0.7058 0.1612 0.0127 -0.9666 -0.7173 -0.4007
mean 0.5002 0.08219 0.006475 0.3804 0.4881 0.6699
tau.u 2.881 0.3735 0.009307 2.233 2.849 3.717
tau.v 1248 1235 87.65 114.8 893.6 4831
The spatial pattern of posterior expected relative risks from the BYM model is the
same as that the Poisson-Gamma and Log-Normal models of the hypospadias
dataset, although the pattern is more distinct (Figure 112).
Figure 112 Hypospadias posterior expected relative risk per 1991 postcode sector from
the BYM model: Scotland 1980-1999
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The probabilities of the relative risks being greater than 1 show a similar spatial
pattern to the relative risks map, so confirming the areas with high and low relative
risk while taking into account the variability of the estimates (Figure 113).
Figure 113 Hypospadias posterior probabilities of expected relative risk per 1991
postcode sector from the BYM model: Scotland 1980-1999
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The spatially correlated heterogeneity term in the BYM shows a similar spatial
pattern as the BYM relative risk estimates (Figure 114). It would appear that the
variability of the random effects has a spatial component, although this could be
evidence of a strong spatial prior? Sensitivity analysis of the prior will be able to
investigate this (6.6.2).
Figure 114 Hypospadias posterior expected correlated Heterogeneity term n, per 1991
postcode sector from the BYM model: Scotland 1980-1999
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Furthermore, the spatial variation of the non-spatially correlated heterogeneity is not
as distinct as produced in the Poisson-Gamma and Log-Normal models (Figure 115).
Figure 115 Hypospadias posterior expected uncorrelated Heterogeneity term v, per
1991 postcode sector from the BYM model: Scotland 1980-1999
This could be because the spatially correlated variability in the estimates of the
relative risks found in the other two Bayesian models is now accounted for by the
spatially correlated heterogeneity term. However, there is evidence that the CAR
model used in the BYM model for the spatially correlated heterogeneity term over-
smoothes the extra variation. For instance, the deterioration in the precision of the
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non-spatially correlated heterogeneity term between the Log-Normal and BYM
model.
6.6.2 Sensitivity Analysis
Table 43 shows the results of the comparison of the relative risks estimated by the
BYM model outlined (Model 1) and those from the BYM model where the prior for
tau.u is changed to gamma(0.5, 0.0005). There appears to be a strong correlation
between the two sets of estimated relative risks, and no significant differences in the
relative risks estimated for the same postcode sector. Therefore the distinct spatial
pattern of the relative risks estimated by the BYM model is not due to the specific
prior for the precision of the spatially correlated heterogeneity.
Table 43 Comparison tests of Relative Risks estimated from BYM models using
prior for tau.u gamma(l,l,) (model 1) and gamma(0.5, 0.0005) (model 2)
Correlation co-efficient of Mean difference in relative risks
Paired t-test - p valuerelative risks (95% CI) (Model 1-2)
0. 9998 0. 0006 (-0.0002, 0.0013) 0. 1308
6.6.3 Assessment of model
The residual analysis for the BYM model is shown in Figure 116.
Figure 116 BYM Model residuals analysis - (a) Normal Plot (b) Residuals v Fitted
-1 0 1
Quantiles of Standard Normal
(a)
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(b)
It would appear that the BYM model is not any more successful than the other two
Bayesian models. The Normal Plot of the residuals (a) does not follow the x=y line
for the extreme values and the residuals are not evenly scattered when plotted by the
fitted values (b), in a similar way to the Poisson-Gamma model.
There does appear to be some spatial correlation of the residuals, in particular in the
North-East of Scotland (Figure 117).
From the Moran's I test results the spatial auto-correlation of the residuals is
confirmed (Table 44). Therefore, as with the other models, the BYM model appears
not to fully account for the heterogeneity in those areas with high relative risks
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Figure 117 Hypospadias residuals of BYM model: Scotland 1980-1999
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It is possible to compare the DIC diagnostics of the three Bayesian Hierarchical
models to assess which is the best fit to the hypospadias data (Table 45).
Table 45 Model fitting results of the three disease count models
Model d d(s pD DIC
Poisson-Gamma model 3429.52 3002.63 426.894 3856.42
Log-Normal model 3443.48 3008.54 434.937 3878.41
BYM model 3397.67 3142.78 254.886 3652.55
From the DIC diagnostics, the BYM model fits the hypospadias dataset the best, with
the Log-Normal model being the worst fit.
6.6.4 Conclusions for BYM model
It would appear that in general the BYM model is slightly better model and fit to the
data compared to the Poisson-Gamma or Log-Normal model. However, it like the
other two models is not successful in accounting for the spatial variation of the
relative risks and the variability of their estimates.
6.7 Inclusion of covariates into Bayesian hierarchical
models of disease count data
The inability of the three Bayesian models to fully account for spatial variation might
not be due to the terms used within the models but that other explanatory variables
might explain the spatial variation of the hypospadias relative risks. This section
assesses if the inclusion of potential explanatory variables does help explain the
increase risk in East and South-West Scotland and lower risk in the area from Central
Border to the West of Scotland.
6.7.1 Assessment of models
Table 46 shows the different models ran in WinBUGs and the results for each of the
DIC diagnostics.
Chapter 6: Hypospadias Analysis 217
Spatial Epidemiology of Indicators of Male Reproductive Health in Scotland
Table 46 Model fitting results of the Bayesian Hierarchical disease count models
with covariates
Model D 4?) pD DIC
1. Poisson-Gamma model 3429.52 3002.63 426.894 3856.42
2. Log-Normal model 3443.48 3008.54 434.937 3878.41
3. BYM model 3397.67 3142.78 254.886 3652.55
4. Log-Normal model plus deprivation (5 groups) 3443.04 3009.22 433.812 3876.85
5. Log-Normal model plus deprivation (7 groups) 3442.8 3008.38 434.418 3877.21
6. Log-Normal model plus urban/rural indicator 3456.01 3049.89 406.12 3862.13
7. Log-Normal model plus radon (mean) 4441.99 4440.02 1.974 4443.96
8. Log-Normal model plus radon (% >200) 3452.89 3044.10 408.792 3861.68
9. BYM model plus deprivation (5 groups) 3357.86 3041.89 315.967 3673.82
10. BYM model plus deprivation (7 groups) 3353.74 3030.32 323.422 3677.16
11. BYM model plus urban/rural indicator 3354.66 3033.81 320.85 3675.52
12. BYM model plus radon (mean) 3402.48 3150.93 251.55 3654.02
13. BYM model plus radon (% >200) 3354.47 3036.73 317.735 3672.2
The inclusion of the percentage of a region that has radon measurements greater than
200 Bq/m or the rural/urban indicator explain some of the spatial variation in the
hypospadias risk within the Log-Normal model. There is also some indication that
deprivation might also improve the fit of the Log-Normal model, although it is not
conclusive if we use a difference of 2 between DIC results as our threshold.
However, when the spatially correlated heterogeneity is added to the models, as is
the case in the BYM model, no model with the inclusion of potential covariates are
an improvement on the basic BYM model. This conclusion is made from comparing
DIC results; however, it would appear that the deviances are improved in the BYM
model when all the covariates, except mean radon, are included. Therefore the data
fits the hypospadias risk better with the inclusion ofmost of the covariates, but they
are not better models when the number of parameters is taken into account. Could
this be because the extra variation is soaked up by the spatially heterogeneity term
and so could not be accounted for by the potential covariates? A comparison of the
posterior estimates produced by these models might indicate what terms are
accounting for the spatial variation in the hypospadias risk.
Figure 118 shows the relative risks produced by the six Log-Normal models
described in Table 45. It would appear that the spatial variation is similar in most of
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Log-Normal models although the values are altered by the particular covariate
included. The spatial pattern of the relative risks the Log-Normal plus mean radon
(model 7) is very different from the other models. The clustering of relative risks is
much more distinct and also has a much narrower range of values (0.77-1.91).
However the DIC result for this model is the worst for any model and so the poor fit
of the hypospadias data to this model has probably produced this disparate spatial
variation. For those two covariates (Models 6 and 8) where the DIC showed that they
improved the Log-Normal model the relative risk values are reduced.
Figure 118 Hypospadias posterior expected relative risk from Log-normal plus
variable models
4 f f
Model 2 Model 4 Model 5
•f/ 4
Model 6 Model 7 Model 8
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Would the inclusion of the spatially correlated heterogeneity term to these models
alter the spatial pattern of the relative risks? Figure 119 shows the relative risks
produced by the six BYM models described in Table 45. All maps have the same
categories and show the same spatial variation in hypospadias risk, even the BYM
model with mean radon (model 12). Although there appears to be a reduction in the
relative risk values produced in the BYM models that include the rural/urban
indicator (Model 11) and the radon >200 (model 13) compared to the basic BYM
model.





Model 3 Model 9 Model 10
Model 11 Model 12 Model 13
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The spatial variation of the heterogeneity terms produced in the models might show
what variation is accounted for with the inclusion of potential covariates. Again the
spatial variation of the non-spatially correlated heterogeneity term is unaffected by
the inclusion of covariates within the Log- Normal model, except in the model with
mean radon included as a potential covariate (Figure 120 - Model 7). The pattern of
the non-spatially correlated heterogeneity term is different in this model and the
values are narrower. This could be as result of the poor fit of this covariate according
to the DIC results. The random heterogeneity values are reduced in the Log-Normal
models with the potential covariates that improve the model (Models 6 and 8).
Therefore for those covariates that improve the Log-Normal model, the non random
variability in the estimates of the relative risks is reduced.
Figure 120 Hypospadias posterior spatially uncorrelated heterogeneity term from Log-
normal plus variable models
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A similar conclusion can be made when comparing the spatial variation of the non-
spatially correlated heterogeneity term produced by the BYM models; all are similar
except for the BYM model with mean radon (Figure 121). However the BYM model
without a covariate included and the BYM model plus mean radon also have a
smaller range of values than the other models.
Figure 121 Hypospadias posterior spatially uncorrelated heterogeneity term from
BYM plus variable models
ir 4 | 4 m 4
Model 3 Model 9 Model 10
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The spatial variation of the spatially correlated heterogeneity term produced by the
BYM models show the same pattern as each other and as the estimates of the relative
risks. However the model with no covariates shows the largest heterogeneity values.
Therefore the inclusion of the other covariates might have explained some of the
extra variation, even though this did not result in a reduction of the DIC values.
Figure 122 Hypospadias posterior spatially correlated heterogeneity term from BYM
plus variable models








Model 11 Model 12 Model 13
Apart from the postcode specific posterior estimates produced by the models, there
are model parameters that might provide more information on how successful the
inclusion of potential covariates have been in explaining the spatial variation of the
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hypospadias risk. Figure 123 shows the posterior estimates of the parameters for the
different Log-Normal models.
Figure 123 Posterior estimates for non postcode specific parameters in Log-Normal
models
Log Normal LN * dep5 LN + dep7 LN + radonl . LN ♦ radon2 LN + urban
Model
Log Normal LN + dep5 LN + dep7 LN + radonl LN + radon2 LN + urban
Model
alpha mean
Log Normal LN + dep5 LN + dep7 LN + radonl LN + radon2 LN + urban
Model
Log Normal LN + dep5 LN + dep7 LN + radon2 LN + urban
Model
tau.v tau.v (without mean radon model)
The mean intercept term (alpha) estimates are generally negative and similar
although the wide credible intervals on a number of the models mean that it is
unclear if all the estimates are negative. The largest negative value is for the Log-
Normal plus mean radon model, which is the worse fitting model to the hypospadias
data. In general then, the intercept is of a small negative value, which is largely
unaltered by the inclusion of possible covariates except in the precision of its
estimate.
The population mean relative risk (mean) estimates shows a similar pattern to the
intercept estimates, in terms of changes made by the inclusion of the potential
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covariates. All estimates from the different models show a population relative risk of
below 1 with different precisions of the estimate for different models. There are
wider credible intervals on the deprivation and urban/rural indicator model. Again
the lowest value is that produced by the Log-Normal plus mean radon model.
The precision of the non-spatially correlated heterogeneity term (tau.v) is similar is
all the models except that with mean radon, where the precision is much poorer. This
is consistent with previous assessments of this model. When looking at the precision
of the non-spatially correlated heterogeneity term for the other models, the precision
deteriorates slightly in those models that appear to improve the fit of the data
compared to the basic Log-Normal model i.e. the urban/rural indicator and the
percentage of a region that has radon measurements greater than 200 Bq/m3 models.
Do any of these parameter estimates alter with the inclusion of the spatially
correlated heterogeneity term? (Figure 124)
Figure 124 Posterior estimates for non postcode specific parameters in BYM models
BYM BYM plus dep5 BYM plus dep7 BYM plus r
Model
1 BYM plus radon2 BYM pi' BYM BYM plus dep5 BYM plus dep7 BYM plus radonl BYM pi
Model
alpha mean
BYM BYM BYM BYM plus dep5 BYM plus dep7 BYM plus radonlBYM plus radon2 BYM
tau.u tau.v
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In general the model parameters are the same, although there are some changes. The
mean intercept terms (alpha) remains below zero except for that for the BYM model
with urban/rural indicator, which is now more likely to be positive. The population
relative risk estimates remains below 1 except again for the urban/rural indicator
model, which now shows an excess relative risk, all be it with wide credible
intervals. The precision of the non-spatial heterogeneity term (tau.v) deteriorates
with the inclusion of the spatially correlated term; however with the inclusion of
most of the covariates (except radon) this is reversed. The estimates of the precision
of the spatially correlated term (tau.u) are increased by the inclusion of any of the
potential covariates worsens it.
6.7.2 Conclusions of Inclusion of Covariates
While the DIC results from the Log-Normal model indicate that the percentage of a
region that has radon measurements greater than 200 Bq/m3 or the rural/urban
indicator might explain some of the spatial variation, this is not confirmed from the
BYM models results. However, from the comparison of the spatial variations of the
relative risks and heterogeneity terms there appears to be a reduction in the
variability of their values in both the Log-Normal and BYM models, when these
covariates are included.
This discrepancy in the performance of the these two covariates in the BYM model
could be due to the spatially correlated heterogeneity term soaking up any extra
variation which we want to explain. For instance, the precision of the non-spatial
heterogeneity term deteriorates with the inclusion of the spatially correlated
heterogeneity term which is then reversed by the inclusion of most of the potential
covariates.
Therefore there is some evidence to show that the spatial variation in the testicular
cancer relative risks might be associated with the rural/urban indicator and the mean
radon measurement of that postcode sector.
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6.8 Summary of Hypospadias Analysis
There does appear to be spatial pattern to the hypospadias relative risks across
Scotland. The relative risk estimates from each of the three Bayesian disease count
models found clusters of high relative risks in the East and South-West of Scotland
with lower risks in the region between the Central Borders and the West of Scotland.
In general the BYM model was the best fit to the hypospadias data although as with
the other two condition/diseases suspicions are raised on the performance of the
spatially correlated term used in the model. While the Poisson-Gamma and the Log-
Normal model identified that the heterogeneity might be spatially correlated, it is not
clear if the term used within the BYM model over-smoothes this heterogeneity.
There is some evidence to show that the percentage of a region that has radon
measurements greater than 200 Bq/m3 or the rural/urban indicator might explain the
spatial variation of the hypospadias relative risks.
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Chapter 7 : Combined analysis of male reproductive
health conditions
7.1 Introduction
This chapter reports the results of the conjoint analysis of the three indicators of male
reproductive health previously analysed separately: cryptorchidism, hypospadias and
testicular cancer. The justification for this approach is detailed in 3.8 where the
development of the multi-indicator model in WinBUGs is also described.
This chapter consists of three sections. Before detailing the results of the multi-
indicator model the first section summarises the results of the individual indicators
disease count models. The purpose of this section is to provide an initial comparison
of the spatial variations of the three indicators. It is not to compare the performance
of the Bayesian models with each of the disease/conditions data, as this been done in
the individual disease/condition result chapters.
The second section details the results from the multi-indicator model in three parts:
(i) 7.3.1 provides a comparison of the goodness of fit of the three multi-indicator
models ran in WinBUGs, to show which heterogeneity terms best explain the
joint spatial distribution of the indicators.
(ii) 7.3.2 details and compares the posterior estimates of the area-specific
estimates produced by the multi-indicator models, to show the spatial
variation of the estimates of the relative risks.
(iii) 7.3.3 assesses the relationships between the relative risks estimates of the
three indicators produced by the three multi-indicator models, to show if
spatial relationships exist between them and further asses the performance of
the multi-indicator models.
Finally, as with all the analysis chapters, the results of the multi-indicator analysis
are summarised and points are highlighted for further discussion.
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7.2 Comparison of individual Bayesian Hierarchical
disease count models
The figures below show the relative risks estimated from the separate Bayesian
Hierarchical disease count models for each indicator. The purpose of these maps is to
compare the spatial variation in relative risks for the three indicators produced
separately by the same model. Therefore we are comparing the variation in colour
gradients rather than values, and so the cut-off values do not need to be, and are not,
the same within each figure.
Comparing the relative risks estimates produced by the Poisson Gamma model
separately for the three indicators, the spatial variation is similar in cryptorchidism
and hypospadias (Figure 125). There are clusters of higher relative risks in the North
East and South West with a corridor of lower relative risks from the central borders
to the West coast. However the spatial pattern is more distinct for the hypospadias
relative risks than cryptorchidism. There is not such a distinct spatial pattern to the
testicular cancer relative risks, nor is it similar to those of the hypospadias and
cryptorchidism estimates.
Figure 125 Comparison of relative risks produced by the Poisson-Gamma model for
the three indicators
Cryptorchidism Hypospadias Testicular cancer
The similarities in spatial variation of the cryptorchidism and hypospadias estimates
produced by the Poisson-Gamma model are also found in those estimated from the
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Log-Normal model (Figure 126). And, as in the Poisson-Gamma model, there does
not appear to be a spatial pattern for the testicular cancer estimates that is similar to
those produced for the cryptorchidism and hypospadias data.
Figure 126 Comparison of relative risks produced by the Log-Normal model for the
three indicators
4 lr - 4 in
Cryptorchidism Hypospadias Testicular cancer
For all the indicators, the estimates produced by the BYM model have a much more
pronounced spatial pattern (Figure 127).
Figure 127 Comparison of relative risks produced by the BYM model for the three
indicators
4 r - 4 i~~ 4
Cryptorchidism Hypospadias Testicular cancer
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Again, the hypospadias and cryptorchidism spatial patterns are similar to each other,
although the patterns are much more distinct than in the other models' estimates. The
testicular cancer spatial pattern produced by the relative risks from the BYM model
is very different from that produced by the other two Bayesian models. There are
similarities to the testicular cancer risk and the hypospadias and cryptorchidism
spatial variation produced by the BYM model. There are higher relative risks in the
north-east like cryptorchidism and hypospadias. However, testicular cancer appears
to also have higher relative risks in the whole of the north and south and lower
relative risks in the central belt.
Yet, as discussed in the individual indicators results chapters, there are suggestions
that the spatially correlated heterogeneity term in the BYM model over-smoothes the
heterogeneity. Therefore the spatial variation of the testicular cancer relative risks
might not be as pronounced as those estimated by the BYM model.
Therefore, there are suggestions that there are similarities in the spatial variation of
cryptorchidism and hypospadias when comparing the estimates produced from the
separate models. However, it is unclear that the spatial variation of testicular cancer
is similar to the other indicators.
7.3 Multi-indicator model results
The previous section compares the spatial pattern of the relative risks estimated
separately for the three indicators. However for reasons already outlined (section 3.8)
a more elegant approach would be to model the three indicators conjointly.
7.3.1 Comparison of multi-indicator models
As well as the multi-indicator model outlined in section 3.8, two other multi-
indicator models were run in WinBUGs to ascertain which of the heterogeneity terms
best explain the joint spatial distribution of the three indicators. Table 47 details the
three models ran and the results of the DIC diagnostics. Comparing the DIC results
for the models, the most successful fit of the data is that which includes both
heterogeneity terms. Therefore the variation of the joint distribution of the three
indicators would appear to have both a spatial and random component.
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Table 47 DIC results ofMulti-indicator models
Model d d(s) pD DIC
1. Multi-indicator model with both heterogeneity terms
2. Model 1 with only uncorrelated heterogeneity













Moreover, the DIC for the model with only the spatially correlated heterogeneity
(model 3) is lower than the model with only the uncorrelated heterogeneity (model
2). Therefore there is evidence to show that the variation of the joint distribution of
the indicators has a stronger spatial component than a random one.
7.3.2 Area-specific posterior estimates of multi-indicator
models
Figures 128-130 show the distributions of the relative risk estimated by the three
multi-indicator models for the three indicators, to see how the inclusion of the
heterogeneity terms alters the relative risk estimates. It is assumed a particular model
is an improvement on another when the distribution of the relative risks is narrower,
as it is indicating a reduction in the variability of the estimates.
For all the conditions, to a lesser or greater extent, the distributions of the relative
risk estimates are altered by the inclusion of the spatially correlated heterogeneity
term. The narrowing of the distributions of the relative risks by the spatially
correlated heterogeneity term can be seen most noticeably for cryptorchidism (Figure
128) and hypospadias (Figure 129).
Figure 128 Cryptorchidism multi-indicator models results: distribution of posterior
estimates of relative risks per 1991 postcode sector
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In both indicators model 2, which has only the non-spatially heterogeneity term,
narrows the distribution of the relative risk estimates the greatest. Furthermore,
model 1, which contains both heterogeneity terms, has produced a distribution very
similar to that for model 3, which only has the spatially heterogeneity term.
Figure 129 Hypospadias multi-indicator models results: distribution of posterior
estimates of relative risks per 1991 postcode sector
Mean Population Relative Risk
Therefore, for these two indicators, the non-spatially heterogeneity has little effect on
the distribution of the relative risk estimates within the model with both
heterogeneity terms, and removes more of the estimates' variability. This provides
more evidence that the heterogeneity for these indicators is strongly spatially
correlated.
The differences in the relative risks distributions between model 2 and models 1 and
3 found in the cryptorchidism and hypospadias datasets is not as distinct in the
testicular cancer estimates (Figure 130). While the distribution of the relative risks
produced by model 2 is narrower than that for the other two models, the difference in
slight. Therefore the spatially correlated heterogeneity term does not impact on the
relative risk estimates produced for the testicular cancer to as great extent as those
for cryptorchidism and hypospadias. So it would appear that there is less of a spatial
component to the variation of the testicular cancer relative risks.
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Figure 130 Testicular cancer multi-indicator models results: distribution of posterior
estimates of relative risks per 1991 postcode sector
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Do the differences in the distributions of the relative risks for the 3 indicators
produced by the multi-indicator models alter the spatial variation of these indicators?
A comparison of the spatial variation of the relative risks produced by the 3 multi-
indicator models will give further insight into the performance of the heterogeneity
terms on the three indicators. The next 3 figures show the spatial variation of the
relative risks for the three indicators produced by the three multi-indicator models
(Figures 131-3). The cut-offs used in each figure are those used for the equivalent
disease in Figures 125 to 127, so that they are equivalent to those produced in the
separate indicator models.
The spatial variations of the relative risks produced from the multi-indicator model
for cryptorchidism are similar to those produced by the separate cryptorchidism
disease count models (Figure 131 vs. cryptorchidism in Figures 126 and 127).
Therefore the spatial variations of the estimates for the cryptorchidism relative risks
have not been altered by being estimated from the multi-indicator model rather than
the separate indicator models. As the spatial variation of the cryptorchidism relative
risks produced by Model 1 and Model 3 (spatially correlated heterogeneity only) are
very similar, it would appear that the uncorrelated heterogeneity term has little
impact on the estimates when included with the spatially correlated heterogeneity.
Furthermore, as the spatial variation of the cryptorchidism relative risks produced by
Model 1 are much more distinct than those produced by Model 2 (uncorrelated
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heterogeneity only), then the spatial correlated heterogeneity appears to have a
greater role in smoothing the variability of the relative risk estimates for
cryptorchidism.
Figure 131 Cryptorchidism multi-indicator model results: posterior estimates of








Similar comparisons and conclusions can be made between the spatial variations of
the relative risks produced from the multi-indicator models for hypospadias (Figure
132).
Figure 132 Hypospadias multi-indicator models results: posterior estimates of relative
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The spatial variations of the relative risk estimates for testicular cancer from the
multi-indicator models are considerably different from those produced by the
individual testicular cancer count models (Figure 133 vs. testicular cancer in Figures
126 and 127).
Figure 133 Testicular cancer (comparison cut-offs) multi-indicator models results:








The spatial variations of the relative risk estimates from these three multi-indicator
models for testicular cancer are very similar; which mirrors the comparison of the
distributions of the estimates of the various multi-indicator models (Figure 130). The
relative risk estimates produced by the multi-indicator models for testicular cancer
are generally larger than those produced by the separate individual models. So it is
likely that the multi-indicator models are not successful at modelling the testicular
cancer relative risks compared to the cryptorchidism and hypospadias data.
In order to compare the spatial variation of the testicular cancer relative risks
produced by the three multi-indicator models, the cut-off values need to be altered.
Figure 134 shows the spatial variation of the three multi-indicator models with the
altered cut-offs.
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Figure 134 Testicular Cancer multi-indicator models results: posterior estimates of







As with cryptorchidism and hypospadias the spatial variation of the testicular cancer
relative risks produced by Model 1 and Model 3 (spatially correlated heterogeneity
only) are very similar. Therefore it would appear that the uncorrelated heterogeneity
term has little impact on the estimates when included with the spatially correlated
heterogeneity term. However, the spatial variation of the testicular cancer relative
risks produced by Model 1 is similar to those produced by Model 2 (uncorrelated
heterogeneity only). So the spatially correlated heterogeneity does not appear to have
as strong effect on smoothing the variability of the relative risk estimates for
testicular cancer, as compared to cryptorchidism and hypospadias.
To further examine the effect of the heterogeneity terms on the overall performance
of the multi-indicator model, we can examine the estimates of the heterogeneity
estimated by the three multi-indicator models. Figure 135 shows the distribution of
the uncorrelated heterogeneity produced for the three indicators from the three multi-
indicator models, while Figure 136 shows the distributions for the spatially
correlated heterogeneity.
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Figure 135 Distribution of Posterior estimates of uncorrelated heterogeneity per 1991
postcode sector from multi-indicator models
Mean Population Uncorrelated heterogeneity
From Figure 135, irrespective of indicator, the uncorrelated heterogeneity is
narrowed for the model with both heterogeneity terms compared to that with only
random heterogeneity. Therefore the variability of the random heterogeneity is
reduced by the inclusion of the spatially correlated heterogeneity and so the inclusion
of both heterogeneity terms reduced the uncorrelated unexplained variation of the
joint distribution of these indicators. Furthermore, the distributions of the
hypospadias and cryptorchidism uncorrelated heterogeneity are narrower than those
for testicular cancer, irrespective of model. Therefore these two indicators are
modelled better in the multi-indicator model than the testicular cancer data.
The same conclusions can be made from the comparisons of the estimates of the
spatially correlated heterogeneity from the multi-indicator models (Figure 136).
However, the differences in the models with both heterogeneity terms compared to
those with only the spatially correlated heterogeneity is not a great as seen for the
uncorrelated heterogeneity distributions. Therefore, this would imply that the
spatially correlated heterogeneity is a stronger component of the multi-indicator
model, than the uncorrelated heterogeneity.
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Figure 136 Distribution of Posterior estimates of spatially correlated heterogeneity per
1991 postcode sector from multi-indicator models
Mean Population Spatially Correlated heterogeneity
7.3.3 Spatial Relationships between disease/conditions
Assessed visually there do appear to be similarities between the spatial variation of
the relative risks of cryptorchidism and hypospadias, and little between them and
testicular cancer. These possible correlations can be tested formally by comparing
particular terms specified in the multi-indicator model. Table 48 summarises the
parameters that are compared across the three multi-indicator models which have
been detailed further in section 3.8. Table 49 shows the posterior means (and 95%
credible intervals) for these parameters produced by the three multi-indicator models.
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Table 48 Descriptions of parameters included in multi-indicator models
Parameter Description of parameter
a[ 1 ] Intercept term for Cryptorchidism model
a[2] Intercept term for Hypospadias model
a[3] Intercept term for Testicular Cancer model
corr.sum 1 Within-area correlation between total heterogeneity of Cryptorchidism and Hypospadias
corrl Within-area correlation between spatial heterogeneity of Cryptorchidism and Hypospadias
corrl .v Within-area correlation between random heterogeneity ofCryptorchidism and Hypospadias
C0rr.sum2 Within-area correlation between total heterogeneity of Cryptorchidism and Testicular Cancer
corr2.u Within-area correlation between spatial heterogeneity of Cryptorchidism and Testicular Cancer
COrr2.v Within-area correlation between random heterogeneity ofCryptorchidism and Testicular Cancer
corr.sum3 Within-area correlation between total heterogeneity of Hypospadias and Testicular Cancer
corr3.u Within-area correlation between spatial heterogeneity of Hypospadias and Testicular Cancer
corr3.v Within-area correlation between random heterogeneity of Hypospadias and Testicular Cancer
sigma.u[l] Standard Deviation of spatial heterogeneity ofCryptorchidism
sigma.u[2] Standard Deviation of spatial heterogeneity of Hypospadias
sigma.u[3] Standard Deviation of spatial heterogeneity of Testicular Cancer
sigma.v[ 1 ] Standard Deviation of random heterogeneity for Cryptorchidism
sigma.v[2] Standard Deviation of random heterogeneity for Hypospadias
sigma.v[3] Standard Deviation of random heterogeneity for Testicular Cancer
Table 49 Parameter estimates from multi-indicator models











a[l] -0.08 (-0.14, -0.03) -0.04 (-0.09, 0.01) l o o 00 (-0.13,-0.02)
a[2] -0.16 (-0.21, -0.12) -0.11 (-0.17,-0.06) -0.22 (-0.28,-0.16)
a[3] -1.72 (-2.44, -0.72) -0.11 (-0.20, -0.02) -1.71 (-2.09,-1.22)
corr.sum 1 0.89 (0.78, 0.97) 0.97 (0.89, 0.99) 0.96 (0.88, 1.00)
corrl.u 0.97 (0.91, 0.99) - 0.94 (0.85, 0.99)
corrl .v -0.34 (-0.86, 0.45) 0.96 (0.89, 0.99) -
corr.sum2 0.15 (-0.10,0.38) 0.25 (0.01, 0.40) 0.19 (-0.04, 0.49)
corr2.u 0.11 (-0.14, 0.35) - 0.26 (-0.01,0.53)
corr2.v 0.71 (-0.18, 0.96) 0.26 (0.05, 0.47) -
corr.sum3 0.09 (-0.11, 0.32) 0.18 (0.05, 0.32) 0.07 (-0.13,0.27)
corr3.u 0.12 (-0.09, 0.34) - 0.06 (-0.12,0.25)
corr3.v -0.38 (-0.84, 0.59) 0.18 (0.04, 0.31) -
sigma[l] 0.34 (0.29, 0.38) - 0.35 (0.27, 0.42)
sigma[2] 0.48 (0.43, 0.56) - 0.49 (0.43, 0.55)
sigma[3] 1.55 (1.35, 1.76) - 1.82 (1.68, 1.96)
sigma.vfl] 0.10 (0.05,0.16) 0.34 (0.29, 0.40) -
sigma.v[2] 0.07 (0.04,0.13) 0.50 (0.46, 0.55) -
sigma.v[3] 0.45 (0.31, 0.58) 1.16 (1.08, 1.23) -
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Irrespective of multi-indicator model, there is evidence to suggest a strong shared
geographical pattern of risk between cryptorchidism and hypospadias. Firstly, there
is a high correlation between the spatially structured risk components for
cryptorchidism and hypospadias (Model 1 - 0.97; 95% CI: 0.91, 0.99). Furthermore,
as the spatial component dominates, the correlation between the total random effect
is also high (Model 1 - 0.89; 95% CI: 0.78, 0.97). Therefore, there does appear to be
a shared geographical pattern of risk between cryptorchidism and hypospadias,
furthermore there is to a lesser extent a spatially uncorrelated risk between the two
diseases. So there would appear to be spatially varying factor(s) associated with the
two conditions, and some evidence that non-geographically varying risk factor(s) are
also associated with cryptorchidism and hypospadias although to a lesser extent.
However, there is evidence that the spatially correlated heterogeneity over-smoothes
the spatially structured component. When comparing the estimates of the parameters
estimated from the three models, most are considerably altered by the removal of the
spatially correlated heterogeneity term (Model 2 v Model 1). This alteration in the
parameters estimates does not occur to the same degree when the spatially
uncorrelated heterogeneity term is removed. For example, the small statistically non¬
significant correlation between the spatially uncorrelated risk of cryptorchidism and
hypospadias (corrl.v) estimated from model 1 (-0.34; 95% CI: -0.86, 0.45), becomes
a strong statistically significant correlation estimated from model 2 (0.96; 95% CI:
0.89, 0.99). As the change in the terms included in these models is the removal of the
spatially correlated heterogeneity, then it would appear that this term has a
considerable effect on the multi-indicator model.
None of the other possible combinations of diseases show a correlation, so providing
further evidence that testicular cancer does not have the same spatial variation as
cryptorchidism and hypospadias. Furthermore, the standard deviations of the
spatially correlated and uncorrelated random heterogeneities (sigma.u[3] and
sigma.v[3] respectively) are the largest for testicular cancer irrespective of model,
which provides evidence that the relative risk estimates for testicular cancer from the
multi-indicator models are highly variable. Therefore the multi-indicator model does
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not appear to successfully fit the testicular cancer data as well as the cryptorchidism
and hypospadias data.
However, this can be tested by comparing the conditional likelihoods estimated
within each multi-indicator model for each disease/condition. Table 50 shows the
conditional likelihood estimates for each disease/condition within each multi-
indicator. These were estimated in order to calculate the DIC results for each model
and will show how well each disease/condition data fit the three multi-indicator
models.
Table 50 Conditional log likelihoods for each disease by multi-indicator model
Conditional log likelihoods (95% credible intervals)
Model 2 Model 3




Disease , . ^0t!* , spatially correlated uncorrelatedhotornnonoitv formc *
heterogeneity heterogeneity
Cryptorchidism 871.8 (832.0,910.4) 919.6 (863.3,968.9) 891.8 (865.4,917.8)
Hypospadias 845.4 (800.2,895.5) 906.6 (833.9,981.5) 859.1 (808.7,913.0)
TestCancer 870.1 (791.4,954.3) 942.9 (859.8,1,031.0) 891.8 (811.5,973.8)
In each multi-indicator model, the hypospadias data is the most successful fit. The
testicular cancer data is the least successful fit in all three models; however in two of
the three models (Models 1 and 3) there is no difference between it and the
cryptorchidism data. Therefore, while the testicular cancer data is the least successful
fit to the multi-indictor models, there is little difference in its success and that of the
cryptorchidism data, contrary to what has been shown previously. However, it is
interesting to note that for the least successful model (model 2), according to the DIC
results seen in Table 50, the testicular cancer data is considerably the least success
fit. As this model does not contain the spatially correlated heterogeneity term it
provides evidence that the variation of the joint distribution of the indicators has a
stronger spatial component than a random one. Therefore as the testicular cancer data
is the least successful fit to this model then the unexplained risk of this disease does
not appear to be spatially correlated.
Finally, the standard deviations (sigma.u#) of the random heterogeneities for the
three indicators are greatly increased when the spatially correlated heterogeneity is
removed from the multi-indicator model (Model 1 v Model 2). Therefore the
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variability of the unexplained variation that is not spatially structured is greatly
increased when both heterogeneity terms are not included in the model. So to
decrease the variability of the estimates of the random heterogeneity the multi-
indicator model with both heterogeneity terms should be used.
7.4 Summary of Multi-Indicator analysis
From the conjoint analysis of the three indicators of male reproductive health there
would appear to be a shared geographical pattern of risk between cryptorchidism and
hypospadias, but not between them and testicular cancer.
Firstly the comparison of the relative risks estimated from the separate Bayesian
Hierarchical disease count models showed a similarity in the spatial pattern between
cryptorchidism and hypospadias. While the testicular cancer relative risks estimated
from both the Poisson-Gamma and Log-Normal models did not produce similar
spatial patterns to those produced for cryptorchidism and hypospadias, there were
similarities for those relative risks produced by the BYM model. Although it must be
noted that there are suspicions that the BYM model over-smoothes the spatial
variation of this disease, based on the difference between the spatial variation of the
estimates produced by the Log-Normal and BYM model.
The similarities in spatial pattern of the relative risks of cryptorchidism and
hypospadias were shown again by the estimates of the relative risks and the
correlations produced by the multi-indicator model. Furthermore, it was shown that
the spatial pattern of the testicular cancer relative risks was not similar to
cryptorchidism and hypospadias, and that the multi-indicator model was an
unsuccessful fit for this disease.
The testicular cancer data would appear to be a poor fit to the multi-indicator model
as the relative risks estimated were considerably different from those produced by
the separate testicular cancer Bayesian models, the higher variability of the estimates
produced and from the comparison of the conditional likelihoods. This poor
performance was probably due to the testicular cancer data not following the
assumptions outlined to be behind the multi-indicator model. It is assumed that in
order for the model to produce smoother relative risks for a particular indicator it
Chapter 7: Multi-indicator Analysis 243
Spatial Epidemiology of Indicators of Male Reproductive Health in Scotland
"borrows strength' from the other indicators. For this to apply the spatial pattern of
the relative risks of the indicators must be similar. While this appears to apply for
cryptorchidism and hypospadias, it is not the case for testicular cancer. Therefore it is
likely that the inclusion of the testicular cancer data would not be successful in the
multi-indicator model.
So the multi-indicator model used here could have been developed further by
reducing it to a two indicator model, including only cryptorchidism and hypospadias
data. However, this was not carried out as this would not have altered the conclusion
already found that these two conditions appear to share geographical pattern of risk.
Where the two-indicator model would have been useful would have been to explore
which of the potential covariates could explain the shared geographically varying
risk. However, as this time it is not possible in WinBUGs to include further
covariates when using the multivariate CAR distribution.
The strong association between the spatial pattern of the cryptorchidism and
hypospadias relative risks does provide some evidence of a common aetiology. It
shows that risk factor(s) that are geographically varying are associated with these
two conditions. However, these spatially-varying risk factors are not necessarily
environmental.
The differences in spatial variation of the testicular cancer relative risks compared to
cryptorchidism and hypospadias could reflect both the known aetiology and the
nature of the geographical data used for testicular cancer. For instance, testicular
cancer incidence mainly occurs decades later than that of cryptorchidism and
hypospadias, which are largely identified at birth. Furthermore, the data used for the
three indicators reflect this difference as the location of each case is based on
incidence. Therefore, the testicular cancer cases will reflect all potential exposure
mechanisms rather than those only occurring in utero which would apply to the
cryptorchidism and hypospadias data.
These conclusions from the combined analysis of the male reproductive conditions
are considered further in the subsequent final discussion chapter.
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Chapter 8 : Discussion
This final chapter will bring together the thesis, by:
> interpreting the results from the analysis in terms of current research,
> discussing the strengths and weaknesses of the research carried out, and
> suggesting further work that stems from this research project.
8.1 Conclusions of spatial analysis
This section will review the results of the spatial analysis for each of the three
disease/conditions and discuss them in relation to current male reproductive health
research. From the spatial analysis carried out on each disease/conditions, only the
relative risks estimated from the BYM model are discussed, as this model was the
most successful fit for each disease/condition. The relative risks estimated from the
conjoint analysis of the three disease/conditions are then compared to those from the
BYM model. This comparison will determine if the conclusions made from the
individual disease/conditions analysis are altered by the conjoint analysis results,
while exploring the spatial relationships between the disease/conditions.
8.1.1 Cryptorchidism
To review the spatial analysis, there does appear to be a distinct spatial pattern to the
relative risks of cryptorchidism across Scotland (Figure 137):
> the East and South-West areas of Scotland have higher relative risks of
cryptorchidism, while
> the North and the corridor from the central Borders to the West Coast are areas
with lower relative risks.
The following area-specific covariates were found to explain the spatial variation of
cryptorchidism: a rural/urban indicator (population density) and both radon
"3
measurements - i.e. mean radon level Bq/m within each postcode area and the
proportion of measurements within a postcode area that exceeds 200 Bq/m3. The
spatial variation of cryptorchidism could also be explained by information
concerning the cases themselves; namely maternal age and co-morbidity with
hypospadias.
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Figure 137 Cryptorchidism posterior mean relative risks from BYM model: Scotland
(1980-95) by 1991 postcode sector
Legend
Posteiioi Mean Relative Risks
0.00 - 0.70
■i 0.71 - 0.85
■10.86 - 1.00
!■ 1.01 - 1.25
1.26 - 1.50
H 1.51 - 2.14
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Previous analysis of cryptorchidism has been criticised due to the use of inconsistent
data (Toppari, Kaleva, and Virtanen, 2001). The reported increases in incidence and
differences across geography were used to argue that an environmental risk factor
was associated with cryptorchidism (Paulozzi, 1999). However this conclusion could
be erroneous due to the inconsistencies in the data both across countries/registries
and time. This research project's use of consistently collected data both over time
and across the study region means that this potential bias is reduced, and we can see
if the differences in time and geography still exist.
While the principle analysis of this project was spatial, a precursory analysis of the
temporal trend of the incidence of cryptorchidism was carried out. In Scotland there
would appear to be an increase in time of the incidence at birth of cryptorchidism
(Figure 25), which mirrors previous results of UK data (Scorer, 1964;Ansell et al.,
1992). The number of cryptorchidism cases at birth in Scotland has risen by 36.8%
over 15 years, from 4.08 cases per 1,000 births in 1980 to 5.58 cases per 1,000 births
in 1995.
This increase in incidence could be due to exposure to increasing levels of an
environmental factor. However, while it is unlikely that this temporal increase is due
to changes in ascertainment, other factors could account for this trend. For instance,
changes in the trends of maternal obesity, lower birth weight, preterm deliveries and
the presence of other congenital malformations, could be involved and all have been
found to be risk factors of cryptorchidism (Berkowitz et al., 1995;Berkowitz and
Lapinski, 1996). Furthermore, as older women might have a higher risk of congenital
malformations and there is a trend to women having children when older, this might
explain the increase in incidence (Baldwin and Nord, 1984). To further explore this,
the spatial models could have been developed into spatial-temporal models.
Therefore, while the temporal trends in the incidence of cryptorchidism at birth
signify that the underlying risk factors are also changing with time; it does not
necessarily suggest that these are environmental risk factors. The aim of this research
project was to examine the geographical variations of the incidence of
cryptorchidism. It is assumed that if there is a geographical pattern to the risk of
cryptorchidism then there is geographical-varying risk factor(s) associated with those
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risks. Furthermore the identification of potential risk factors would highlight if the
underlying risk is explained by environmental exposures and/or due to other
geographically-varying risk factors.
As the relative risks of cryptorchidism have a distinct spatial pattern it would appear
that the risk of cryptorchidism is associated with geographically-varying risk
factor(s) (Figure 137). Furthermore, as cryptorchidism is identified at birth then there
does appear to be evidence that the condition has geographically-varying foetal-
origin aetiology (Kolon, 2002). Therefore the spatial variation of cryptorchidism risk
provides some evidence to support the TDS hypothesis, namely that a
geographically-varying factor for which exposure occurs in utero is associated with
the condition. Flowever as just highlighted, this possible aetiology does not
necessarily have to be an environmental exposure. The assessment of the spatial
pattern of the risk of cryptorchidism and those covariates found to be associated with
it might highlight the nature of the underlying risk factors.
As can be seen in Figure 137, the higher relative risks in the East and South-West in
Scotland are mainly rural areas. Furthermore, the rural/urban indicator used in the
research project did explain some of the spatial variation of cryptorchidism, when
included to the Bayesian disease count models. Therefore there would appear to be
some rural/urban differences in the cryptorchidism risk in Scotland. One reason that
these rural areas could have higher risks is that they might be farming areas. These
areas might have a high use of pesticides, of which particular types are believed to
have oestrogenic and/or anti-androgenic properties. Previous work has shown an
association between semen quality and pesticide exposure (Jensen et al., 1996).
However not all rural areas in Scotland appear to have high relative risks i.e. central
Borders, West and far North, so it is likely that this possible exposure is not uniform
across all rural areas (Figure 137). The non uniformity of the possible exposure could
be due to the different types of rural areas in Scotland, e.g. farming and non-farming
or different types of farming using different types and levels of pesticides. Therefore,
to look at the role of farming and so pesticide use in more detail, it would be
appropriate to use geo-referenced data on the different types of rural areas in
Scotland and pesticide use.
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The covariate used as the rural/urban indicator in this project was based on
population density and so did not give any detail of the type of rural areas.
Furthermore, this proxy measure may well encapsulate other rural/urban differences
such as types of deprivation, diet and occupation. As seen in the review of the
epidemiology of cryptorchidism and the other anomalies of male reproductive health
these factors might also be associated with this condition (Berkowitz et ah,
1995;Berkowitz and Lapinski, 1996;Moller and Skakkebaek, 1996). Therefore, while
there is an indication that there are rural/urban differences in the cryptorchidism risk
in Scotland and the possible aetiology might be related to farming, the other
differences between rural/urban areas might also explain the differences.
Both radon measurements also appeared to explain the spatial variation of
cryptorchidism when included to the Bayesian disease count models. Radon
exposure during pregnancy might result in damage to the foetus; whether directly to
the boy's reproductive system or resulting in a genetic defect that results in a
susceptibility to environmental chemicals. Although radon levels vary from home to
home, the largest source of radon is geological; and the North-East of Scotland is the
one region in Scotland with high levels of naturally occurring radon (NRPB, 2003).
This is one of the areas with high relative risks of cryptorchidism and so radon might
be associated with cryptorchidism risk. However, the inclusion of radon
measurements into the Bayesian disease models might have been a success due to
this strong correlation in values in one region of Scotland, rather than a 'true'
association. This does not only apply to the inclusion of radon but the other
covariates and is a disadvantage of ecological studies i.e. the spatial variation of a
potential covariate might mirror the spatial variation of disease risk but not explain
its aetiology. The potential of ecological bias was discussed in the methods chapter
(3.3.4) and as will be seen shortly this potential bias was explored in relation to the
cryptorchidism data.
Furthermore, there might be confounding between the rural/urban indicator and
radon that could have resulted in all three variables being associated with
cryptorchidism risk. Those regions that show high levels of radon are on the whole
rural areas and vice-versa, and so there is an apparent association between these
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covariates. Further development of the spatial models as outlined in 8.3.1.4 could
explore this further.
The spatial pattern of the relative risks of cryptorchidism might also indicate genetic
differences. It has been hypothesised that the decline in male reproductive heath is
due to the impact of both genetic susceptibility and exposure to environmental
factors (Skakkebaek, Rajpert-De Meyts, and Main, 2001). And so the spatial
differences in the cryptorchidism risk might reflect underlying genetic susceptibility.
For instance, the impact of Nordic and Celtic settlements in Scotland could reflect
the geographical variation of cryptorchidism and so particular 'ethnic groups' might
have a different genetic susceptibility to the impact in utero of environmental
chemicals. In broad terms, Nordic settlements were mainly in the East and North,
while Celtic settlements were in the West. However, migration patterns both within
and outwith Scotland will have diluted these settlement patterns. Furthermore, any
genetic differences would be better explored and assessed by other types of studies.
While the assessment of the spatial variation of the risk of cryptorchidism and the
area-specific covariates has highlighted potential aetiology, the individual analysis of
the cryptorchidism cases can give further insights into the possible risk factors of this
condition. The spatial variation of the maternal age is similar to the cryptorchidism
relative risks in the North-East and North-West, but not in the South. For those in the
North-East and North-West, those with older mothers have a higher risk of
cryptorchidism. This reflects previous research that has found older women might
have a higher risk of having children with congenital malformations (Baldwin and
Nord, 1984). The association would only appear to apply to the spatial variation of
cryptorchidism in the North-East and North-West of Scotland, and not to the south of
Scotland. So it would appear that the cryptorchidism cases in the South have a
different aetiology than those in the North and so different risk factors are associated
with the variation in cryptorchidism risk in this region. Therefore, it is likely that
within Scotland various risk factors will be associated with the spatial variation of
cryptorchidism risk and which ones will be important will differ between regions of
Scotland.
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The spatial variation of the risk of the cryptorchidism cases also being diagnosed
with hypospadias has similarities to that of the cryptorchidism risk in Scotland.
Therefore, this similarity in the spatial variation of the co-morbidity of these two
conditions does indicate some common aetiology that is geographically varying. This
would correspond with the hypothesis that these and other anomalies of male
reproductive health have a common aetiology (Skakkebaek, Rajpert-De Meyts, and
Main, 2001). However as the number of cases that have both conditions are relatively
small it can not be the only aetiology that is associated with either of these
conditions. Of the 2,524 cryptorchidism cases that were geo-referenced to the 1991
postcode sectors in Scotland, only 47 babies were also born with hypospadias.
Finally, those covariates that were not found to explain the spatial variation of the
cryptorchidism relative risks might also give some insight into the possible aetiology
of this condition. Deprivation was not found to explain the spatial variation of
cryptorchidism. Deprivation could reflect various possible aetiologies to varying
extents e.g. employment (different jobs could have different potential exposures),
rural/ urban differences, diet and lifestyle. As these various factors might be
associated with cryptorchidism then one measure that encompasses them all is more
unlikely to show an association with cryptorchidism risk as the differing factors
within the covariate might counteract each other.
The Year of Birth of the cryptorchidism cases was not found to vary spatially, which
provides some evidence that the increases in incidence over time of cryptorchidism
do not appear to vary spatially. Therefore, while the geographically varying risk
factor associated with cryptorchidism might increase over time and so explain the
temporal rise in incidence, it would appear unlikely that the rate of change of the
exposure varied over geography. Therefore in relation to the proposed aetiology of
cryptorchidism and the other anomalies of male reproductive health, if an increasing
environmental exposure to oestrogens and/or anti-androgens was responsible for the
increase in the incidence of these conditions then it would appear that while the
exposure might vary across areas of Scotland the rate of increase of exposure did not
vary across the same regions.
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The spatial analysis of cryptorchidism cases in Scotland showed a geographically
varying risk for this condition of foetal origin. And as first discussed in Chapter 2
and confirmed by this analysis, the cryptorchidism aetiology in Scotland appears to
be multivariate and could involve environmental, genetic and life-style factors. This
research project was not designed to be able to identify which particular mechanisms
would be involved in any changes in male reproductive health but rather to suggest
possible aetiology for further investigation.
8.1.2 Hypospadias
To summarise the analysis, the spatial pattern of the relative risks of hypospadias
across Scotland is similar to that of cryptorchidism (Figure 138):
> the North East, South-East and South-West areas of Scotland have higher
relative risks of hypospadias, and
> the North and the corridor from central Border to the West have lower relative
risks.
The spatial variation of hypospadias can, as with cryptorchidism, be partly explained
by the rural/urban indicator. The variation of hypospadias risk can also be explained
by and one of the radon measurements namely, the proportion of measurements
within a postcode area that exceeds 200 Bq/m3, but unlike the spatial variation of
cryptorchidism it can not be explained by the mean radon level.
As there are similarities in the spatial patterns of cryptorchidism and hypospadias
and the covariates that explain their spatial variations, then it suggests some common
aetiology. Therefore those potential aetiologies discussed in relation to the spatial
variation of cryptorchidism and covariates rural/urban indicators and radon apply to
hypospadias and so are not re-iterated here.
However, these possible risk factors are probably not the only aetiology for these two
conditions and other risk factors are perhaps involved that are particular to each. As
discussed in relation to the spatial variation of the co-morbidity of cryptorchidism
with hypospadias, if a common aetiology was the strongest risk factor for these
conditions then we would expect to see a higher number of cases with both
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congenital malformations. Only 0.8% of cases in the joint hypospadias and
cryptorchidism database used in the project had both conditions (Table 6).
Furthermore, the spatial variation of hypospadias was explained by the excess radon
measurement but not the mean radon, while cryptorchidism was explained by both.
This could mean that the hypospadias risk could be associated with a threshold dose
of radon, while cryptorchidism could be associated with a cumulative dose as well as
a threshold effect. Therefore different biological mechanisms would appear to be
involved with these two conditions.
Finally, the incidence of hypospadias did not show a general increase with time in
Scotland (Figure 92). After an initial increase in incidence of hypospadias the rate
fluctuated and then fell so that the number of hypospadias cases were similar in 1995
(9.10 per 1,000 birth) to that in 1980 (8.04 per 1,000 births). Therefore, using
consistently collected data, both over geography and time, did not show the same
temporal trend in incidence as seen previously (Paulozzi, 1999). This difference
could be because the potential ascertainment bias has been removed which accounted
for the temporal differences and reflect that the aetiology of hypospadias does not
appear to have changed with time. This is contrary to the proposed hypothesis that
there has been a decline in male reproductive health, including hypospadias.
Providing further evidence that while there is some common aetiology there are
some dissimilates in the risk factors associated with these two congenital
malformations.
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Figure 138 Hypospadias posterior mean relative risks from BYM model: Scotland
(1980-95) by 1991 postcode sector
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8.1.3 Testicular Cancer
The spatial pattern of the relative risks of Testicular Cancer across Scotland is
different from cryptorchidism and hypospadias (Figure 139):
> while the North-East has higher relative risks, as with cryptorchidism and
hypospadias, the area of higher relative risks is larger for testicular cancer,
including the North, West and a larger area of the South-East,
> the lower relative risks for Testicular Cancer are found in the Central Belt
down to the South-East.
As with hypospadias and cryptorchidism the spatial variation of testicular cancer risk
can be explained by the rural/urban indicator. Like cryptorchidism, the spatial
variation of testicular cancer risk can be explained by the mean radon level Bq/m3
within each postcode area, although it is not explained by the proportion of
measurements within a postcode area that exceeds 200 Bq/m3, unlike hypospadias
and cryptorchidism.
So while the spatial variation of testicular cancer was different from cryptorchidism
and hypospadias, it like these conditions was explained by the rural/urban indicator.
Furthermore, the spatial variation of testicular cancer was explained by the mean
radon measurements as was cryptorchidism.
Therefore, there is evidence of common aetiology between the three conditions, and
as hypospadias and cryptorchidism are of foetal origin this potential risk factor must
occur in utero. However as the spatial variation is so different for testicular cancer
and the potential pathways for exposure are much greater, then these common risk
factors do not play as much of a role in testicular cancer's aetiology than that of
cryptorchidism and hypospadias.
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Figure 139 Testicular Cancer posterior mean relative risks from BYM model:
Scotland (1975-99) by 1991 postcode sector
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The differences in spatial variation of the testicular cancer relative risks compared to
cryptorchidism and hypospadias probably reflects both the known aetiology of the
condition/diseases and the nature of the geographical data used for testicular cancer.
Firstly, testicular cancer incidence mainly occurs decades later than that of
cryptorchidism and hypospadias (Bringhurst and Amato, 2002), which are largely
identified at birth or early in a boys life (Kolon, 2002;Duckett, 1998). Therefore, the
testicular cancer cases will reflect all potential exposure mechanisms rather than
those only occurring in utero, which would apply to the cryptorchidism and
hypospadias data. Furthermore, the data used for the three indicators reflect this
difference as the location of each case is based on incidence. Therefore the location
of the testicular cancer cases was recorded when the cancer was diagnosed, while the
location of the hypospadias and cryptorchidism cases was the residence of the
mother. Consequently the location of the cases reflects the differences in the
potential exposure mechanisms experienced by the various disease/conditions and so
it is unsurprising that there are dissimilarities in the spatial variation of risk between
the congenital malformations and testicular cancer.
From the spatial pattern of the testicular cancer relative risks there appears to be
strong rural/urban differences (Figure 139), which is reflected in the rural/urban
indicator explaining the spatial variation when included in the Bayesian disease
count models. The rural areas have higher risks of testicular cancer compared to the
urban areas (except in Aberdeen). As discussed in relation to cryptorchidism, the
difference in rural areas between farming and non-farming and types of farming
could elucidate if pesticide use is associated with elevated risk of testicular cancer. It
would not necessarily mean in the case of testicular cancer that exposure in utero is
the potential pathway. As already highlighted, the location of the case is at incidence
which is typically when men are in their 20's or 30's; therefore potential exposure
could have occurred in the meantime. Furthermore, these differences in relative risks
between rural/urban areas could also be reflecting a protective effect of living in
urban areas and differences in life-style factors (e.g. diet, occupation) between the
regions. This is further complicated by the Aberdeen area (on the North-east of
Scotland) having higher relative risks for all three of the disease/conditions studied
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while being a relatively urban area in Scotland. Therefore it is not so clear cut that
there are rural/urban differences in the risk of these conditions.
Finally, there does appear to be a temporal increase in the incidence of testicular
cancer in Scotland in the last 25 years for which data are available (Figure 61), which
supports previous studies (Adami et al., 1994;Bergstrom et al., 1996;McKiernan et
al., 1999). Furthermore, that there is an age cohort effect on the incidence rates in
Scotland, which again corresponds with the known aetiology of testicular cancer
(Bringhurst and Amato, 2002;Buetow, 1995;Robbins et al., 1999). Those age groups
with the higher incidence (20 to 49) also experienced the highest rate of increase of
incidence over time. Therefore whatever exposure is resulting in the increase in
incidence of testicular cancer in these age groups, it is likely to be what is changing
the incidence rates overall. As seen in the review of the morphology of testicular
cancer, age is related to morphology type and the majority of cases are germ cell
neoplasms (Bringhurst and Amato, 2002;Buetow, 1995;Robbins et al., 1999).
Therefore particular morphology groups of testicular cancer are showing the
temporal increases and so further investigation of the aetiology and morphology of
these types of testicular cancer could elucidate potential mechanisms.
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8.1.4 Combined analysis of the three indicators
From the conjoint spatial analysis of the three conditions the spatial patterns
produced for cryptorchidism and hypospadias are similar to those produced by the
separate models, but altered for testicular cancer.
The spatial pattern of the relative risks of cryptorchidism produced by the conjoint
model is similar to that produced by the individual cryptorchidism models (Figure
140):
> higher relative risks of cryptorchidism can be found in the East and South-West
areas of Scotland as previously but also in the North, while
> lower relative risks of cryptorchidism are still found in the corridor from
central Borders to the West Coast.
The spatial pattern of the relative risks of hypospadias produced by the conjoint
model is similar to that produced by the individual hypospadias model and so is
similar to that of cryptorchidism (Figure 141):
> higher relative risks of hypospadias can be found in the North, North East,
South-East and South-West areas of Scotland, and
> lower relative risks of hypospadias are found in the corridor from central
Borders to the West Coast.
The spatial pattern of the relative risks of testicular cancer across Scotland is
considerably altered when estimates produced by multi-indicator model (Figure 142).
There are:
> clusters of higher relative risks in the North, North-East, South-West, and
> clusters of lower relative risks in the South East and West.
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Figure 140 Cryptorchidism multi-indicator model (with both heterogeneity terms)
results: posterior estimates of relative risks by 1991 postcode sector,
Scotland 1980-95
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Figure 141 Hypospadias multi-indicator model (with both heterogeneity terms)
results: posterior estimates of relative risks by 1991 postcode sector,
Scotland 1980-95
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Figure 142 Testicular Cancer multi-indicator model (with both heterogeneity terms)
results: posterior estimates of relative risks by 1991 postcode sector,
Scotland 1975-99
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From the conjoint analysis of the three indicators of male reproductive health there
would appear to be a shared geographical pattern of risk between cryptorchidism and
hypospadias, but not between them and testicular cancer.
One benefit of the multi-indicator model, as detailed in Section 3.8, is to reduce the
variability of the estimates of the relative risk as within each postcode sector every
disease/conditions borrows strength from other disease. The potential power gain
only applies when the spatial patterns of the indicators included are similar, which
applies to cryptorchidism and hypospadias. Therefore, more robust estimates of the
relative risks for cryptorchidism and hypospadias show the same pattern as the
individual disease models and so the possible aetiology discussed for both conditions
earlier is still applicable. In particular, there is evidence to show that there is some
common geographically-varying aetiology between the two congenital
malformations.
The similarities in spatial pattern of the relative risks of cryptorchidism and
hypospadias were confirmed by the correlations produced by the multi-indicator
model. The correlation of the unexplained risk between these two conditions was
strongly spatially structured (r = 0.97). So there is a relationship between the risk of
these two conditions and a shared spatially-varying risk factor. So in line with the
hypothesised aetiology this research has shown that there is a common aetiology
between these two conditions. However, as seen in the outline of previous research
of male reproductive health and the discussion of the results for these conditions this
common aetiology could be environmental exposure and also various other potential
risk factors. Furthermore, the difference between the spatial pattern of these
conditions and testicular cancer does highlight that other potential mechanisms are
involved in the subsequent development of these anomalies.
As noted in the conclusion of the conjoint analysis chapter, the testicular cancer data
would appear to be a poor fit to the multi-indicator model. This was due to the
different spatial pattern of the testicular cancer risk compare to cryptorchidism and
hypospadias. And as discussed in relation to the spatial analysis of the testicular
cancer risk, these differences in spatial variation of the testicular cancer relative risks
could reflect both the known aetiology and the nature of the geographical data used
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for testicular cancer. Therefore, the difference in the spatial variation of testicular
cancer risk reflects all potential exposure mechanisms rather than those only
occurring in utero which would apply to the cryptorchidism and hypospadias data.
In the paper that first outlined the TDS hypothesis, the authors proposed that while
the overall incidence of TDS decreases with its severity, the relative incidence of
testicular cancer increases while the relative incidence of the other conditions
decrease (Skakkebaek, Rajpert-De Meyts, and Main, 2001). Do these proposed
relationships between the disease/conditions of TDS correspond with the results of
this research project?
From these statements we would expect a negative spatial correlation between either
cryptorchidism or hypospadias and testicular cancer, as the relative incidence of
these conditions are proposed to decrease with an increase in testicular cancer. This
is not the case with these results - a small positive correlation was found rather than
a strong negative (Table 49). However, as already discussed the testicular cancer data
was based on incidence rather than potential exposure therefore the spatial
relationship between testicular cancer and cryptorchidism and hypospadias has been
compromised and can not be compared directly with these data. It is proposed that
the incidence of TDS decreases with severity and that the relative incidence of
cryptorchidism and hypospadias also decrease. Therefore expect inverse
relationships between these conditions and any exposure, as we would expect the
relationships to mirror that between severity and exposure. However in the analysis
of the disease/conditions this would appear not to be the case - those areas we expect
to have higher levels of pesticides (i.e. rural) are in the main those areas with higher
relative risks of cryptorchidism or hypospadias. Therefore these data do not follow
the proposed relationships outlined in the TDS hypothesis.
8.2 Limitations of results and research project
In order to fully evaluate the conclusions made from the spatial analysis, the
limitations of this research project need to be discussed. The limitations can be
grouped into two categories: the data used in the research project; and the analysis
carried out.
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8.2.1 Data Issues
Specific issues concerning the data used were raised from the analysis and might
have implications for the conclusions made.
8.2.1.1 Cryptorchidism and Hypospadias
Although the data used for these two conditions has been collected consistently over
geography and time in Scotland, and so overcoming the limitations of previous work,
there are two issues highlighted from the analysis that need to be considered.
For each of these condition when the cases were re-assigned to the 1991 postcode
sectors, there were a high number of records in one area of Scotland where the Local
Council was recorded instead of the postcode sector. As these records could not be
geo-referenced they were excluded from the spatial analysis. Therefore there would
be underreporting of cases in the postcode sectors covered by Kirkcaldy, North East
Fife and Dunfermline. This could have meant that the relative risk estimates for these
areas would be lower than should be. However, as the denominator data used to
calculate the expected values were based on the same datasets, the same level of
under-reporting in Kirkcaldy, North-East Fife and Dunfermline of total birth events
was seen. Therefore the impact of under-reporting in these areas would have been
minimised in the resulting relative risks/SMRs.
Under-reporting will also have occurred if cases of hypospadias and cryptorchidism
have not been identified at birth but later in the boy's life. As the datasets used for
these conditions were based on births then those cases would not have been included.
From the current knowledge of these conditions this will have been of greater impact
to the cryptorchidism data than the hypospadias. As discussed in Chapter 2, due to
differing clinical practice a cryptorchidism case might be left to see if testes descend
of their own accord (Kolon, 2002); while hypospadias is largely treated by surgery
and clearly identified at birth (Duckett, 1998). Furthermore, those cases ascertained
at birth might be different from those determined later for both conditions. For
instance, milder cases that would be more likely to be identified later might have a
different aetiology than the more severe cases. It might be possible to assess the size
of this potential under-reporting by comparing the case ascertainment in these
datasets with other local congenital abnormality registers. However, according to
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sources at ISD these registers are not consistent over geography and time and so this
exercise would only be able to estimate a lower limit of the under-registrations. As
the proportion of under-reporting might be linked to clinical practice their levels
might be different with geography and time.
It should be remembered that while an advantage of the data used is that it is of high
quality and is consistently collected over the study region and time, we can not be
certain that differences in ascertainment could explain the spatial variation in risk.
Apart from those just discussed other differences in case ascertainment/reporting
between hospitals could be at play and we are unaware of them.
8.2.1.2 Denominator Data
As discussed in relation to cryptorchidism and hypospadias the birth data would be
affected by under-reporting in Kirkcaldy, North-East Fife and Dunfermline. However
as already mentioned, the impact on the relative risks estimated might be minimised
as the number of cases were under-reported in the same areas for the same reasons.
As the population data used to standardise the testicular cancer cases is based on
Census data there are issues with respect to under-reporting. According to GRO
Scotland the under-reporting of the population was 2% in the 1991 Census. However
the population data used in this project had been adjusted for under-reporting
dependent on the following groups within areas: the elderly, those aged 20-24 or
those areas in the inner-cites, as these groups/areas were assessed to be most affected
by under-reporting.
8.2.1.3 No birth postcode sector data for testicular cancer
As already noted both in assessing the spatial variation of testicular cancer and its
inclusion in the conjoint analysis, the testicular cancer cases' spatial location were
based on incidence postcode, which was typically decades after birth and therefore
probably at a different location to that at birth. Therefore the spatial variation of the
testicular cancer represents all the potential pathways of exposure rather than just
those in utero and includes possible migration. To investigate if in utero aetiology is
associated with testicular cancer it would be necessary to find out the place of birth
of the testicular cancer cases.
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This was considered at the beginning of the research project and a possible solution
was found. At that time it was stated that ISD could match the testicular cancer cases
to corresponding birth records, so as to obtain the postcode sector of mother's
residence at birth. However it became apparent that birth data was only available
electronically for births in 1974 onwards. As can be seen, the majority of testicular
cancer cases in the dataset were born in the 1940's through to the 1960's and only a
small proportion (3%) were born since 1974 (Figure 143). Therefore for the majority
of testicular cancer cases it was not possible to match electronically to birth location.
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It would have been possible to obtain the mother's place of residence at birth by
searching manually the microfiche birth data records. However, it would have taken
approximately 52 weeks full time to complete this task. There are plans underway
within GRO to digitise birth records back to 1855, but this would not be available
until the end of 2004. Therefore, the spatial analysis of the testicular cancer dataset
was based on the location at registration.
To investigate if in utero risk factors are associated with testicular cancer incidence
the matching of testicular cancer cases to place of birth and subsequent analysis
could be done in the future.
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8.2.1.4 Different time spans of disease/condition datasets
There were differences in the time-spans of the datasets included in the multi-
indicator models that might impact on the subsequent results. Cryptorchidism and
hypospadias cases span births from 1980-1995, while testicular cancer cases span
incidence from 1975 to 1999. Firstly, the larger number of years covered by the
testicular cancer dataset would mean that higher number of testicular cancer cases
was included than if it had been testicular cancer incidence from 1980 to 1995.
Therefore, there might be over-representation of testicular cancer cases in the multi-
indicator model. Furthermore, as this was testicular cancer incidence, than as seen in
Figure 143, this represents births spanning 1887 to 1995. So if a birth cohort effect is
associated with these three conditions the birth cohorts are not comparable between
the datasets.
8.2.1.5 Potential Covariates
Issues were raised from the analysis concerning particular covariates that might have
consequences for the conclusions.
As already highlighted the rural/ urban indicator was a proxy for attempting to see if
farming areas, a source of pesticides use, have an association with the spatial
variation of the relative risks of the three conditions. However as a proxy for
pesticide exposure it has limitations which need to be discussed. While a rural/urban
indicator will show which areas are 'rural' or 'urban, there are many other factors
apart from pesticide use that differentiate between those areas. As already discussed
in 8.1.1 in relation to cryptorchidism, the various factors (e.g. diet, lifestyle,
occupation) might have different impacts on heath in general and male reproductive
health specifically. Furthermore, this rural/urban indicator is actually measuring the
population density of areas and so farming areas might not always equate to less
densely populated areas or indeed to rural areas, particularly in Scotland.
Therefore other data would be better placed to explore pesticide use and other
potential endocrine disruptors association with the spatial distributions of these
disease/conditions. For instance, within the Census the percentage of the population
farming might be a better proxy, as it indicates actual farming areas rather just rural
areas. It would however still be a proxy, i.e. it does not indicate if a faming area uses
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pesticides or other chemicals. As the use of pesticides etc. would be dependent on
what type of farming was undertaken, another possible data to investigate would be
land use/cover data which are available from the Countryside Survey
(www.cs2000.org.uk). These data could indicate different types of farming (arable,
livestock) that are likely to use different types of chemicals (e.g. herbicides and
phosphates). At present the associations found between rural/urban areas and the
indicators of male reproductive health are limited by the indicator used, to be able to
confirm an association between pesticide exposure and subsequent decline in male
reproductive health. To investigate the association between farming/pesticides and
male reproductive health these potential covariates should be used, and would have
been in this research project if this researcher had been aware of them.
While unaware of the data just outlined, other information that would also have been
important potential covariates was not included in this research project for other
reasons. As summarised in Table 8, various potential covariates were not included
due to lack of availability to this researcher and in the appropriate format. Therefore
to show how environmental data could be used in the spatial mode, radon data were
included. As admitted in 3.4.5.3 there are no previous research to show an
association between male reproductive health and radon, and while associations were
found between radon and the disease/conditions, it is more likely due to other
reasons than aetiology. Firstly, there might be confounding between the rural/ urban
indicator and radon. Those regions that show high levels of radon are on the whole
rural areas and vice-versa. Therefore, the radon measurements might have
associations with the disease/conditions because of their association with the
rural/urban indicator. Further development of the spatial models as outlined in
8.3.1.4 could explore possible confounding.
Furthermore, the spatial resolution of the radon measurements could have had an
impact on its apparent associations with the disease/conditions. As the radon
measurements are at postcode area levels and one of the areas with the highest levels
of radon (NE Scotland) is also one of the areas with the highest risks of
cryptorchidism, hypospadias and testicular cancer, then the spatial association found
could just mirror this rather than actually explain aetiology. Therefore to fully
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explore if there are spatial relationships between radon and male reproductive health,
we would require radon data at a higher spatial resolution, which will be available
soon for the North East, where the highest levels of radon in Scotland can be found
(NRPB, 2003).
Further discussion of potential covariates which could be included in future analysis
can be found in 8.3.1.
8.2.2 Analysis Issues
There are particular issues that arose from the analysis that need to be considered.
8.2.2.1 Establishing a Common Geography
As outlined in Section 3.5, it was necessary to re-assign postcode sectors to those
valid as at 1991 Census. This resulted in a small proportion (3.7%) of the postcode
units been mis-assigned to neighbouring postcode sectors. This could potentially
have resulted in particular postcode sectors having less or more cases depending on if
they were a postcode sector that gained a postcode unit or lost one. As we are dealing
with areas with small number of cases this could have changed the relative risks in
particular postcode sectors considerably. The birth denominator data used for
cryptorchidism and hypospadias relative risks also had to be re-assigned to 1991
postcode sector boundaries, and the same mis-assignment of these data occurred.
Therefore, the potential disparity between the observed and expected values is likely
to be minimised. However this potential minimisation of the mis-assignment effect
does not apply to the testicular cancer cases as the population data was already
assigned to 1991 postcode sectors.
8.2.2.2 Performance of Bayesian Hierarchical Disease Count
Models
In each of the individual disease/condition spatial analysis as disease count data,
none of the three Bayesian Hierarchical models used were completely appropriate at
fully explaining the datasets. Each Bayesian Hierarchical model smoothed the crude
relative risks (SMRs) and so reduced their variability for each disease/condition.
However from the analysis of the residuals for each model, none were able to
successfully fit the higher relative risk values.
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Although the best of the three Bayesian Hierarchical disease count models was the
BYM according to the DIC results, there were concerns raised about the spatially
correlated heterogeneity term used within it. While the assumption that the
heterogeneity of the estimates might be spatially correlated is a valid one i.e. a
particular postcode might be similar to its neighbours, the implementation of this
term within WinBUGs has raised concerns. As seen in the visual assessments of the
spatial variation of the relative risks produced by the Bayesian Hierarchical models
and the comparison of the Log-Normal and BYM models with the inclusion of
covariates it is unclear if the spatially correlated heterogeneity term might actually
over-smooth the spatially correlated heterogeneity. Particularly in the case of the
testicular cancer data, the stark difference in the spatial variation of the relative risk
estimates produced by the Log-Normal and BYM models does suggest that the
spatially correlated heterogeneity term included in the BYM model over smoothes
the spatially correlated variability of the estimates. Furthermore, failure of potential
covariates to explain the spatial variation of the estimates from the BYM model after
explaining the variation in the estimates of the Log-Normal model suggest that any
variation in the data had already been 'soaked up' by the spatially correlated
heterogeneity term. Finally, the sensitivity analysis carried out on the BYM within
each disease/condition that compared the relative risks produced by the BYM model
and the same model with a less specific prior for the precision of the spatially
correlated heterogeneity, showed that the prior used did not explain the over-
smoothing of the relative risks.
Further analysis and development of the CAR model's performance, and the spatial
Bayesian Hierarchical models used WinBUGs is needed. Indeed as yet unpublished
work has shown that another model known as the Lawson & Clark model has been
found to perform better than BYM in particular cases (Hossain and Lawson, 2005).
Spatial analysis using Bayesian methods is still a relatively new field and the
development of appropriate models is still ongoing.
For the spatially correlated heterogeneity term used in this research project it would
have been possible to add multiple levels of neighbours i.e. not only direct
neighbours to a postcode sector but also those next to the neighbours. While these
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could have been added with the appropriate weighting, it was felt that as the spatially
correlated heterogeneity term was already appearing to over-correlate the estimates
then it might not have been appropriate.
8.2.2.3 Performance ofmulti-indicator model
While the multi-indicator model outlined in 3.8 is based on a previously specified
model (Knorr-Held and Best, 2001), as it was extended to include three diseases
rather than the original two, there are limitations and problems associated with its use
in this research project.
Firstly, the large number of nodes to be estimated using a modest amount of data
resulted in requiring a considerable number of iterations (20,000) to obtain stable
estimates of the relevant nodes. Indeed running of the multi-indicator models would
take several days on the PC and no other computer packages could be used
concurrently during this time or WinBUGs would crash.
These time and processing constraints limited the development of the multi-indicator
further. For instance, no sensitivity analysis of the hyper-priors was carried out on
these models. This analysis would be important as it is a relatively new model and
has not previously been extended to use three diseases. Furthermore with a large
number of nodes to estimate and comparatively modest data to use the resultant
nodes would probably have been dependent on the hyper-priors specified.
8.2.2.4 Edge effects
Edge effects in spatial analysis occur due to the proximity to the study window edge.
The spatially correlated heterogeneity term correlates a specific postcode sector's
relative risk estimate to its neighbours. But for those postcode sectors which are on
the edge of the study window there are neighbours which are not included in this. In
this research study, this would only concern the Borders of Scotland as the remaining
edges of the study window are coast or islands, and so do not have any neighbours.
The two basic methods of dealing with edge effects (1) use of weighting correction
systems or (2) guard areas were not employed. Therefore the estimates in the Border
region estimated by the BYM model could have been re-estimated, dependent on
which method of dealing with the edge effects were used and the assumptions made
about the unknown areas.
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8.2.2.5 Spatial Resolution Implications
There are particular analysis issues raised from this research project that are relevant
to all spatial epidemiological studies that use disease count data. Due to
interpretations of data confidentiality legislation the spatial resolution of the
disease/condition data was at postcode sector rather than the preferred full postcode
unit. The use of the data at this resolution had an impact on the analysis carried out
and so on the subsequent conclusions.
Firstly, as already discussed the postcode sectors had to be re-assigned to one
common geography and this resulted in some cases being mis-assigned. If full
postcode unit had been provided the assignment to the postcode sector boundaries
would have been carried out without that potential mis-assignment. Furthermore, if
the postcode unit of each case had been provided the potential problems of what is
known as the 'modifiable area problem' would not have been relevant. This occurs
when the use of different boundary systems can result in clusters either been masked
or fabricated and is a potential consequence of using aggregated data, i.e. a particular
postcode sector might have high number of cases just because of the boundary
location, and a slight change might result in the case in that postcode sector been
dispersed to neighbouring postcode sectors. This is very much related to the issue of
ecological fallacy which was discussed in detail in Chapter 3.
If the disease/condition datasets had been provided at postcode unit level the
possibility of ecological fallacy would have been greatly reduced. As seen from the
cryptorchidism individual analysis, the possibility of ecological bias can not be ruled
out with these data. This bias is a considerable limitation to the analysis of disease
count data.
The potential for confounding also needs to be discussed in relation to aggregated
data. In the context of the research study, the geographical variations found in the
analysis may well be due to geographical varying environmental agent. However,
there might be a non-environmental factor(s) that accounts for the geographical
variation that has not been included in any of the spatial models. Furthermore, the
covariates that appear to explain the geographical variations within the analysis
might mirror the spatial variation of the disease/condition model and another
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covariate that has not been included. Further spatial analysis is required to overcome
some of these issues.
8.3 Future Research
This research has shown that there are geographical variations to the three
disease/conditions in Scotland and has indicated possible aetiologies for further
investigation. Apart from highlighting the complex nature of these conditions and the
potential pathways for exposure to possible risk factors, there are as with any
research, other questions and issues that require further investigation. The issues that
are discussed here stem from the research project but are in the context of current
male reproductive health research. Some of this potential future work have already
been raised in the previous discussion and so are only summarised here. Those issues
not raised previously are discussed in more detail.
8.3.1 Potential Covariates
As already mentioned further analysis of data pertaining to rural/urban differences
and radon measurements are required to further assess if these risk factors are
associated with these disease/conditions. Furthermore, the research project only
included five covariates for investigation. Therefore apart from the further analysis
of potential covariates previously mentioned other area-specific covariates could
have been included in the Bayesian models to explain the spatial variation of the
three disease/conditions. The covariates suggested here are far from exhaustive but
rather that they have been highlighted by current male reproductive health or have
arisen as a result of this research project.
8.3.1.1 Smoking
Previous research has found an association with poor health of resulting children and
women smoking while pregnant (DiFranza, Aligne, and Weitzman, 2004).
Specifically in terms of male reproductive health, recent research has found that
men's subsequent semen quality can be adversely affected if his mother smoked
while pregnant with him (Jensen et al., 2004). If information concerning mother's
smoking status could be found it might be included in either the disease count
models or as individual assessment of spatial variation.
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In order to see ifmother's smoking status explains the spatial variation produced by
the Bayesian Hierarchical Models we require information at postcode sector level.
The Census's do provide the proportion of people who smoke within a postcode
sector, although it does not appear to ascertain the proportions that are pregnant
women. Therefore, this area-specific information on smoking would be a proxy for
the exact information required, but might indicate if there is some association.
As seen in the file format of the cryptorchidism and hypospadias data the smoking
status of these cases was recorded (Appendix 1). However, an individual model was
not developed for the cryptorchidism cases for this covariate as it was poorly
completed. This record was not compulsory and less than a third of cryptorchidism
cases were completed appropriately. Therefore, it would not have been suitable to
develop a model to assess the spatial variation of this covariate, to see if it was
similar to cryptorchidism relative risks.
8.3.1.2 Genetic predisposition
As seen from the discussion of the analysis, the possible spatial variation of the three
conditions might in part be due to the underlying genetic differences in the Scottish
population. Therefore, genetic information that is geo-referenced would be required
to explore any association with this and the spatial variation in risk of the three
disease/conditions. However, other types of epidemiological studies might be more
appropriate to explore genetic associations.
8.3.1.3 Environmental chemicals exposure
While the TDS hypothesis postulates that male reproductive health has deteriorated
due to increasing exposure to oestrogens and/or anti-androgens, no covariate has
been included in the analysis in relation to 'environmental chemicals'. As discussed
in 3.4.5 the geo-referenced environmental data available to this researcher was
limited, either across Scotland or at appropriate spatial resolution. Further
investigation for data on sources of human exposure to endocrine disrupters across
Scotland is required, as this is the key explanatory factor. As well as those data
discussed in relation to an alternative to the rural/urban indicator used in the research
project (8.2.1.5), other data that stem from the review of potential sources of human
exposure to endocrine disruptors (2.3.2 and Table 2) and the discussion of how these
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potential covariates were identified and selected (3.4.5), would need to be explored
further. Table 51 summarises those data that have been brought my attention since
completion of the analysis was completed that require further investigation.
Table 51 Data requiring investigation on suitability to be included as potential
covariates concerned with sources of human exposure to endocrine
disruptors
Data Description Source
Air Pollution Concentration of chemicals (e.g. sulphur dioxide and
emission data nitrogen oxides) from industrial sites etc. across Scotland -
create emission maps
Air quality Concentrations of air-borne particulates (e.g. nitrogen
data dioxide and sulphur dioxide) from sample sites across
Scotland - create air quality maps
Drinking % of samples failing coliform test (indication of breach of
Water data water supply) - create drinking water quality maps
River Water Digitised River Network (DRN) that classifies quality of a
Quality Data quarter of Scotland's river network (i.e. the major
watercourses). Also contains concentration levels (e.g.
nitrates and orthophosphates) - create river water quality












8.3.1.4 Associations between covariates
Also highlighted by the proposed TDS hypothesis is that a genetic-environmental
interaction might explain the proposed deterioration in male reproductive health.
This highlights that there is probably associations between risk factors which has not
been accounted for in this research project. Not only would there likely to be
associations between the covariates included in the analysis (e.g. deprivation and
rural/urban differences) but also between them and other proposed covariates (e.g.
deprivation and smoking). Therefore, to attempt to fully account for the various risk
factors that might be associated with these conditions, these associations would have
to be included to the Bayesian Hierarchical models.
8.3.2 Other indicators of male reproductive health
This research project included three of the disease/conditions that are believed to
have increased in incidence in the last few decades. The spatial variation of these
three indicators was carried out as the data were collected consistently over
geography and time. However other indicators could have been analysed, as they too
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are believed to have been affected by the same aetiology as testicular cancer,
cryptorchidism and hypospadias.
8.3.2.1 Semen Quality data
As seen in Chapter 2 the previous research that shows a decline in semen quality
over the last few decades remains controversial. While a spatial analysis of semen
quality would not address this issue, the exploration of the semen quality in a country
might, as we have seen in this research project, highlight possible aetiology for
further investigation.
In order for this to be accomplished semen quality data are required from a randomly
selected group of the population. This would mean that the data would hopefully
represent the general population rather than particular sub-groups, so overcoming
criticisms of previous research. As already noted, a population based study of semen
quality has just been completed in Scotland. Spatial analysis of these data could
provide insights into the possible aetiology of semen quality. As with testicular
cancer, semen quality aetiology is complicated by the various potential pathways for
exposure to risk factors, as it is largely only ascertained when men are in their 20's
and 30's. The population based study in Scotland includes information on the various
stages of a man life and looks at the various potential risk factors which could also be
included in any spatial analysis.
However the spatial analysis of the semen quality would have to employ very
different methods from those shown in this research project. While disease data used
here are count data i.e. the number of cases within a particular postcode sector, the
semen quality would be a particular semen quality measurement for a particular
individual at a specific location. Therefore the inclusion of the semen quality to a
multi-indicator model would require further developments in spatial models
methodology.
8.3.2.2 Birth events data
Although not included in the review of previous research concerning male
reproductive health, some studies looking at the changes in sex ratio of births and
numbers of twins have also been used to argue that changes have occurred in these
birth events and that these too are related to the TDS hypothesis.
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Both indicators, twin births (Lloyd et al., 1988;Lloyd, Lloyd, and Holland, 1984) and
sex ratios of live births (Williams, Lawson, and Lloyd, 1992) have been used
previously to assess the impact of air pollution caused by industry on the surrounding
area. Furthermore, these indicators have been used by other authors to support the
TDS hypothesis as it is believed that both are affected by the intrauterine
environment (Moller, 1998). However, as with other anomalies of male reproductive
health there are other factors that are associated with these two indicators that mean
the assessment of their possible aetiologies is complex.
As discussed by Williams et al. (1992) the sex ratio of births (male/female) is not
static and can vary geographically, and can be affected by exposure to pollutants in
the air, by age and blood group of mother, season of the year, exposure to Hepatitis
B, exposure to pollutants in the water and paternal occupation. It is believed that the
mechanisms which cause the ratio to vary are also related to the hormonal levels of
the mother and father. As with the sex ratio, twinning rates are also influenced by
genetic and environments factors such as maternal age, parity, height of mother,
geographical variation, seasonality, genetics and infertility treatment (Derom et al.,
1995). Furthermore, there also appears to be a relationship between sex ratio and
multiple births. Derom et al., (1995) reported that the proportion of males decreases
with each increase in the number of foetuses per pregnancy.
Data on both these birth events are collected consistently over geography and time
and are available at postcode sector level in Scotland. Indeed, the data was requested
as part of the denominator data used for the cryptorchidism and hypospadias relative
risks. Therefore, the investigation of the spatial variation of these two indicators is
possible in Scotland and would add to the analysis already carried out. However, as
with the anomalies analysed in this research project the various other risk factors that
are associated with these events also have to be accounted for.
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8.3.3 Future development in Bayesian Spatial Analysis
There are a number of issues highlighted from the analysis that stem from the
particular Bayesian Hierarchical Model used that require further development.
8.3.3.1 Disease Count Models
As already discussed, the further development of models of disease count models is
required. For example, the spatially correlated heterogeneity term in the BYM model
does appear to over-smooth the heterogeneity. Furthermore, there is evidence that the
Lawson & Clarke model appears to be more appropriate than the BYM model in
particular circumstances (Hossain & Lawson, 2005). This is an emerging field and so
the development of disease count models in a Bayesian context is continuing.
8.3.3.2 Inclusion of Individual level information
The individual level spatial analysis was carried out only on a subset of the
cryptorchidism dataset; and not on the hypospadias and testicular cancer datasets. To
fully assess the impact of individual level information on these three
disease/conditions further, spatial analysis of these potential covariates are required;
not just the covariates included in disease/conditions datasets but also other relevant
individual information e.g. complete data on mother's smoking status, diet and
occupation.
While the cryptorchidism individual level analysis highlights that individual factors
may explain the spatial variation in disease risks it does not give direct relationships
between individual covariates and the spatial variation of cryptorchidism. Therefore,
the development of Bayesian hierarchical disease count models that could include
both individual and area level covariates is a methodological issue which needs to be
resolved. The need to test for the possibility of ecological fallacy is crucial in disease
count models and therefore a model that could include both area and individual
specific covariates would be appropriate. Furthermore, as seen in male reproductive
health research, and applicable to many other areas of health research, there are area
and individual specific risk factors that might explain the spatial variation of these
conditions. Therefore a model that included both area and individual specific
covariates would more realistically reflect the potential aetiology.
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8.3.3.3 Multi-indicator models
An analysis that might give further insight into male reproductive health would be
the development within the multi-indicator model of one measure for all the
indicators. As already discussed, more spatial analyses are now being carried out
jointly on more than one disease. The common burden of disease caused by a
particular environmental factor is not an uncommon aim of research e.g. a putative
health hazard might have an impact on a number of health indicators. Therefore for
the development of a joint measure of more than one disease/condition would
provide insights into the common burden of disease and so aetiology.
8.3.4 Future directions for male reproductive health research
In 2.3.1 the Bradford Hill criteria were used to assess if the Skakkebaek and
colleagues paper that outlined the TDS hypothesis, also proved causality (Hill,
1965;Skakkebaek, Rajpert-De Meyts, and Main, 2001). These criteria can also be
used to assess if this research project has fulfilled the hypothesis that in utero
exposure to oestrogens and/or anti-androgens results in various symptoms of TDS.
This research project was able to show that the three indicators of male reproductive
health have geographical variation and so appear to have geographically varying risk
factors associated with them. Furthermore, as the spatial variation of cryptorchidism
and hypospadias is similar it is likely that they have some common aetiology which
must occur in utero. As the same risk factors were found to be associated with
testicular cancer and the congenital malformations, then this carcinoma appears to
share some aetiology with cryptorchidism and hypospadias. Therefore there are
geographically varying risk factors whose exposure occurs in utero, that are
associated with all three conditions, providing some evidence to support the
proposed hypothesis.
However, the common aetiology of these conditions could not only to be
environmental but also due to genetic and life-style factors, that could pertain to the
individual cases rather than the specific area. Furthermore, the limitations of the
potential covariates used in the research project mean that further analysis with more
robust data is required. Therefore, while this research project lends some argument
that in utero risk factors are associated with these conditions it was not able to prove
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causality i.e. in utero exposure to environmental oestrogens/anti-androgens results in
various symptoms of TDS.
This research project aim was only to indicate potential explanatory factors and in
order to fully assess associations between possible factors and these
disease/conditions further studies are required.
Further studies are required that look at the overall burden of male reproductive
health disease i.e. all conditions based on good quality data. This research project
appears to be the first of its kind to assess several indicators of male reproductive
heath jointly, but more are required to fully explore potential explanatory factors and
the common aetiology of these disease/conditions.
Although there appears to be studies that attempt to estimate semen quality on a
representative sample of the population, more are required. These studies would not
only provide an estimate of semen quality that would overcome some of the
limitations of previous work but provide an estimate of a current birth cohort. This
cohort could then be compared with another cohort selected in the future so as to
assess if there are temporal trends in semen quality. Furthermore, these population
studies could be used to explore possible aetiology of semen quality and give a
consensus on conclusions based on data where some of the limitations of previous
work have been minimised.
As mentioned earlier there might be under-reporting of cryptorchidism and
hypospadias in these datasets as cases have not been identified at birth. The need for
high quality, consistently collected data on congenital anomalies is one that would
not only assist in future work on male reproductive health but other aspects of
epidemiology. While logistically this is not straightforward, developments of
national congenital registers is currently underway at ISD.
Although not highlighted by this research project the final suggestion for future
research on male reproductive health stems from the assessment of current research
and is a key issue. Further work is required to explain and describe the biological
mechanisms between environmental oestrogens and/or anti-androgens and the
anomalies of male reproductive health. In particular, to show the relationship
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between in utero exposure to oestrogens and/or anti-androgens and the male
reproductive health anomalies. One possible study would be to assess the foetal
environment and follow up for the subsequent outcomes. The ethical and practical
obstacles to this type of study would be substantial. However, there is a potential
source for these data. The Avon Longitudinal Study of Parents and Children
(ALSPAC - www.alspac.bris.ac.uk) is a birth cohort study that has data both from
children and parents. This source of data would potentially include all elements that
might be associated with the conditions and so fully assess the possibly multifaceted
aetiology. Until research is carried that looks at all the potential pathways and
mechanisms to these conditions ofmale reproductive health then the TDS hypothesis
will remain just that, a hypothesis.
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File format of hypospadias and cryptorchidism datasetAppendix 1
Description
Year and month of birth of baby





Diagnosis Code of Interest 1
Diagnosis Code of Interest 2
Diagnosis Code of Interest 3
Year and month of birth ofmother
Sex of baby 1
Sex of baby 2




99999 = missing postcode sector
ICD9/10 coding dependent on date of birth
ICD9/10 coding dependent on date of birth
ICD9/10 coding dependent on date ofbirth
0=Not Known, l=Male, 2=Female,
8=Other or not known, 9=Not specified
As baby 1
As baby I - not on records prior to April 1997
0=Not Applicable, l=Certain
2=Uncertain, 9=Not known
0=No, l=Yes, 9=Not known
This field is not mandatory
From 1981
1= Home with mother
2=Home with mother
3=To care of relative
4=Transfer to other ward or hospital (medical)
5= Transfer to other ward or hospital (surgery)







3=To care of relative




Condition on discharge 9=Not known





5=To other hosp with mother





1 l=Discharge from NHS Care
12=Transfer within the same provide unit
13=Transfer to another provide unit
18=Other type pf regular discharge
40=Death no additional detail
41= Death (PM)
Appendices
Spatial Epidemiology of Indicators of Male Reproductive Health in Scotland
Appendix 2 File format of testicular cancer dataset
Description Notes
Year and month of birth of baby
Cancer Incidence date
Cancer Diagnostic Code
Morphology (histology) of the tumour
Hospital or GP of diagnosis
Postcode sector of registration
Deprivation category (5) - 1991 Census
Deprivation category (7) - 1991 Census
Deprivation category (5)- 1981 Census
Deprivation category (7)- 1981 Census
Year and month date of Death
Full date
As detailed in 3.4.2
First 4 digits of the 1CD-0 or lCD-0(2) morphology
code dependent on if ICD9 or ICD10 diagnostic code
Prior 1997 this field only contain hospital codes
Via Postcode at registration
1 = least deprived, 5 = most deprived, 9 = not known
Via Postcode at registration
1 = least deprived, 7 = most deprived, 9 = not known
Via Postcode at registration
1 = least deprived, 5 = most deprived, 9 = not known
Via Postcode at registration
1 = least deprived, 7 = most deprived, 9 = not known
From linked death records (only available from
1981)
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